Country Name,Country Code,Indicator Name,Indicator Code,1960,1961,1962,1963,1964,1965,1966,1967,1968,1969,1970,1971,1972,1973,1974,1975,1976,1977,1978,1979,1980,1981,1982,1983,1984,1985,1986,1987,1988,1989,1990,1991,1992,1993,1994,1995,1996,1997,1998,1999,2000,2001,2002,2003,2004,2005,2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021
Aruba,ABW,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.9153976,70.8105388,71.70568,72.2839554,72.8622308,73.4405062,74.0187816,74.597057,75.5041962,76.4113354,77.3184746,78.2256138,79.132753,79.7013808,80.2700086,80.8386364,81.4072642,81.975892,82.2639768,82.5520616,82.8401464,83.1282312,83.416316,83.5971108,83.7779056,83.9587004,84.1394952,84.32029,84.379384,84.438478,84.497572,84.556666,84.61576,84.6742388,84.7327176,84.7911964,84.8496752,84.908154,84.9633444,85.0185348,85.0737252,85.1289156,85.184106,85.3831966,85.5822872,85.7813778,85.9804684,86.179559,86.3573188,86.5350786,86.7128384,86.8905982,87.068358,87.2402536,87.4121492,87.5840448,87.7559404,87.927836,88.0852474,88.2426588,88.4000702,
Africa Eastern and Southern,AFE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,37.33819856,37.95732921,38.56967733,39.07897192,39.59134695,40.10979881,40.6362323,41.16719006,41.69929532,42.23035362,42.75808621,43.28988565,43.81706946,44.27275109,44.72623326,45.17894476,45.6315181,46.08397494,46.41133044,46.74310976,47.07788643,47.43194099,47.78244936,48.13905392,48.49169484,48.84041261,49.19022636,49.53539495,49.32011971,49.09883108,48.88038896,48.70248616,48.54728352,48.16944258,47.7628454,47.32819271,46.88187835,46.4237766,46.35937488,46.29676348,46.23879172,46.19245713,46.15654398,47.3528578,48.55441859,49.76109113,50.97323189,52.19230738,53.97901812,55.75849003,57.53130323,59.29961163,61.06277671,62.13396222,63.2024519,64.26828036,65.33373827,66.39726906,66.92631138,67.45408678,67.98039496,
Afghanistan,AFG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,21.4780472,22.1057936,22.73354,23.331085,23.92863,24.526175,25.12372,25.721265,26.3893846,27.0575042,27.7256238,28.3937434,29.061863,29.8381722,30.6144814,31.3907906,32.1670998,32.943409,33.8757898,34.8081706,35.7405514,36.6729322,37.605313,38.6634362,39.7215594,40.7796826,41.8378058,42.895929,43.8678956,44.8398622,45.8118288,46.7837954,47.755762,48.599696,49.44363,50.287564,51.131498,51.975432,52.6949104,53.4143888,54.1338672,54.8533456,55.572824,56.429403,57.285982,58.142561,58.99914,59.855719,60.7424844,61.6292498,62.5160152,63.4027806,64.289546,64.946512,65.603478,66.260444,66.91741,67.574376,68.161778,68.74918,69.336582,
Africa Western and Central,AFW,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.64022747,30.20977803,30.78164754,31.30802391,31.8317027,32.35170598,32.87217299,33.38954186,34.05270496,34.71594311,35.38017283,36.05215111,36.72404555,37.46195614,38.19913728,38.93539602,39.67295161,40.4085359,41.07687703,41.74508512,42.41448295,43.09505692,43.77682719,44.11449591,44.45207016,44.78809731,45.12400953,45.457202,45.55375021,45.65011881,45.74768191,45.85107336,45.9562931,45.70100532,45.44155195,45.17821728,44.91589763,44.65103919,44.6706913,44.68736864,44.70222072,44.72021826,44.73857141,45.53918537,46.3399303,47.14122634,47.94833394,48.75514603,49.51550564,50.27515952,51.03395084,51.79230022,52.55029609,53.27914723,54.00521176,54.72854316,55.45267228,56.17453278,56.69840927,57.22158626,57.74457637,
Angola,AGO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,30.30936,30.660013,31.010666,31.4477962,31.8849264,32.3220566,32.7591868,33.196317,33.6620282,34.1277394,34.5934506,35.0591618,35.524873,35.9742048,36.4235366,36.8728684,37.3222002,37.771532,38.110529,38.449526,38.788523,39.12752,39.466517,39.6502826,39.8340482,40.0178138,40.2015794,40.385345,40.4101276,40.4349102,40.4596928,40.4844754,40.509258,40.6790884,40.8489188,41.0187492,41.1885796,41.35841,42.0462474,42.7340848,43.4219222,44.1097596,44.797597,46.1644822,47.5313674,48.8982526,50.2651378,51.632023,53.2021724,54.7723218,56.3424712,57.9126206,59.48277,60.3193652,61.1559604,61.9925556,62.8291508,63.665746,64.186799,64.707852,65.228905,
Albania,ALB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,68.0644458,69.8695254,71.674605,71.9995106,72.3244162,72.6493218,72.9742274,73.299133,73.9002482,74.5013634,75.1024786,75.7035938,76.304709,76.8612656,77.4178222,77.9743788,78.5309354,79.087492,79.6918406,80.2961892,80.9005378,81.5048864,82.109235,82.763607,83.417979,84.072351,84.726723,85.381095,85.335072,85.289049,85.243026,85.197003,85.15098,85.4004566,85.6499332,85.8994098,86.1488864,86.398363,86.806862,87.215361,87.62386,88.032359,88.440858,88.605522,88.770186,88.93485,89.099514,89.264178,89.609936,89.955694,90.301452,90.64721,90.992968,91.0234534,91.0539388,91.0844242,91.1149096,91.145395,91.2225726,91.2997502,91.3769278,
Andorra,AND,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Arab World,ARB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.51643543,45.25295462,45.9982189,46.81638473,47.63317486,48.44693975,49.26161208,50.0723254,50.83102865,51.59271193,52.35784107,53.13217417,53.90900284,54.83053232,55.73600589,56.62185513,57.47861541,58.31540843,59.35539107,60.4045465,61.47064633,62.56988126,63.68770911,64.5976044,65.50584741,66.40652888,67.29953032,68.18548664,68.78642235,69.38459068,70.01484158,70.62550662,71.13188134,71.69817649,72.2601306,72.89048478,73.452583,74.00733111,74.39575389,74.77817803,75.15556809,75.52934575,75.89971638,76.34549529,76.79082427,77.23737839,77.70142447,78.16466591,78.47626521,78.78015952,79.07521914,79.36210851,79.6430749,79.89905965,80.1462995,80.38648243,80.62138948,80.85155372,81.06349325,81.27677829,81.49403159,
United Arab Emirates,ARE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,52.736516,53.913675,55.090834,56.3029546,57.5150752,58.7271958,59.9393164,61.151437,62.289207,63.426977,64.564747,65.702517,66.840287,67.733021,68.625755,69.518489,70.411223,71.303957,71.976098,72.648239,73.32038,73.992521,74.664662,75.168563,75.672464,76.176365,76.680266,77.184167,77.6024672,78.0207674,78.4390676,78.8573678,79.275668,79.6592108,80.0427536,80.4262964,80.8098392,81.193382,81.7361232,82.2788644,82.8216056,83.3643468,83.907088,84.2595604,84.6120328,84.9645052,85.3169776,85.66945,86.0049838,86.3405176,86.6760514,87.0115852,87.347119,87.634559,87.921999,88.209439,88.496879,88.784319,88.9439466,89.1035742,89.2632018,
Argentina,ARG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,71.8853156,72.4272218,72.969128,73.2342536,73.4993792,73.7645048,74.0296304,74.294756,74.6994426,75.1041292,75.5088158,75.9135024,76.318189,76.7196626,77.1211362,77.5226098,77.9240834,78.325557,78.7422966,79.1590362,79.5757758,79.9925154,80.409255,80.6213588,80.8334626,81.0455664,81.2576702,81.469774,81.6295872,81.7894004,81.9492136,82.1090268,82.26884,82.483726,82.698612,82.913498,83.128384,83.34327,83.5419286,83.7405872,83.9392458,84.1379044,84.336563,84.520485,84.704407,84.888329,85.072251,85.256173,85.4267028,85.5972326,85.7677624,85.9382922,86.108822,86.2671692,86.4255164,86.5838636,86.7422108,86.900558,87.0438168,87.1870756,87.3303344,
Armenia,ARM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,73.3827262,74.0824806,74.782235,75.3744994,75.9667638,76.5590282,77.1512926,77.743557,78.1348604,78.5261638,78.9174672,79.3087706,79.700074,79.6659536,79.6318332,79.5977128,79.5635924,79.529472,79.589854,79.650236,79.710618,79.771,79.831382,78.848331,77.86528,76.882229,75.899178,74.916127,75.2798112,75.6434954,76.0071796,76.3708638,76.734548,77.2885136,77.8424792,78.3964448,78.9504104,79.504376,80.2451324,80.9858888,81.7266452,82.4674016,83.208158,83.3246414,83.4411248,83.5576082,83.6740916,83.790575,84.1840484,84.5775218,84.9709952,85.3644686,85.757942,86.2334166,86.7088912,87.1843658,87.6598404,88.135315,88.2750314,88.4147478,88.5544642,
American Samoa,ASM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Antigua and Barbuda,ATG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.3115062,64.2429066,65.174307,65.9071062,66.6399054,67.3727046,68.1055038,68.838303,69.2750714,69.7118398,70.1486082,70.5853766,71.022145,71.552361,72.082577,72.612793,73.143009,73.673225,74.3499182,75.0266114,75.7033046,76.3799978,77.056691,77.6538874,78.2510838,78.8482802,79.4454766,80.042673,80.3404462,80.6382194,80.9359926,81.2337658,81.531539,81.8257818,82.1200246,82.4142674,82.7085102,83.002753,83.3456344,83.6885158,84.0313972,84.3742786,84.71716,84.9797006,85.2422412,85.5047818,85.7673224,86.029863,86.0901376,86.1504122,86.2106868,86.2709614,86.331236,86.3464152,86.3615944,86.3767736,86.3919528,86.407132,86.5828732,86.7586144,86.9343556,
Australia,AUS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.4014436,80.5443408,80.687238,80.67864,80.670042,80.661444,80.652846,80.644248,80.9260326,81.2078172,81.4896018,81.7713864,82.053171,82.5451122,83.0370534,83.5289946,84.0209358,84.512877,84.9087576,85.3046382,85.7005188,86.0963994,86.49228,86.7657914,87.0393028,87.3128142,87.5863256,87.859837,88.167146,88.474455,88.781764,89.089073,89.396382,89.5987924,89.8012028,90.0036132,90.2060236,90.408434,90.6336584,90.8588828,91.0841072,91.3093316,91.534556,91.6890052,91.8434544,91.9979036,92.1523528,92.306802,92.4045604,92.5023188,92.6000772,92.6978356,92.795594,92.928301,93.061008,93.193715,93.326422,93.459129,93.5613138,93.6634986,93.7656834,
Austria,AUT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.0217154,79.5174142,80.013113,80.2069258,80.4007386,80.5945514,80.7883642,80.982177,81.2403296,81.4984822,81.7566348,82.0147874,82.27294,82.6228924,82.9728448,83.3227972,83.6727496,84.022702,84.285015,84.547328,84.809641,85.071954,85.334267,85.745908,86.157549,86.56919,86.980831,87.392472,87.6061846,87.8198972,88.0336098,88.2473224,88.461035,88.7219274,88.9828198,89.2437122,89.5046046,89.765497,89.9608984,90.1562998,90.3517012,90.5471026,90.742504,90.9222246,91.1019452,91.2816658,91.4613864,91.641107,91.7274724,91.8138378,91.9002032,91.9865686,92.072934,92.1627908,92.2526476,92.3425044,92.4323612,92.522218,92.6650272,92.8078364,92.9506456,
Azerbaijan,AZE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,71.4108562,71.6064996,71.802143,71.9805366,72.1589302,72.3373238,72.5157174,72.694111,72.8203714,72.9466318,73.0728922,73.1991526,73.325413,73.3299634,73.3345138,73.3390642,73.3436146,73.348165,73.3643044,73.3804438,73.3965832,73.4127226,73.428862,73.5307106,73.6325592,73.7344078,73.8362564,73.938105,74.031642,74.125179,74.218716,74.312253,74.40579,74.7063566,75.0069232,75.3074898,75.6080564,75.908623,76.0442158,76.1798086,76.3154014,76.4509942,76.586587,77.5153338,78.4440806,79.3728274,80.3015742,81.230321,81.539424,81.848527,82.15763,82.466733,82.775836,82.9828526,83.1898692,83.3968858,83.6039024,83.810919,83.9783186,84.1457182,84.3131178,
Burundi,BDI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.0869686,35.5001748,35.913381,36.3297112,36.7460414,37.1623716,37.5787018,37.995032,38.1921426,38.3892532,38.5863638,38.7834744,38.980585,39.25306,39.525535,39.79801,40.070485,40.34296,40.448071,40.553182,40.658293,40.763404,40.868515,40.987752,41.106989,41.226226,41.345463,41.4647,41.0544824,40.6442648,40.2340472,39.8238296,39.413612,39.4542096,39.4948072,39.5354048,39.5760024,39.6166,40.8590984,42.1015968,43.3440952,44.5865936,45.829092,47.2662854,48.7034788,50.1406722,51.5778656,53.015059,54.0938096,55.1725602,56.2513108,57.3300614,58.408812,59.0422542,59.6756964,60.3091386,60.9425808,61.576023,62.1553096,62.7345962,63.3138828,
Belgium,BEL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.2092106,80.5571528,80.905095,81.0359076,81.1667202,81.2975328,81.4283454,81.559158,81.7885954,82.0180328,82.2474702,82.4769076,82.706345,83.007252,83.308159,83.609066,83.909973,84.21088,84.5067472,84.8026144,85.0984816,85.3943488,85.690216,86.011714,86.333212,86.65471,86.976208,87.297706,87.5214052,87.7451044,87.9688036,88.1925028,88.416202,88.5714952,88.7267884,88.8820816,89.0373748,89.192668,89.31803,89.443392,89.568754,89.694116,89.819478,89.9294194,90.0393608,90.1493022,90.2592436,90.369185,90.48243,90.595675,90.70892,90.822165,90.93541,91.0624592,91.1895084,91.3165576,91.4436068,91.570656,91.6810834,91.7915108,91.9019382,
Benin,BEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,28.4387576,29.0950468,29.751336,30.6165584,31.4817808,32.3470032,33.2122256,34.077448,35.1594608,36.2414736,37.3234864,38.4054992,39.487512,40.4819738,41.4764356,42.4708974,43.4653592,44.459821,45.1089368,45.7580526,46.4071684,47.0562842,47.7054,48.7188514,49.7323028,50.7457542,51.7592056,52.772657,53.5083764,54.2440958,54.9798152,55.7155346,56.451254,56.2102822,55.9693104,55.7283386,55.4873668,55.246395,55.4399402,55.6334854,55.8270306,56.0205758,56.214121,56.8810236,57.5479262,58.2148288,58.8817314,59.548634,59.9402624,60.3318908,60.7235192,61.1151476,61.506776,61.9508874,62.3949988,62.8391102,63.2832216,63.727333,64.2169872,64.7066414,65.1962956,
Burkina Faso,BFA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,26.6841104,27.2999862,27.915862,28.5550452,29.1942284,29.8334116,30.4725948,31.111778,31.773027,32.434276,33.095525,33.756774,34.418023,35.3485418,36.2790606,37.2095794,38.1400982,39.070617,40.6547088,42.2388006,43.8228924,45.4069842,46.991076,47.1799308,47.3687856,47.5576404,47.7464952,47.93535,47.7880312,47.6407124,47.4933936,47.3460748,47.198756,47.3518328,47.5049096,47.6579864,47.8110632,47.96414,48.2688774,48.5736148,48.8783522,49.1830896,49.487827,50.3190202,51.1502134,51.9814066,52.8125998,53.643793,54.569029,55.494265,56.419501,57.344737,58.269973,59.0135844,59.7571958,60.5008072,61.2444186,61.98803,62.6870182,63.3860064,64.0849946,
Bangladesh,BGD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.2941512,39.0358496,39.777548,40.4049908,41.0324336,41.6598764,42.2873192,42.914762,42.4829798,42.0511976,41.6194154,41.1876332,40.755851,42.2728818,43.7899126,45.3069434,46.8239742,48.341005,49.0414066,49.7418082,50.4422098,51.1426114,51.843013,52.7217128,53.6004126,54.4791124,55.3578122,56.236512,57.2314528,58.2263936,59.2213344,60.2162752,61.211216,62.255883,63.30055,64.345217,65.389884,66.434551,67.2322976,68.0300442,68.8277908,69.6255374,70.423284,71.132092,71.8409,72.549708,73.258516,73.967324,74.586759,75.206194,75.825629,76.445064,77.064499,77.4911494,77.9177998,78.3444502,78.7711006,79.197751,79.5995176,80.0012842,80.4030508,
Bulgaria,BGR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.3956298,78.4014844,79.407339,79.7500548,80.0927706,80.4354864,80.7782022,81.120918,81.2838786,81.4468392,81.6097998,81.7727604,81.935721,82.0133646,82.0910082,82.1686518,82.2462954,82.323939,82.4132854,82.5026318,82.5919782,82.6813246,82.770671,82.882219,82.993767,83.105315,83.216863,83.328411,83.2935608,83.2587106,83.2238604,83.1890102,83.15416,83.102722,83.051284,82.999846,82.948408,82.89697,83.1901448,83.4833196,83.7764944,84.0696692,84.362844,84.565565,84.768286,84.971007,85.173728,85.376449,85.5417354,85.7070218,85.8723082,86.0375946,86.202881,86.2686724,86.3344638,86.4002552,86.4660466,86.531838,86.6871608,86.8424836,86.9978064,
Bahrain,BHR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,54.9112074,56.6033182,58.295429,59.7498342,61.2042394,62.6586446,64.1130498,65.567455,66.6849414,67.8024278,68.9199142,70.0374006,71.154887,71.9719044,72.7889218,73.6059392,74.4229566,75.239974,75.837743,76.435512,77.033281,77.63105,78.228819,78.643924,79.059029,79.474134,79.889239,80.304344,80.6644574,81.0245708,81.3846842,81.7447976,82.104911,82.4612478,82.8175846,83.1739214,83.5302582,83.886595,84.2204718,84.5543486,84.8882254,85.2221022,85.555979,85.873391,86.190803,86.508215,86.825627,87.143039,87.3312438,87.5194486,87.7076534,87.8958582,88.084063,88.2657154,88.4473678,88.6290202,88.8106726,88.992325,89.1450618,89.2977986,89.4505354,
"Bahamas, The",BHS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.6800356,65.9732388,66.266442,66.6243292,66.9822164,67.3401036,67.6979908,68.055878,68.654041,69.252204,69.850367,70.44853,71.046693,71.5416464,72.0365998,72.5315532,73.0265066,73.52146,73.779691,74.037922,74.296153,74.554384,74.812615,75.2545184,75.6964218,76.1383252,76.5802286,77.022132,77.1163134,77.2104948,77.3046762,77.3988576,77.493039,77.4332382,77.3734374,77.3136366,77.2538358,77.194035,77.500285,77.806535,78.112785,78.419035,78.725285,78.9294952,79.1337054,79.3379156,79.5421258,79.746336,79.9260174,80.1056988,80.2853802,80.4650616,80.644743,80.9725796,81.3004162,81.6282528,81.9560894,82.283926,82.4683624,82.6527988,82.8372352,
Bosnia and Herzegovina,BIH,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.4670784,65.4542232,66.441368,67.2887384,68.1361088,68.9834792,69.8308496,70.67822,71.5231382,72.3680564,73.2129746,74.0578928,74.902811,75.6602088,76.4176066,77.1750044,77.9324022,78.6898,79.0063544,79.3229088,79.6394632,79.9560176,80.272572,80.550525,80.828478,81.106431,81.384384,81.662337,81.6141016,81.5658662,81.5176308,81.4693954,81.42116,82.016583,82.612006,83.207429,83.802852,84.398275,84.7869062,85.1755374,85.5641686,85.9527998,86.341431,86.5118762,86.6823214,86.8527666,87.0232118,87.193657,87.5045348,87.8154126,88.1262904,88.4371682,88.748046,88.917573,89.0871,89.256627,89.426154,89.595681,89.7425306,89.8893802,90.0362298,
Belarus,BLR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.1750112,76.9740826,77.773154,78.2407578,78.7083616,79.1759654,79.6435692,80.111173,80.3042204,80.4972678,80.6903152,80.8833626,81.07641,81.1349648,81.1935196,81.2520744,81.3106292,81.369184,81.3932484,81.4173128,81.4413772,81.4654416,81.489506,81.7802088,82.0709116,82.3616144,82.6523172,82.94302,82.6157008,82.2883816,81.9610624,81.6337432,81.306424,80.8374616,80.3684992,79.8995368,79.4305744,78.961612,79.0353388,79.1090656,79.1827924,79.2565192,79.330246,79.7872588,80.2442716,80.7012844,81.1582972,81.61531,82.3560634,83.0968168,83.8375702,84.5783236,85.319077,85.8408472,86.3626174,86.8843876,87.4061578,87.927928,88.064965,88.202002,88.339039,
Belize,BLZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.059581,61.944398,62.829215,63.724561,64.619907,65.515253,66.410599,67.305945,68.1572476,69.0085502,69.8598528,70.7111554,71.562458,72.3370148,73.1115716,73.8861284,74.6606852,75.435242,75.9968932,76.5585444,77.1201956,77.6818468,78.243498,78.6483688,79.0532396,79.4581104,79.8629812,80.267852,79.9021786,79.5365052,79.1708318,78.8051584,78.439485,78.0634832,77.6874814,77.3114796,76.9354778,76.559476,76.7279792,76.8964824,77.0649856,77.2334888,77.401992,77.5677796,77.7335672,77.8993548,78.0651424,78.23093,78.5634408,78.8959516,79.2284624,79.5609732,79.893484,80.3139564,80.7344288,81.1549012,81.5753736,81.995846,82.1712418,82.3466376,82.5220334,
Bermuda,BMU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bolivia,BOL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,37.689005,38.122685,38.556365,39.0641974,39.5720298,40.0798622,40.5876946,41.095527,41.6811194,42.2667118,42.8523042,43.4378966,44.023489,44.6864712,45.3494534,46.0124356,46.6754178,47.3384,48.0731084,48.8078168,49.5425252,50.2772336,51.011942,51.8065776,52.6012132,53.3958488,54.1904844,54.98512,55.8217384,56.6583568,57.4949752,58.3315936,59.168212,60.0235612,60.8789104,61.7342596,62.5896088,63.444958,64.244624,65.04429,65.843956,66.643622,67.443288,68.1173842,68.7914804,69.4655766,70.1396728,70.813769,71.4069106,72.0000522,72.5931938,73.1863354,73.779477,74.1798554,74.5802338,74.9806122,75.3809906,75.781369,76.1184064,76.4554438,76.7924812,
Brazil,BRA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,52.4505066,53.3454478,54.240389,55.1061846,55.9719802,56.8377758,57.7035714,58.569367,59.341933,60.114499,60.887065,61.659631,62.432197,63.0909778,63.7497586,64.4085394,65.0673202,65.726101,66.3094304,66.8927598,67.4760892,68.0594186,68.642748,69.192131,69.741514,70.290897,70.84028,71.389663,71.95451,72.519357,73.084204,73.649051,74.213898,74.8425956,75.4712932,76.0999908,76.7286884,77.357386,77.8699734,78.3825608,78.8951482,79.4077356,79.920323,80.3516264,80.7829298,81.2142332,81.6455366,82.07684,82.3929576,82.7090752,83.0251928,83.3413104,83.657428,83.9189164,84.1804048,84.4418932,84.7033816,84.96487,85.1678924,85.3709148,85.5739372,
Barbados,BRB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.9778726,71.0119438,72.046015,72.6622008,73.2783866,73.8945724,74.5107582,75.126944,75.4009934,75.6750428,75.9490922,76.2231416,76.497191,77.108668,77.720145,78.331622,78.943099,79.554576,80.0194958,80.4844156,80.9493354,81.4142552,81.879175,82.0658782,82.2525814,82.4392846,82.6259878,82.812691,82.8762704,82.9398498,83.0034292,83.0670086,83.130588,83.2928518,83.4551156,83.6173794,83.7796432,83.941907,84.0154208,84.0889346,84.1624484,84.2359622,84.309476,84.4210422,84.5326084,84.6441746,84.7557408,84.867307,84.9502116,85.0331162,85.1160208,85.1989254,85.28183,85.3813936,85.4809572,85.5805208,85.6800844,85.779648,85.90178,86.023912,86.146044,
Brunei Darussalam,BRN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,52.7882008,53.8968164,55.005432,55.9096836,56.8139352,57.7181868,58.6224384,59.52669,60.5370266,61.5473632,62.5576998,63.5680364,64.578373,65.4830202,66.3876674,67.2923146,68.1969618,69.101609,69.8471394,70.5926698,71.3382002,72.0837306,72.829261,73.415125,74.000989,74.586853,75.172717,75.758581,76.3517314,76.9448818,77.5380322,78.1311826,78.724333,79.2002262,79.6761194,80.1520126,80.6279058,81.103799,81.4102562,81.7167134,82.0231706,82.3296278,82.636085,82.7681672,82.9002494,83.0323316,83.1644138,83.296496,83.395057,83.493618,83.592179,83.69074,83.789301,83.8677134,83.9461258,84.0245382,84.1029506,84.181363,84.3902656,84.5991682,84.8080708,
Bhutan,BTN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,22.2027746,22.5547948,22.906815,23.5036272,24.1004394,24.6972516,25.2940638,25.890876,26.5493036,27.2077312,27.8661588,28.5245864,29.183014,29.7603356,30.3376572,30.9149788,31.4923004,32.069622,32.9883004,33.9069788,34.8256572,35.7443356,36.663014,37.5998124,38.5366108,39.4734092,40.4102076,41.347006,42.4141974,43.4813888,44.5485802,45.6157716,46.682963,47.7908348,48.8987066,50.0065784,51.1144502,52.222322,53.542706,54.86309,56.183474,57.503858,58.824242,59.9608192,61.0973964,62.2339736,63.3705508,64.507128,65.1105592,65.7139904,66.3174216,66.9208528,67.524284,68.1964664,68.8686488,69.5408312,70.2130136,70.885196,71.414696,71.944196,72.473696,
Botswana,BWA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.2205084,47.9044522,48.588396,49.243928,49.89946,50.554992,51.210524,51.866056,52.4969978,53.1279396,53.7588814,54.3898232,55.020765,55.8728016,56.7248382,57.5768748,58.4289114,59.280948,59.9411636,60.6013792,61.2615948,61.9218104,62.582026,62.9727034,63.3633808,63.7540582,64.1447356,64.535413,62.484261,60.433109,58.381957,56.330805,54.279653,52.1918302,50.1040074,48.0161846,45.9283618,43.840539,42.4639712,41.0874034,39.7108356,38.3342678,36.9577,39.0614946,41.1652892,43.2690838,45.3728784,47.476673,51.1244968,54.7723206,58.4201444,62.0679682,65.715792,67.722395,69.728998,71.735601,73.742204,75.748807,76.0065802,76.2643534,76.5221266,
Central African Republic,CAF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.1221118,29.7052714,30.288431,31.0321326,31.7758342,32.5195358,33.2632374,34.006939,35.1023698,36.1978006,37.2932314,38.3886622,39.484093,40.5603714,41.6366498,42.7129282,43.7892066,44.865485,45.380123,45.894761,46.409399,46.924037,47.438675,47.2931594,47.1476438,47.0021282,46.8566126,46.711097,45.8363238,44.9615506,44.0867774,43.2120042,42.337231,40.8737782,39.4103254,37.9468726,36.4834198,35.019967,34.1955312,33.3710954,32.5466596,31.7222238,30.897788,31.6815974,32.4654068,33.2492162,34.0330256,34.816835,35.848615,36.880395,37.912175,38.943955,39.975735,41.428307,42.880879,44.333451,45.786023,47.238595,47.7429616,48.2473282,48.7516948,
Canada,CAN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.5161652,80.8871096,81.258054,81.4743012,81.6905484,81.9067956,82.1230428,82.33929,82.5683108,82.7973316,83.0263524,83.2553732,83.484394,83.7960394,84.1076848,84.4193302,84.7309756,85.042621,85.3779586,85.7132962,86.0486338,86.3839714,86.719309,86.9386124,87.1579158,87.3772192,87.5965226,87.815826,87.995797,88.175768,88.355739,88.53571,88.715681,88.8773768,89.0390726,89.2007684,89.3624642,89.52416,89.6765242,89.8288884,89.9812526,90.1336168,90.285981,90.4177182,90.5494554,90.6811926,90.8129298,90.944667,91.1181934,91.2917198,91.4652462,91.6387726,91.812299,91.8826254,91.9529518,92.0232782,92.0936046,92.163931,92.2575774,92.3512238,92.4448702,
Central Europe and the Baltics,CEB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.30456841,77.23529534,78.16445332,78.44596873,78.72916875,79.01373759,79.29442843,79.57399624,79.78679149,80.00085969,80.21150863,80.42749857,80.6434804,80.75980316,80.87676166,80.99379602,81.10955289,81.22931892,81.2607098,81.29179517,81.32069525,81.34863386,81.37423065,81.46016504,81.5464331,81.63370852,81.72039024,81.80933281,81.91728791,82.0258029,82.13372629,82.24422288,82.354057,82.61921274,82.88640415,83.15300813,83.41696658,83.68638721,84.04252641,84.39645548,84.74151583,85.09946186,85.4632769,85.69436096,85.92442042,86.15547437,86.38638735,86.62042282,86.92489465,87.22564782,87.52352204,87.82077699,88.11690339,88.31293787,88.5088673,88.7049821,88.90228677,89.09949584,89.23599224,89.37236247,89.50817477,
Switzerland,CHE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,81.8855948,82.2977284,82.709862,83.0059962,83.3021304,83.5982646,83.8943988,84.190533,84.5139758,84.8374186,85.1608614,85.4843042,85.807747,86.160105,86.512463,86.864821,87.217179,87.569537,87.7580994,87.9466618,88.1352242,88.3237866,88.512349,88.7357158,88.9590826,89.1824494,89.4058162,89.629183,89.729584,89.829985,89.930386,90.030787,90.131188,90.3126926,90.4941972,90.6757018,90.8572064,91.038711,91.1902128,91.3417146,91.4932164,91.6447182,91.79622,91.9576614,92.1191028,92.2805442,92.4419856,92.603427,92.7610566,92.9186862,93.0763158,93.2339454,93.391575,93.5048256,93.6180762,93.7313268,93.8445774,93.957828,94.0561438,94.1544596,94.2527754,
Channel Islands,CHI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.8509758,81.0679024,81.284829,81.55315,81.821471,82.089792,82.358113,82.626434,82.781353,82.936272,83.091191,83.24611,83.401029,83.6204084,83.8397878,84.0591672,84.2785466,84.497926,84.808013,85.1181,85.428187,85.738274,86.048361,86.2584458,86.4685306,86.6786154,86.8887002,87.098785,87.3469268,87.5950686,87.8432104,88.0913522,88.339494,88.7617654,89.1840368,89.6063082,90.0285796,90.450851,90.7141312,90.9774114,91.2406916,91.5039718,91.767252,92.0199436,92.2726352,92.5253268,92.7780184,93.03071,93.1495542,93.2683984,93.3872426,93.5060868,93.624931,93.725129,93.825327,93.925525,94.025723,94.125921,94.210822,94.295723,94.380624,
Chile,CHL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.091698,59.768999,60.4463,61.176627,61.906954,62.637281,63.367608,64.097935,65.0754482,66.0529614,67.0304746,68.0079878,68.985501,70.0642768,71.1430526,72.2218284,73.3006042,74.37938,75.3462588,76.3131376,77.2800164,78.2468952,79.213774,79.757965,80.302156,80.846347,81.390538,81.934729,82.5056394,83.0765498,83.6474602,84.2183706,84.789281,85.1159296,85.4425782,85.7692268,86.0958754,86.422524,86.7075514,86.9925788,87.2776062,87.5626336,87.847661,88.0666284,88.2855958,88.5045632,88.7235306,88.942498,89.132558,89.322618,89.512678,89.702738,89.892798,89.9286714,89.9645448,90.0004182,90.0362916,90.072165,90.1646294,90.2570938,90.3495582,
China,CHN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.1245156,36.1748108,36.225106,39.7704574,43.3158088,46.8611602,50.4065116,53.951863,56.0663408,58.1808186,60.2952964,62.4097742,64.524252,65.9016684,67.2790848,68.6565012,70.0339176,71.411334,72.1458272,72.8803204,73.6148136,74.3493068,75.0838,75.5313082,75.9788164,76.4263246,76.8738328,77.321341,77.5804754,77.8396098,78.0987442,78.3578786,78.617013,78.9832248,79.3494366,79.7156484,80.0818602,80.448072,80.8674596,81.2868472,81.7062348,82.1256224,82.54501,83.005911,83.466812,83.927713,84.388614,84.849515,85.3211408,85.7927666,86.2643924,86.7360182,87.207644,87.5392486,87.8708532,88.2024578,88.5340624,88.865667,89.0280694,89.1904718,89.3528742,
Cote d'Ivoire,CIV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.4578564,30.4283982,31.39894,32.2157052,33.0324704,33.8492356,34.6660008,35.482766,36.813323,38.14388,39.474437,40.804994,42.135551,43.1083946,44.0812382,45.0540818,46.0269254,46.999769,47.704492,48.409215,49.113938,49.818661,50.523384,50.8961786,51.2689732,51.6417678,52.0145624,52.387357,51.9357716,51.4841862,51.0326008,50.5810154,50.12943,48.9756324,47.8218348,46.6680372,45.5142396,44.360442,43.5451102,42.7297784,41.9144466,41.0991148,40.283783,40.9110732,41.5383634,42.1656536,42.7929438,43.420234,44.4003234,45.3804128,46.3605022,47.3405916,48.320681,49.2576886,50.1946962,51.1317038,52.0687114,53.005719,53.531259,54.056799,54.582339,
Cameroon,CMR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.6551314,36.2696442,36.884157,37.489138,38.094119,38.6991,39.304081,39.909062,40.6797546,41.4504472,42.2211398,42.9918324,43.762525,44.4924574,45.2223898,45.9523222,46.6822546,47.412187,47.9811296,48.5500722,49.1190148,49.6879574,50.2569,50.7178322,51.1787644,51.6396966,52.1006288,52.561561,52.1671788,51.7727966,51.3784144,50.9840322,50.58965,49.9539604,49.3182708,48.6825812,48.0468916,47.411202,47.0613594,46.7115168,46.3616742,46.0118316,45.661989,46.2030456,46.7441022,47.2851588,47.8262154,48.367272,49.3309218,50.2945716,51.2582214,52.2218712,53.185521,53.9576392,54.7297574,55.5018756,56.2739938,57.046112,57.588547,58.130982,58.673417,
"Congo, Dem. Rep.",COD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,34.4903094,34.7838892,35.077469,35.4516732,35.8258774,36.2000816,36.5742858,36.94849,37.4457068,37.9429236,38.4401404,38.9373572,39.434574,39.6772382,39.9199024,40.1625666,40.4052308,40.647895,41.065298,41.482701,41.900104,42.317507,42.73491,43.0499936,43.3650772,43.6801608,43.9952444,44.310328,44.686631,45.062934,45.439237,45.81554,46.191843,46.0009238,45.8100046,45.6190854,45.4281662,45.237247,46.0664414,46.8956358,47.7248302,48.5540246,49.383219,50.4407188,51.4982186,52.5557184,53.6132182,54.670718,55.4493906,56.2280632,57.0067358,57.7854084,58.564081,59.2330428,59.9020046,60.5709664,61.2399282,61.90889,62.3601988,62.8115076,63.2628164,
"Congo, Rep.",COG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,41.1679056,42.0530628,42.93822,43.6339962,44.3297724,45.0255486,45.7213248,46.417101,46.961744,47.506387,48.05103,48.595673,49.140316,49.6172014,50.0940868,50.5709722,51.0478576,51.524743,51.8755266,52.2263102,52.5770938,52.9278774,53.278661,53.3525544,53.4264478,53.5003412,53.5742346,53.648128,52.8183032,51.9884784,51.1586536,50.3288288,49.499004,48.3802874,47.2615708,46.1428542,45.0241376,43.905421,44.0895996,44.2737782,44.4579568,44.6421354,44.826314,46.5212932,48.2162724,49.9112516,51.6062308,53.30121,54.665933,56.030656,57.395379,58.760102,60.124825,61.1139882,62.1031514,63.0923146,64.0814778,65.070641,65.4740832,65.8775254,66.2809676,
Colombia,COL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,58.3324776,59.0615388,59.7906,60.4289692,61.0673384,61.7057076,62.3440768,62.982446,63.708801,64.435156,65.161511,65.887866,66.614221,67.3719878,68.1297546,68.8875214,69.6452882,70.403055,71.308489,72.213923,73.119357,74.024791,74.930225,75.5058038,76.0813826,76.6569614,77.2325402,77.808119,78.1748144,78.5415098,78.9082052,79.2749006,79.641596,80.0459258,80.4502556,80.8545854,81.2589152,81.663245,82.0016428,82.3400406,82.6784384,83.0168362,83.355234,83.6214238,83.8876136,84.1538034,84.4199932,84.686183,84.9078444,85.1295058,85.3511672,85.5728286,85.79449,85.9984866,86.2024832,86.4064798,86.6104764,86.814473,86.9836638,87.1528546,87.3220454,
Comoros,COM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,33.7883796,34.3331458,34.877912,35.4349124,35.9919128,36.5489132,37.1059136,37.662914,38.3984142,39.1339144,39.8694146,40.6049148,41.340415,41.962227,42.584039,43.205851,43.827663,44.449475,45.3520338,46.2545926,47.1571514,48.0597102,48.962269,49.8550776,50.7478862,51.6406948,52.5335034,53.426312,54.2006296,54.9749472,55.7492648,56.5235824,57.2979,57.7545696,58.2112392,58.6679088,59.1245784,59.581248,59.703836,59.826424,59.949012,60.0716,60.194188,60.6007694,61.0073508,61.4139322,61.8205136,62.227095,62.8698146,63.5125342,64.1552538,64.7979734,65.440693,65.850395,66.260097,66.669799,67.079501,67.489203,67.8592872,68.2293714,68.5994556,
Cabo Verde,CPV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.732506,43.942707,44.152908,45.0315302,45.9101524,46.7887746,47.6673968,48.546019,49.4205206,50.2950222,51.1695238,52.0440254,52.918527,54.5920538,56.2655806,57.9391074,59.6126342,61.286161,61.887,62.487839,63.088678,63.689517,64.290356,64.8628976,65.4354392,66.0079808,66.5805224,67.153064,67.6956014,68.2381388,68.7806762,69.3232136,69.865751,70.6249412,71.3841314,72.1433216,72.9025118,73.661702,74.9973236,76.3329452,77.6685668,79.0041884,80.33981,80.7156884,81.0915668,81.4674452,81.8433236,82.219202,82.454704,82.690206,82.925708,83.16121,83.396712,83.660124,83.923536,84.186948,84.45036,84.713772,84.9256352,85.1374984,85.3493616,
Costa Rica,CRI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.4334474,64.6384362,65.843425,66.7826858,67.7219466,68.6612074,69.6004682,70.539729,71.4329326,72.3261362,73.2193398,74.1125434,75.005747,75.8413312,76.6769154,77.5124996,78.3480838,79.183668,79.950212,80.716756,81.4833,82.249844,83.016388,83.4048824,83.7933768,84.1818712,84.5703656,84.95886,85.1823686,85.4058772,85.6293858,85.8528944,86.076403,86.295258,86.514113,86.732968,86.951823,87.170678,87.3402068,87.5097356,87.6792644,87.8487932,88.018322,88.1373068,88.2562916,88.3752764,88.4942612,88.613246,88.7676436,88.9220412,89.0764388,89.2308364,89.385234,89.5576804,89.7301268,89.9025732,90.0750196,90.247466,90.3860216,90.5245772,90.6631328,
Caribbean small states,CSS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.62702347,66.19881866,66.77212789,67.24384767,67.71477041,68.18269738,68.64598197,69.10354496,69.48051545,69.8602613,70.24599818,70.64472791,71.05193768,71.4725129,71.89752485,72.32343648,72.74638154,73.16492773,73.5335247,73.89981387,74.26697639,74.64525012,75.02973569,75.31511855,75.60321765,75.88987052,76.16966699,76.44714001,76.69218097,76.9340372,77.1729654,77.41110033,77.64719645,77.68383602,77.72235475,77.76358054,77.80536042,77.84794907,78.03390264,78.22449083,78.41885439,78.61764825,78.81967052,79.14675785,79.46802713,79.78268693,80.08458021,80.38161882,80.48253744,80.58506236,80.68991047,80.79806684,80.90767313,81.06177467,81.21637346,81.37098756,81.52582195,81.68057686,81.86212485,82.04391001,82.22614672,
Cuba,CUB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.6443352,70.5041746,71.364014,72.2465678,73.1291216,74.0116754,74.8942292,75.776783,76.3834484,76.9901138,77.5967792,78.2034446,78.81011,79.185175,79.56024,79.935305,80.31037,80.685435,80.9808892,81.2763434,81.5717976,81.8672518,82.162706,82.3038438,82.4449816,82.5861194,82.7272572,82.868395,82.8904756,82.9125562,82.9346368,82.9567174,82.978798,83.416371,83.853944,84.291517,84.72909,85.166663,85.406414,85.646165,85.885916,86.125667,86.365418,86.521177,86.676936,86.832695,86.988454,87.144213,87.205213,87.266213,87.327213,87.388213,87.449213,87.4989954,87.5487778,87.5985602,87.6483426,87.698125,87.8023552,87.9065854,88.0108156,
Curacao,CUW,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,68.3594428,69.2509824,70.142522,70.734253,71.325984,71.917715,72.509446,73.101177,73.8812766,74.6613762,75.4414758,76.2215754,77.001675,77.946691,78.891707,79.836723,80.781739,81.726755,82.1423626,82.5579702,82.9735778,83.3891854,83.804793,84.0349636,84.2651342,84.4953048,84.7254754,84.955646,85.0246182,85.0935904,85.1625626,85.2315348,85.300507,85.3218804,85.3432538,85.3646272,85.3860006,85.407374,85.5590362,85.7106984,85.8623606,86.0140228,86.165685,86.367444,86.569203,86.770962,86.972721,87.17448,87.4373036,87.7001272,87.9629508,88.2257744,88.488598,88.6259942,88.7633904,88.9007866,89.0381828,89.175579,89.3072556,89.4389322,89.5706088,
Cayman Islands,CYM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Cyprus,CYP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.1388706,80.6117838,81.084697,81.4906456,81.8965942,82.3025428,82.7084914,83.11444,83.464568,83.814696,84.164824,84.514952,84.86508,85.1680744,85.4710688,85.7740632,86.0770576,86.380052,86.6441518,86.9082516,87.1723514,87.4364512,87.700551,87.9313584,88.1621658,88.3929732,88.6237806,88.854588,89.058036,89.261484,89.464932,89.66838,89.871828,90.0513574,90.2308868,90.4104162,90.5899456,90.769475,90.9293312,91.0891874,91.2490436,91.4088998,91.568756,91.7110956,91.8534352,91.9957748,92.1381144,92.280454,92.4841226,92.6877912,92.8914598,93.0951284,93.298797,93.3945096,93.4902222,93.5859348,93.6816474,93.77736,93.8679776,93.9585952,94.0492128,
Czech Republic,CZE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.5069228,80.8726544,81.238386,81.2415316,81.2446772,81.2478228,81.2509684,81.254114,81.2827216,81.3113292,81.3399368,81.3685444,81.397152,81.5787226,81.7602932,81.9418638,82.1234344,82.305005,82.3215722,82.3381394,82.3547066,82.3712738,82.387841,82.6090052,82.8301694,83.0513336,83.2724978,83.493662,83.7534284,84.0131948,84.2729612,84.5327276,84.792494,85.1981324,85.6037708,86.0094092,86.4150476,86.820686,87.0823342,87.3439824,87.6056306,87.8672788,88.128927,88.3720372,88.6151474,88.8582576,89.1013678,89.344478,89.5829966,89.8215152,90.0600338,90.2985524,90.537071,90.6532024,90.7693338,90.8854652,91.0015966,91.117728,91.2356564,91.3535848,91.4715132,
Germany,DEU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.3632298,79.7003014,80.037373,80.2446774,80.4519818,80.6592862,80.8665906,81.073895,81.2678064,81.4617178,81.6556292,81.8495406,82.043452,82.3696726,82.6958932,83.0221138,83.3483344,83.674555,84.0027646,84.3309742,84.6591838,84.9873934,85.315603,85.6370658,85.9585286,86.2799914,86.6014542,86.922917,87.1355906,87.3482642,87.5609378,87.7736114,87.986285,88.2654462,88.5446074,88.8237686,89.1029298,89.382091,89.5927986,89.8035062,90.0142138,90.2249214,90.435629,90.5679772,90.7003254,90.8326736,90.9650218,91.09737,91.176483,91.255596,91.334709,91.413822,91.492935,91.6233514,91.7537678,91.8841842,92.0146006,92.145017,92.300414,92.455811,92.611208,
Djibouti,DJI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.6959588,39.3128854,39.929812,40.533346,41.13688,41.740414,42.343948,42.947482,43.9934454,45.0394088,46.0853722,47.1313356,48.177299,48.6539698,49.1306406,49.6073114,50.0839822,50.560653,51.1818492,51.8030454,52.4242416,53.0454378,53.666634,54.0886676,54.5107012,54.9327348,55.3547684,55.776802,56.0280844,56.2793668,56.5306492,56.7819316,57.033214,56.8429638,56.6527136,56.4624634,56.2722132,56.081963,55.9650408,55.8481186,55.7311964,55.6142742,55.497352,56.1334068,56.7694616,57.4055164,58.0415712,58.677626,59.5746006,60.4715752,61.3685498,62.2655244,63.162499,64.849553,66.536607,68.223661,69.910715,71.597769,72.050411,72.503053,72.955695,
Dominica,DMA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Denmark,DNK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,82.024836,82.268749,82.512662,82.6024352,82.6922084,82.7819816,82.8717548,82.961528,83.0656182,83.1697084,83.2737986,83.3778888,83.481979,83.5906782,83.6993774,83.8080766,83.9167758,84.025475,83.9767238,83.9279726,83.8792214,83.8304702,83.781719,83.7615646,83.7414102,83.7212558,83.7011014,83.680947,83.8318456,83.9827442,84.1336428,84.2845414,84.43544,84.7118042,84.9881684,85.2645326,85.5408968,85.817261,86.2068306,86.5964002,86.9859698,87.3755394,87.765109,88.0201276,88.2751462,88.5301648,88.7851834,89.040202,89.3510794,89.6619568,89.9728342,90.2837116,90.594589,90.6957992,90.7970094,90.8982196,90.9994298,91.10064,91.2138468,91.3270536,91.4402604,
Dominican Republic,DOM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,51.0294614,52.0301282,53.030795,53.9283996,54.8260042,55.7236088,56.6212134,57.518818,58.2960842,59.0733504,59.8506166,60.6278828,61.405149,61.9759808,62.5468126,63.1176444,63.6884762,64.259308,64.7715598,65.2838116,65.7960634,66.3083152,66.820567,67.448474,68.076381,68.704288,69.332195,69.960102,70.5696088,71.1791156,71.7886224,72.3981292,73.007636,73.3930356,73.7784352,74.1638348,74.5492344,74.934634,75.3121564,75.6896788,76.0672012,76.4447236,76.822246,77.176527,77.530808,77.885089,78.23937,78.593651,78.8734088,79.1531666,79.4329244,79.7126822,79.99244,80.2604,80.52836,80.79632,81.06428,81.33224,81.5210248,81.7098096,81.8985944,
Algeria,DZA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.9376186,43.5337458,44.129873,44.7068728,45.2838726,45.8608724,46.4378722,47.014872,47.5492956,48.0837192,48.6181428,49.1525664,49.68699,50.6601326,51.6332752,52.6064178,53.5795604,54.552703,56.6961312,58.8395594,60.9829876,63.1264158,65.269844,66.5605502,67.8512564,69.1419626,70.4326688,71.723375,72.2396994,72.7560238,73.2723482,73.7886726,74.304997,74.8161054,75.3272138,75.8383222,76.3494306,76.860539,77.4494954,78.0384518,78.6274082,79.2163646,79.805321,80.4139128,81.0225046,81.6310964,82.2396882,82.84828,83.1694998,83.4907196,83.8119394,84.1331592,84.454379,84.7293842,85.0043894,85.2793946,85.5543998,85.829405,86.0510094,86.2726138,86.4942182,
East Asia & Pacific (excluding high income),EAP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,39.8457371,40.18687773,40.49862659,43.29184603,46.07943545,48.85841944,51.64245195,54.42633794,56.0987422,57.77341796,59.44829323,61.12240262,62.79007728,63.99902625,65.20669853,66.4140264,67.62978746,68.84639953,69.61078877,70.37412683,71.13391071,71.89477835,72.6558423,73.15752058,73.65468249,74.14986141,74.6458239,75.13952805,75.47076337,75.80115995,76.13261664,76.45709888,76.78766342,77.11460262,77.43998392,77.76126099,78.09320094,78.4164964,78.78508385,79.15649158,79.53501398,79.91597947,80.30448862,80.76920778,81.2314494,81.68802871,82.13889661,82.58556094,83.036189,83.48427979,83.93074501,84.37396646,84.81843359,85.13385449,85.44666991,85.75637956,86.06594057,86.37348397,86.53097127,86.68891308,86.84861477,
Early-demographic dividend,EAR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,37.74010021,38.60896521,39.48101554,40.40808626,41.32934813,42.24312463,43.16003371,44.07085888,44.99053924,45.90827369,46.825835,47.74735206,48.66751586,49.63831575,50.60576241,51.57095034,52.54370281,53.51513449,54.2928822,55.06917847,55.84433073,56.62548621,57.40567688,58.02830423,58.64770106,59.26419333,59.88425231,60.49869119,61.20228126,61.90423813,62.61782427,63.3299742,64.04391871,64.66113434,65.27103484,65.87370128,66.48118324,67.08287162,67.51593544,67.94854046,68.38236652,68.82239684,69.26265283,69.80648583,70.34987652,70.89272505,71.43831725,71.98357873,72.63298596,73.27934631,73.92198836,74.56477869,75.20419835,75.58453476,75.96412572,76.3439627,76.7238905,77.1051227,77.42405346,77.7431017,78.06199976,
East Asia & Pacific,EAS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,45.03599382,45.57319652,46.05367152,48.52688997,50.98212762,53.40756278,55.82899026,58.24023671,59.70585651,61.17412027,62.64450919,64.14568009,65.62166651,66.70833968,67.79717325,68.88651054,69.97652241,71.07276469,71.76544922,72.45694412,73.14343202,73.83340173,74.52065118,74.97952759,75.43863375,75.90020534,76.36543321,76.83203229,77.14223101,77.45284018,77.76233902,78.07338593,78.38439176,78.68256407,78.98100408,79.27883814,79.58141351,79.88105889,80.22493235,80.56856614,80.91566015,81.26895998,81.62469326,82.03592173,82.44694869,82.85633351,83.26564526,83.6737908,84.08242416,84.48825266,84.89251157,85.29381721,85.69637936,85.98691931,86.27654808,86.56471983,86.85428903,87.14225894,87.29002008,87.43854122,87.58729391,
Europe & Central Asia (excluding high income),ECA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,72.22117488,73.01300462,73.81637161,74.21424685,74.60668911,74.9889599,75.36775502,75.73805338,75.89295392,76.0502764,76.21214064,76.3875063,76.56380512,76.53810793,76.51411797,76.49180369,76.47351501,76.46005361,76.53970432,76.62381038,76.71334504,76.80996868,76.91067404,77.27422313,77.63946941,78.00481287,78.37221773,78.74054056,78.45736424,78.18061138,77.90734283,77.64584158,77.39307805,77.3323609,77.2779615,77.22728876,77.18079922,77.13986289,77.22350646,77.30949905,77.39789428,77.49131511,77.59152232,78.04359932,78.49542302,78.94661415,79.40038572,79.85172896,80.48965542,81.12742472,81.76514853,82.40461719,83.04722195,83.43607123,83.82570885,84.21558988,84.60768655,85.00023111,85.19204509,85.38211774,85.57060901,
Europe & Central Asia,ECS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.37907488,76.99011419,77.60698505,77.91899214,78.22726913,78.53017052,78.83201972,79.1281739,79.32964976,79.53190823,79.73527482,79.9432436,80.15462817,80.30485701,80.45546952,80.60638808,80.76117678,80.91742152,81.08966927,81.26624743,81.44778281,81.63075015,81.81704406,82.09831162,82.37751643,82.65525116,82.93348332,83.21056875,83.19972736,83.19365863,83.19416488,83.20183062,83.21321381,83.32135777,83.43026411,83.53838766,83.63846944,83.73780823,83.88074654,84.0255981,84.17188034,84.3324671,84.49968221,84.78850431,85.07544029,85.36010906,85.64578579,85.92996281,86.28784509,86.64293386,86.99774445,87.34943857,87.71206185,87.94579656,88.18193753,88.4180752,88.65970143,88.9021041,89.05220478,89.19923074,89.34691681,
Ecuador,ECU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,52.1477346,53.0322378,53.916741,54.6567516,55.3967622,56.1367728,56.8767834,57.616794,58.4543868,59.2919796,60.1295724,60.9671652,61.804758,62.6452902,63.4858224,64.3263546,65.1668868,66.007419,66.8398668,67.6723146,68.5047624,69.3372102,70.169658,70.9865852,71.8035124,72.6204396,73.4373668,74.254294,74.880296,75.506298,76.1323,76.758302,77.384304,77.7946756,78.2050472,78.6154188,79.0257904,79.436162,79.8551344,80.2741068,80.6930792,81.1120516,81.531024,81.7983706,82.0657172,82.3330638,82.6004104,82.867757,83.0968782,83.3259994,83.5551206,83.7842418,84.013363,84.3203596,84.6273562,84.9343528,85.2413494,85.548346,85.7505808,85.9528156,86.1550504,
"Egypt, Arab Rep.",EGY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,50.9977792,51.7492386,52.500698,53.1269228,53.7531476,54.3793724,55.0055972,55.631822,56.0191974,56.4065728,56.7939482,57.1813236,57.568699,58.4843494,59.3999998,60.3156502,61.2313006,62.146951,62.9062006,63.6654502,64.4246998,65.1839494,65.943199,66.8010524,67.6589058,68.5167592,69.3746126,70.232466,70.688585,71.144704,71.600823,72.056942,72.513061,73.096324,73.679587,74.26285,74.846113,75.429376,75.6789228,75.9284696,76.1780164,76.4275632,76.67711,76.8862474,77.0953848,77.3045222,77.5136596,77.722797,78.0385198,78.3542426,78.6699654,78.9856882,79.301411,79.649061,79.996711,80.344361,80.692011,81.039661,81.3074496,81.5752382,81.8430268,
Euro area,EMU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.22152235,79.68897616,80.15857027,80.45006304,80.7423635,81.0348569,81.32698236,81.6182951,81.91191481,82.20542087,82.50001166,82.79393902,83.08615124,83.452517,83.81834086,84.18326804,84.54851808,84.91542593,85.23457083,85.55297437,85.87030312,86.18790345,86.50506245,86.77903405,87.0537767,87.32914658,87.60424976,87.87935376,88.07840814,88.27678595,88.47523705,88.67572759,88.87766621,89.09784107,89.31736585,89.53596637,89.7534766,89.97063258,90.15936595,90.34678256,90.53389187,90.72284307,90.91288747,91.06214544,91.21215341,91.36227009,91.51237764,91.66298354,91.78047065,91.89643473,92.01190873,92.12891514,92.24144201,92.35909609,92.47605665,92.59076655,92.70645276,92.82365942,92.93894249,93.05287639,93.16781229,
Eritrea,ERI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.3602986,32.2936288,33.226959,33.7888014,34.3506438,34.9124862,35.4743286,36.036171,36.5159224,36.9956738,37.4754252,37.9551766,38.434928,38.8430688,39.2512096,39.6593504,40.0674912,40.475632,40.7991886,41.1227452,41.4463018,41.7698584,42.093415,42.3865234,42.6796318,42.9727402,43.2658486,43.558957,44.1164562,44.6739554,45.2314546,45.7889538,46.346453,47.04018,47.733907,48.427634,49.121361,49.815088,50.5023856,51.1896832,51.8769808,52.5642784,53.251576,54.3590424,55.4665088,56.5739752,57.6814416,58.788908,59.7658532,60.7427984,61.7197436,62.6966888,63.673634,64.5095528,65.3454716,66.1813904,67.0173092,67.853228,68.4670766,69.0809252,69.6947738,
Spain,ESP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.3716738,79.0418814,79.712089,80.1967024,80.6813158,81.1659292,81.6505426,82.135156,82.539787,82.944418,83.349049,83.75368,84.158311,84.652176,85.146041,85.639906,86.133771,86.627636,87.0615536,87.4954712,87.9293888,88.3633064,88.797224,88.998361,89.199498,89.400635,89.601772,89.802909,89.9877618,90.1726146,90.3574674,90.5423202,90.727173,90.9539736,91.1807742,91.4075748,91.6343754,91.861176,92.0167256,92.1722752,92.3278248,92.4833744,92.638924,92.769315,92.899706,93.030097,93.160488,93.290879,93.3821442,93.4734094,93.5646746,93.6559398,93.747205,93.863064,93.978923,94.094782,94.210641,94.3265,94.4255138,94.5245276,94.6235414,
Estonia,EST,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.0857784,79.8113352,80.536892,80.841679,81.146466,81.451253,81.75604,82.060827,82.0832918,82.1057566,82.1282214,82.1506862,82.173151,82.0475278,81.9219046,81.7962814,81.6706582,81.545035,81.4392748,81.3335146,81.2277544,81.1219942,81.016234,81.1902804,81.3643268,81.5383732,81.7124196,81.886466,81.5005498,81.1146336,80.7287174,80.3428012,79.956885,80.1937222,80.4305594,80.6673966,80.9042338,81.141071,81.628477,82.115883,82.603289,83.090695,83.578101,84.107669,84.637237,85.166805,85.696373,86.225941,86.8540704,87.4821998,88.1103292,88.7384586,89.366588,89.643494,89.9204,90.197306,90.474212,90.751118,90.8658448,90.9805716,91.0952984,
Ethiopia,ETH,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.359828,32.293616,33.227404,33.7892564,34.3511088,34.9129612,35.4748136,36.036666,36.4125714,36.7884768,37.1643822,37.5402876,37.916193,38.1240514,38.3319098,38.5397682,38.7476266,38.955485,38.7305032,38.5055214,38.2805396,38.0555578,37.830576,38.5660224,39.3014688,40.0369152,40.7723616,41.507808,41.9729888,42.4381696,42.9033504,43.3685312,43.833712,44.2311128,44.6285136,45.0259144,45.4233152,45.820716,46.344989,46.869262,47.393535,47.917808,48.442081,50.3589882,52.2758954,54.1928026,56.1097098,58.026617,59.745953,61.465289,63.184625,64.903961,66.623297,67.3747876,68.1262782,68.8777688,69.6292594,70.38075,70.9760526,71.5713552,72.1666578,
European Union,EUU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.6445536,79.21205705,79.7814132,80.06604431,80.35122091,80.63744358,80.92129202,81.20339229,81.47558764,81.74852098,82.02191448,82.29771992,82.57094543,82.872391,83.17403972,83.47606146,83.77878855,84.08614148,84.33757521,84.58956416,84.8399577,85.08979918,85.33635296,85.55701858,85.77804555,86.00067265,86.22183496,86.44491414,86.63186359,86.82081106,87.00929227,87.20259928,87.39427478,87.62297659,87.84996993,88.0780246,88.30556531,88.53449222,88.76042392,88.98501474,89.21132983,89.44500005,89.68034457,89.85318821,90.02596752,90.1991276,90.3723781,90.54953022,90.71488515,90.87540341,91.03539165,91.1931169,91.3506584,91.48880317,91.62691162,91.7637492,91.90159293,92.04067441,92.16663041,92.29000236,92.41385885,
Fragile and conflict affected situations,FCS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.44469068,44.07397596,44.68047109,45.1500615,45.61786918,46.08924008,46.59429147,47.10088284,47.56561381,48.02118998,48.46379657,48.9477368,49.41219298,49.77191197,50.12255248,50.46863235,50.82432756,51.17769773,51.51316268,51.85903278,52.2178343,52.62842242,53.03570377,53.40347154,53.76358848,54.10999988,54.46725196,54.81250572,54.88843686,54.95751581,55.08152314,55.15451883,55.22906012,55.18825749,55.14199264,55.10213473,55.09648042,55.09829304,55.30410189,55.50329213,55.69333709,55.88370703,56.07072889,56.70646754,57.3492144,58.0003622,58.67544792,59.35293157,60.12425198,60.88822301,61.64472486,62.40580514,63.16453387,63.71127163,64.24597648,64.77584268,65.29994301,65.81894834,66.15656214,66.50393148,66.86569124,
Finland,FIN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.3288476,79.7248078,80.120768,80.4531018,80.7854356,81.1177694,81.4501032,81.782437,82.2323994,82.6823618,83.1323242,83.5822866,84.032249,84.4763712,84.9204934,85.3646156,85.8087378,86.25286,86.596085,86.93931,87.282535,87.62576,87.968985,88.0459198,88.1228546,88.1997894,88.2767242,88.353659,88.5430312,88.7324034,88.9217756,89.1111478,89.30052,89.4982196,89.6959192,89.8936188,90.0913184,90.289018,90.3790122,90.4690064,90.5590006,90.6489948,90.738989,90.8353344,90.9316798,91.0280252,91.1243706,91.220716,91.4209608,91.6212056,91.8214504,92.0216952,92.22194,92.3542506,92.4865612,92.6188718,92.7511824,92.883493,92.9889004,93.0943078,93.1997152,
Fiji,FJI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,63.1840368,64.1062834,65.02853,65.4105918,65.7926536,66.1747154,66.5567772,66.938839,67.0004522,67.0620654,67.1236786,67.1852918,67.246905,67.5020584,67.7572118,68.0123652,68.2675186,68.522672,68.7611742,68.9996764,69.2381786,69.4766808,69.715183,70.0419234,70.3686638,70.6954042,71.0221446,71.348885,71.1808824,71.0128798,70.8448772,70.6768746,70.508872,70.2717446,70.0346172,69.7974898,69.5603624,69.323235,69.496084,69.668933,69.841782,70.014631,70.18748,70.1835916,70.1797032,70.1758148,70.1719264,70.168038,70.4500006,70.7319632,71.0139258,71.2958884,71.577851,71.7867128,71.9955746,72.2044364,72.4132982,72.62216,72.9378194,73.2534788,73.5691382,
France,FRA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.421869,80.895982,81.370095,81.6126302,81.8551654,82.0977006,82.3402358,82.582771,82.8827536,83.1827362,83.4827188,83.7827014,84.082684,84.4449594,84.8072348,85.1695102,85.5317856,85.894061,86.1711576,86.4482542,86.7253508,87.0024474,87.279544,87.5470634,87.8145828,88.0821022,88.3496216,88.617141,88.8085158,88.9998906,89.1912654,89.3826402,89.574015,89.7360504,89.8980858,90.0601212,90.2221566,90.384192,90.5125152,90.6408384,90.7691616,90.8974848,91.025808,91.146026,91.266244,91.386462,91.50668,91.626898,91.7271634,91.8274288,91.9276942,92.0279596,92.128225,92.1713104,92.2143958,92.2574812,92.3005666,92.343652,92.4187036,92.4937552,92.5688068,
Faroe Islands,FRO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Micronesia, Fed. Sts.",FSM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,54.217023,54.890189,55.563355,56.2104628,56.8575706,57.5046784,58.1517862,58.798894,59.4794834,60.1600728,60.8406622,61.5212516,62.201841,62.8109628,63.4200846,64.0292064,64.6383282,65.24745,65.5472954,65.8471408,66.1469862,66.4468316,66.746677,66.8828076,67.0189382,67.1550688,67.2911994,67.42733,67.6289908,67.8306516,68.0323124,68.2339732,68.435634,68.6113608,68.7870876,68.9628144,69.1385412,69.314268,69.5415616,69.7688552,69.9961488,70.2234424,70.450736,70.8051888,71.1596416,71.5140944,71.8685472,72.223,72.5228192,72.8226384,73.1224576,73.4222768,73.722096,73.9742354,74.2263748,74.4785142,74.7306536,74.982793,75.2226232,75.4624534,75.7022836,
Gabon,GAB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,33.406734,33.819312,34.23189,35.3842126,36.5365352,37.6888578,38.8411804,39.993503,41.1339746,42.2744462,43.4149178,44.5553894,45.695861,46.8497698,48.0036786,49.1575874,50.3114962,51.465405,52.6614866,53.8575682,55.0536498,56.2497314,57.445813,58.4675366,59.4892602,60.5109838,61.5327074,62.554431,62.429168,62.303905,62.178642,62.053379,61.928116,61.1341164,60.3401168,59.5461172,58.7521176,57.958118,57.1467684,56.3354188,55.5240692,54.7127196,53.90137,54.5682694,55.2351688,55.9020682,56.5689676,57.235867,58.6849998,60.1341326,61.5832654,63.0323982,64.481531,65.8323006,67.1830702,68.5338398,69.8846094,71.235379,71.580687,71.925995,72.271303,
United Kingdom,GBR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.6557966,80.8294698,81.003143,81.163738,81.324333,81.484928,81.645523,81.806118,81.9026108,81.9991036,82.0955964,82.1920892,82.288582,82.4470266,82.6054712,82.7639158,82.9223604,83.080805,83.3526422,83.6244794,83.8963166,84.1681538,84.439991,84.681798,84.923605,85.165412,85.407219,85.649026,85.9633064,86.2775868,86.5918672,86.9061476,87.220428,87.4478978,87.6753676,87.9028374,88.1303072,88.357777,88.562668,88.767559,88.97245,89.177341,89.382232,89.5567972,89.7313624,89.9059276,90.0804928,90.255058,90.4288884,90.6027188,90.7765492,90.9503796,91.12421,91.15373,91.18325,91.21277,91.24229,91.27181,91.3491128,91.4264156,91.5037184,
Georgia,GEO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,72.6328814,73.3184172,74.003953,74.615551,75.227149,75.838747,76.450345,77.061943,77.492104,77.922265,78.352426,78.782587,79.212748,79.6386302,80.0645124,80.4903946,80.9162768,81.342159,81.3254334,81.3087078,81.2919822,81.2752566,81.258531,81.4841544,81.7097778,81.9354012,82.1610246,82.386648,82.3966382,82.4066284,82.4166186,82.4266088,82.436599,82.1498226,81.8630462,81.5762698,81.2894934,81.002717,81.2050828,81.4074486,81.6098144,81.8121802,82.014546,82.3854266,82.7563072,83.1271878,83.4980684,83.868949,84.2062724,84.5435958,84.8809192,85.2182426,85.555566,85.8512846,86.1470032,86.4427218,86.7384404,87.034159,87.1896954,87.3452318,87.5007682,
Ghana,GHA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.025135,40.72216,41.419185,41.941849,42.464513,42.987177,43.509841,44.032505,44.6392204,45.2459358,45.8526512,46.4593666,47.066082,47.5241934,47.9823048,48.4404162,48.8985276,49.356639,49.76653,50.176421,50.586312,50.996203,51.406094,52.0374288,52.6687636,53.3000984,53.9314332,54.562768,55.3629324,56.1630968,56.9632612,57.7634256,58.56359,57.9795038,57.3954176,56.8113314,56.2272452,55.643159,55.70505,55.766941,55.828832,55.890723,55.952614,56.8992302,57.8458464,58.7924626,59.7390788,60.685695,61.1394208,61.5931466,62.0468724,62.5005982,62.954324,63.5739886,64.1936532,64.8133178,65.4329824,66.052647,66.5222738,66.9919006,67.4615274,
Gibraltar,GIB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Guinea,GIN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,26.4151216,26.7173188,27.019516,27.255402,27.491288,27.727174,27.96306,28.198946,28.6175038,29.0360616,29.4546194,29.8731772,30.291735,30.9768392,31.6619434,32.3470476,33.0321518,33.717256,34.6974316,35.6776072,36.6577828,37.6379584,38.618134,40.2214058,41.8246776,43.4279494,45.0312212,46.634493,47.524852,48.415211,49.30557,50.195929,51.086288,50.6687494,50.2512108,49.8336722,49.4161336,48.998595,48.4869634,47.9753318,47.4637002,46.9520686,46.440437,47.9429454,49.4454538,50.9479622,52.4504706,53.952979,54.4965986,55.0402182,55.5838378,56.1274574,56.671077,57.6744708,58.6778646,59.6812584,60.6846522,61.688046,62.242623,62.7972,63.351777,
"Gambia, The",GMB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,22.72253,23.046936,23.371342,24.0148478,24.6583536,25.3018594,25.9453652,26.588871,27.8219438,29.0550166,30.2880894,31.5211622,32.754235,33.9959206,35.2376062,36.4792918,37.7209774,38.962663,40.161559,41.360455,42.559351,43.758247,44.957143,45.9078636,46.8585842,47.8093048,48.7600254,49.710746,50.0384002,50.3660544,50.6937086,51.0213628,51.349017,51.8639412,52.3788654,52.8937896,53.4087138,53.923638,54.3933136,54.8629892,55.3326648,55.8023404,56.272016,56.8679426,57.4638692,58.0597958,58.6557224,59.251649,59.6977924,60.1439358,60.5900792,61.0362226,61.482366,61.9131992,62.3440324,62.7748656,63.2056988,63.636532,64.2257536,64.8149752,65.4041968,
Guinea-Bissau,GNB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.04375,31.44531,31.84687,32.324635,32.8024,33.280165,33.75793,34.235695,34.6803312,35.1249674,35.5696036,36.0142398,36.458876,36.9843994,37.5099228,38.0354462,38.5609696,39.086493,39.6590842,40.2316754,40.8042666,41.3768578,41.949449,42.4439172,42.9383854,43.4328536,43.9273218,44.42179,44.9716894,45.5215888,46.0714882,46.6213876,47.171287,47.4271692,47.6830514,47.9389336,48.1948158,48.450698,48.6499106,48.8491232,49.0483358,49.2475484,49.446761,49.6388456,49.8309302,50.0230148,50.2150994,50.407184,51.1313616,51.8555392,52.5797168,53.3038944,54.028072,54.3338838,54.6396956,54.9455074,55.2513192,55.557131,56.1074302,56.6577294,57.2080286,
Equatorial Guinea,GNQ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.2347972,29.6430606,30.051324,30.4641752,30.8770264,31.2898776,31.7027288,32.11558,32.5338496,32.9521192,33.3703888,33.7886584,34.206928,34.6341228,35.0613176,35.4885124,35.9157072,36.342902,37.33759,38.332278,39.326966,40.321654,41.316342,41.7784006,42.2404592,42.7025178,43.1645764,43.626635,44.2530384,44.8794418,45.5058452,46.1322486,46.758652,47.386703,48.014754,48.642805,49.270856,49.898907,50.1805404,50.4621738,50.7438072,51.0254406,51.307074,51.3566976,51.4063212,51.4559448,51.5055684,51.555192,52.0612926,52.5673932,53.0734938,53.5795944,54.085695,54.4088864,54.7320778,55.0552692,55.3784606,55.701652,56.2481418,56.7946316,57.3411214,
Greece,GRC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.89981,77.633795,78.36778,78.6781808,78.9885816,79.2989824,79.6093832,79.919784,80.3128252,80.7058664,81.0989076,81.4919488,81.88499,82.2111672,82.5373444,82.8635216,83.1896988,83.515876,84.0723518,84.6288276,85.1853034,85.7417792,86.298255,86.5490548,86.7998546,87.0506544,87.3014542,87.552254,88.1698222,88.7873904,89.4049586,90.0225268,90.640095,90.7971146,90.9541342,91.1111538,91.2681734,91.425193,91.596838,91.768483,91.940128,92.111773,92.283418,92.3587704,92.4341228,92.5094752,92.5848276,92.66018,92.724349,92.788518,92.852687,92.916856,92.981025,93.0420884,93.1031518,93.1642152,93.2252786,93.286342,93.3754178,93.4644936,93.5535694,
Grenada,GRD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.3602428,67.0609964,67.76175,68.2017668,68.6417836,69.0818004,69.5218172,69.961834,70.2888166,70.6157992,70.9427818,71.2697644,71.596747,71.9290254,72.2613038,72.5935822,72.9258606,73.258139,73.3888694,73.5195998,73.6503302,73.7810606,73.911791,74.088566,74.265341,74.442116,74.618891,74.795666,75.3233668,75.8510676,76.3787684,76.9064692,77.43417,78.1043594,78.7745488,79.4447382,80.1149276,80.785117,81.0714806,81.3578442,81.6442078,81.9305714,82.216935,82.2212438,82.2255526,82.2298614,82.2341702,82.238479,82.0816168,81.9247546,81.7678924,81.6110302,81.454168,81.4120544,81.3699408,81.3278272,81.2857136,81.2436,81.3073608,81.3711216,81.4348824,
Greenland,GRL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Guatemala,GTM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.867815,41.690626,42.513437,43.4984202,44.4834034,45.4683866,46.4533698,47.438353,48.4618132,49.4852734,50.5087336,51.5321938,52.555654,53.3044024,54.0531508,54.8018992,55.5506476,56.299396,57.0381144,57.7768328,58.5155512,59.2542696,59.992988,60.842128,61.691268,62.540408,63.389548,64.238688,65.09891,65.959132,66.819354,67.679576,68.539798,69.4009792,70.2621604,71.1233416,71.9845228,72.845704,73.4593504,74.0729968,74.6866432,75.3002896,75.913936,76.322694,76.731452,77.14021,77.548968,77.957726,78.4560146,78.9543032,79.4525918,79.9508804,80.449169,80.7395496,81.0299302,81.3203108,81.6106914,81.901072,82.1777868,82.4545016,82.7312164,
Guam,GUM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.1195808,64.9258194,65.732058,66.5190672,67.3060764,68.0930856,68.8800948,69.667104,70.3895346,71.1119652,71.8343958,72.5568264,73.279257,73.8844738,74.4896906,75.0949074,75.7001242,76.305341,76.8296718,77.3540026,77.8783334,78.4026642,78.926995,79.3820026,79.8370102,80.2920178,80.7470254,81.202033,81.5927174,81.9834018,82.3740862,82.7647706,83.155455,83.6212324,84.0870098,84.5527872,85.0185646,85.484342,85.9875622,86.4907824,86.9940026,87.4972228,88.000443,88.4139058,88.8273686,89.2408314,89.6542942,90.067757,90.3740796,90.6804022,90.9867248,91.2930474,91.59937,91.8726282,92.1458864,92.4191446,92.6924028,92.965661,93.0785256,93.1913902,93.3042548,
Guyana,GUY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,62.7984706,63.0369828,63.275495,63.5035818,63.7316686,63.9597554,64.1878422,64.415929,64.4938084,64.5716878,64.6495672,64.7274466,64.805326,64.9957626,65.1861992,65.3766358,65.5670724,65.757509,65.9423998,66.1272906,66.3121814,66.4970722,66.681963,66.9600948,67.2382266,67.5163584,67.7944902,68.072622,68.2200946,68.3675672,68.5150398,68.6625124,68.809985,68.980082,69.150179,69.320276,69.490373,69.66047,69.4994658,69.3384616,69.1774574,69.0164532,68.855449,69.2837836,69.7121182,70.1404528,70.5687874,70.997122,71.372452,71.747782,72.123112,72.498442,72.873772,73.0583862,73.2430004,73.4276146,73.6122288,73.796843,73.9852224,74.1736018,74.3619812,
High income,HIC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.37879225,77.86240151,78.34723747,78.64965229,78.95335846,79.25778071,79.55990476,79.86398785,80.18518157,80.50604028,80.82596199,81.15347638,81.47836098,81.86176027,82.2467221,82.63315838,83.02057288,83.41132688,83.70741297,84.0055889,84.30512723,84.60598793,84.90711279,85.14853721,85.39254175,85.63989264,85.88966783,86.14196162,86.36213742,86.58417686,86.80527166,87.02843902,87.25603106,87.46479165,87.67265586,87.87640637,88.08392088,88.29013948,88.48055945,88.67050002,88.86153697,89.05515773,89.24985469,89.40793028,89.56468006,89.72070011,89.87834594,90.03694851,90.16450877,90.29018356,90.41594089,90.539734,90.66477281,90.72008909,90.77582538,90.83140664,90.8893184,90.94846299,91.04438918,91.13970907,91.22857512,
"Hong Kong SAR, China",HKG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.0951342,75.9752306,76.855327,77.4636258,78.0719246,78.6802234,79.2885222,79.896821,80.3928928,80.8889646,81.3850364,81.8811082,82.37718,82.7304274,83.0836748,83.4369222,83.7901696,84.143417,84.6340936,85.1247702,85.6154468,86.1061234,86.5968,87.02397,87.45114,87.87831,88.30548,88.73265,89.05037,89.36809,89.68581,90.00353,90.32125,90.66888,91.01651,91.36414,91.71177,92.0594,92.2761034,92.4928068,92.7095102,92.9262136,93.142917,93.2660536,93.3891902,93.5123268,93.6354634,93.7586,93.8092004,93.8598008,93.9104012,93.9610016,94.011602,94.1444838,94.2773656,94.4102474,94.5431292,94.676011,94.7554504,94.8348898,94.9143292,
Honduras,HND,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,41.5340456,42.5813668,43.628688,44.5377204,45.4467528,46.3557852,47.2648176,48.17385,49.0875826,50.0013152,50.9150478,51.8287804,52.742513,53.7637598,54.7850066,55.8062534,56.8275002,57.848747,58.9988312,60.1489154,61.2989996,62.4490838,63.599168,64.7753286,65.9514892,67.1276498,68.3038104,69.479971,70.1391304,70.7982898,71.4574492,72.1166086,72.775768,73.3990922,74.0224164,74.6457406,75.2690648,75.892389,76.2359316,76.5794742,76.9230168,77.2665594,77.610102,77.94604,78.281978,78.617916,78.953854,79.289792,79.6104686,79.9311452,80.2518218,80.5724984,80.893175,81.1361862,81.3791974,81.6222086,81.8652198,82.108231,82.3210348,82.5338386,82.7466424,
Heavily indebted poor countries (HIPC),HPC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.93602116,33.53660111,34.13647,34.66070677,35.18371985,35.70575938,36.23379683,36.76017054,37.34121865,37.9201538,38.49727887,39.08081916,39.66230722,40.22162945,40.78018043,41.33871168,41.90188316,42.4648238,42.93022453,43.39904778,43.87075324,44.35441434,44.83574639,45.28936854,45.73593898,46.17505271,46.61124965,47.03960811,47.05200187,47.05878901,47.06945376,47.10620209,47.16754197,47.2782196,47.37100387,47.44550584,47.51390304,47.57137355,48.00789774,48.44106187,48.87395948,49.31467482,49.75825128,50.85680064,51.95316883,53.04704302,54.14355253,55.23843883,56.43112477,57.62428484,58.81862443,60.01959277,61.22228786,62.09326895,62.96171663,63.8275761,64.69254427,65.55635008,66.07684035,66.59622831,67.11489833,
Croatia,HRV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,71.7595342,72.5066286,73.253723,73.9355262,74.6173294,75.2991326,75.9809358,76.662739,77.2563618,77.8499846,78.4436074,79.0372302,79.630853,80.1254266,80.6200002,81.1145738,81.6091474,82.103721,82.225773,82.347825,82.469877,82.591929,82.713981,82.99751,83.281039,83.564568,83.848097,84.131626,84.4349946,84.7383632,85.0417318,85.3451004,85.648469,86.0779412,86.5074134,86.9368856,87.3663578,87.79583,87.880231,87.964632,88.049033,88.133434,88.217835,88.4655838,88.7133326,88.9610814,89.2088302,89.456579,89.6214672,89.7863554,89.9512436,90.1161318,90.28102,90.4778422,90.6746644,90.8714866,91.0683088,91.265131,91.3930708,91.5210106,91.6489504,
Haiti,HTI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.2833542,35.8025646,36.321775,36.7854544,37.2491338,37.7128132,38.1764926,38.640172,39.0829424,39.5257128,39.9684832,40.4112536,40.854024,41.8032368,42.7524496,43.7016624,44.6508752,45.600088,46.1530318,46.7059756,47.2589194,47.8118632,48.364807,48.8829014,49.4009958,49.9190902,50.4371846,50.955279,51.4596998,51.9641206,52.4685414,52.9729622,53.477383,53.976026,54.474669,54.973312,55.471955,55.970598,56.245701,56.520804,56.795907,57.07101,57.346113,58.0352188,58.7243246,59.4134304,60.1025362,60.791642,61.4123768,62.0331116,62.6538464,63.2745812,63.895316,64.5302246,65.1651332,65.8000418,66.4349504,67.069859,67.5225026,67.9751462,68.4277898,
Hungary,HUN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.8274844,77.4586352,78.089786,78.3768732,78.6639604,78.9510476,79.2381348,79.525222,79.4955108,79.4657996,79.4360884,79.4063772,79.376666,79.3752628,79.3738596,79.3724564,79.3710532,79.36965,79.2365208,79.1033916,78.9702624,78.8371332,78.704004,78.8023936,78.9007832,78.9991728,79.0975624,79.195952,79.202407,79.208862,79.215317,79.221772,79.228227,79.6428864,80.0575458,80.4722052,80.8868646,81.301524,81.6780458,82.0545676,82.4310894,82.8076112,83.184133,83.4021298,83.6201266,83.8381234,84.0561202,84.274117,84.5584364,84.8427558,85.1270752,85.4113946,85.695714,85.9970702,86.2984264,86.5997826,86.9011388,87.202495,87.3456266,87.4887582,87.6318898,
IBRD only,IBD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,45.38449706,46.02486878,46.64351351,48.29311139,49.93581727,51.55954415,53.19372371,54.82319679,55.96191943,57.10389596,58.24983289,59.41116955,60.56928444,61.48532606,62.39888222,63.31049364,64.23736815,65.16279587,65.76115975,66.36655356,66.97888152,67.61290946,68.25370929,68.7454908,69.23162926,69.7129563,70.19820555,70.67811826,71.07581025,71.47361007,71.87388246,72.27172879,72.68068299,73.08205256,73.48203615,73.87740069,74.29196539,74.69717994,75.04164949,75.39008171,75.74598237,76.10543756,76.4744098,76.92509221,77.37276645,77.81418595,78.25358316,78.68727358,79.18521708,79.68085866,80.17454721,80.66980587,81.16495477,81.47306859,81.77897663,82.08283365,82.38543953,82.68898822,82.88754584,83.08554501,83.28343553,
IDA & IBRD total,IBT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.78267645,44.41427427,45.03205684,46.51072572,47.98370647,49.44339225,50.91601136,52.38649497,53.42574096,54.46728633,55.50971015,56.56972981,57.62430316,58.49995378,59.37105166,60.23813711,61.12290627,62.00357609,62.60852198,63.21900961,63.83451936,64.4778334,65.12523912,65.61997851,66.10501491,66.58162572,67.06085399,67.53105578,67.88038888,68.22485607,68.56781973,68.9075349,69.25717849,69.59237822,69.92158886,70.24130126,70.59087021,70.92406078,71.24239489,71.5637906,71.89282125,72.22656152,72.56995978,73.07311193,73.57201672,74.06266332,74.55507896,75.03929938,75.5847861,76.12648371,76.66521436,77.20701379,77.74924176,78.08520823,78.41742681,78.74618302,79.0757041,79.40511791,79.60029307,79.79479057,79.98977892,
IDA total,IDA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,35.31362625,36.00271041,36.68873829,37.32144394,37.95631209,38.59437166,39.24480193,39.89737667,40.4132023,40.92704234,41.43855671,41.96082148,42.4814175,43.16220923,43.84274063,44.52556474,45.22193595,45.92428038,46.61861302,47.30831549,47.9928301,48.68463675,49.37284151,49.90651496,50.43354013,50.95337136,51.47188787,51.98168992,52.20189938,52.4152251,52.62822554,52.84439122,53.06640799,53.24603803,53.41583382,53.58008523,53.76290239,53.94321867,54.33891622,54.72867108,55.11596977,55.50715652,55.89383399,56.76499078,57.63490248,58.50421558,59.38549867,60.26358976,61.19925468,62.12614839,63.04873109,63.96716158,64.87664136,65.508952,66.13900968,66.76843054,67.40395575,68.03876525,68.44533524,68.85353073,69.2636905,
IDA blend,IDB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,37.90322689,38.73682846,39.56429194,40.27634956,40.99723945,41.72950911,42.47931879,43.23729132,43.9640928,44.6901644,45.41393746,46.1493581,46.88060116,47.57018136,48.2583923,48.94597731,49.63943647,50.33061104,50.94021066,51.5492879,52.1586662,52.78660748,53.41355917,53.71131701,54.00388681,54.28905726,54.56839321,54.83767947,54.79728156,54.74703311,54.69701489,54.63001353,54.56086748,54.32007188,54.07372212,53.82876005,53.61462418,53.41017333,53.4622975,53.50941438,53.56207226,53.63167176,53.69661255,54.42237643,55.14849423,55.87517673,56.61254906,57.3473757,58.24148639,59.12606452,60.01591823,60.89353754,61.74805048,62.29871764,62.84225706,63.37760852,63.91499509,64.44233228,64.78849707,65.13411954,65.48055877,
Indonesia,IDN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,45.0197728,45.8316894,46.643606,47.3393054,48.0350048,48.7307042,49.4264036,50.122103,50.8489618,51.5758206,52.3026794,53.0295382,53.756397,54.5016784,55.2469598,55.9922412,56.7375226,57.482804,58.2568758,59.0309476,59.8050194,60.5790912,61.353163,61.9198318,62.4865006,63.0531694,63.6198382,64.186507,64.7879424,65.3893778,65.9908132,66.5922486,67.193684,67.6806474,68.1676108,68.6545742,69.1415376,69.628501,69.9584464,70.2883918,70.6183372,70.9482826,71.278228,71.895028,72.511828,73.128628,73.745428,74.362228,74.9308286,75.4994292,76.0680298,76.6366304,77.205231,77.6356866,78.0661422,78.4965978,78.9270534,79.357509,79.6647694,79.9720298,80.2792902,
IDA only,IDX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,34.1272316,34.75023192,35.37135128,35.96772445,36.56377083,37.15994192,37.76544611,38.37093428,38.79155866,39.2090945,39.6232476,40.04368749,40.46222094,41.13218976,41.80112542,42.47253921,43.1582357,43.85310424,44.57455303,45.29031744,45.99949806,46.71008664,47.41732147,48.05650992,48.69051566,49.31934543,49.95049069,50.57555023,50.92229252,51.26454656,51.60630722,51.96318039,52.32943787,52.71669953,53.09178446,53.45765711,53.8359943,54.20635296,54.77223567,55.33197037,55.88581639,56.43689352,56.98376254,57.92785381,58.87005618,59.81116246,60.76491518,61.71536359,62.67300654,63.62247677,64.56426004,65.50442639,66.44152541,67.11480032,67.78797091,68.46371843,69.14605452,69.83185438,70.26569064,70.70226362,71.14145006,
Isle of Man,IMN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
India,IND,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,28.1208018,28.9934944,29.866187,30.9910744,32.1159618,33.2408492,34.3657366,35.490624,36.7754834,38.0603428,39.3452022,40.6300616,41.914921,43.1190436,44.3231662,45.5272888,46.7314114,47.935534,48.667207,49.39888,50.130553,50.862226,51.593899,52.0993274,52.6047558,53.1101842,53.6156126,54.121041,55.0152888,55.9095366,56.8037844,57.6980322,58.59228,59.4436538,60.2950276,61.1464014,61.9977752,62.849149,63.4488502,64.0485514,64.6482526,65.2479538,65.847655,66.4197816,66.9919082,67.5640348,68.1361614,68.708288,69.4066532,70.1050184,70.8033836,71.5017488,72.200114,72.6018084,73.0035028,73.4051972,73.8068916,74.208586,74.5944894,74.9803928,75.3662962,
Not classified,INX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Ireland,IRL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.9432496,77.4193318,77.895414,78.1120154,78.3286168,78.5452182,78.7618196,78.978421,79.2207248,79.4630286,79.7053324,79.9476362,80.18994,80.5234838,80.8570276,81.1905714,81.5241152,81.857659,82.2194324,82.5812058,82.9429792,83.3047526,83.666526,84.0079718,84.3494176,84.6908634,85.0323092,85.373755,85.7246236,86.0754922,86.4263608,86.7772294,87.128098,87.3404392,87.5527804,87.7651216,87.9774628,88.189804,88.482995,88.776186,89.069377,89.362568,89.655759,89.9063432,90.1569274,90.4075116,90.6580958,90.90868,91.0139688,91.1192576,91.2245464,91.3298352,91.435124,91.6174632,91.7998024,91.9821416,92.1644808,92.34682,92.5900864,92.8333528,93.0766192,
"Iran, Islamic Rep.",IRN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.1482814,37.0582332,37.968185,38.9144826,39.8607802,40.8070778,41.7533754,42.699673,43.6851704,44.6706678,45.6561652,46.6416626,47.62716,48.8073588,49.9875576,51.1677564,52.3479552,53.528154,54.7341136,55.9400732,57.1460328,58.3519924,59.557952,60.7299862,61.9020204,63.0740546,64.2460888,65.418123,66.4570274,67.4959318,68.5348362,69.5737406,70.612645,71.534296,72.455947,73.377598,74.299249,75.2209,76.0997558,76.9786116,77.8574674,78.7363232,79.615179,80.3562982,81.0974174,81.8385366,82.5796558,83.320775,84.1052104,84.8896458,85.6740812,86.4585166,87.242952,87.741789,88.240626,88.739463,89.2383,89.737137,89.9502738,90.1634106,90.3765474,
Iraq,IRQ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,40.659587,42.086924,43.514261,45.1028554,46.6914498,48.2800442,49.8686386,51.457233,52.5497046,53.6421762,54.7346478,55.8271194,56.919591,57.6834378,58.4472846,59.2111314,59.9749782,60.738825,62.0938838,63.4489426,64.8040014,66.1590602,67.514119,68.4247056,69.3352922,70.2458788,71.1564654,72.067052,72.8616894,73.6563268,74.4509642,75.2456016,76.040239,76.5395344,77.0388298,77.5381252,78.0374206,78.536716,78.1676918,77.7986676,77.4296434,77.0606192,76.691595,76.7513028,76.8110106,76.8707184,76.9304262,76.990134,77.0570256,77.1239172,77.1908088,77.2577004,77.324592,77.5579304,77.7912688,78.0246072,78.2579456,78.491284,78.7386294,78.9859748,79.2333202,
Iceland,ISL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,83.81839,84.195186,84.571982,84.5432076,84.5144332,84.4856588,84.4568844,84.42811,84.4391764,84.4502428,84.4613092,84.4723756,84.483442,84.9812122,85.4789824,85.9767526,86.4745228,86.972293,87.3322452,87.6921974,88.0521496,88.4121018,88.772054,88.6832994,88.5945448,88.5057902,88.4170356,88.328281,88.5217216,88.7151622,88.9086028,89.1020434,89.295484,89.4835682,89.6716524,89.8597366,90.0478208,90.235905,90.4698572,90.7038094,90.9377616,91.1717138,91.405666,91.6611486,91.9166312,92.1721138,92.4275964,92.683079,92.7574646,92.8318502,92.9062358,92.9806214,93.055007,93.1570676,93.2591282,93.3611888,93.4632494,93.56531,93.7052694,93.8452288,93.9851882,
Israel,ISR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.256035,78.53645,78.816865,79.08393,79.350995,79.61806,79.885125,80.15219,80.438123,80.724056,81.009989,81.295922,81.581855,81.9033994,82.2249438,82.5464882,82.8680326,83.189577,83.5325994,83.8756218,84.2186442,84.5616666,84.904689,85.2453648,85.5860406,85.9267164,86.2673922,86.608068,86.8778522,87.1476364,87.4174206,87.6872048,87.956989,88.315215,88.673441,89.031667,89.389893,89.748119,90.0250368,90.3019546,90.5788724,90.8557902,91.132708,91.3403744,91.5480408,91.7557072,91.9633736,92.17104,92.317585,92.46413,92.610675,92.75722,92.903765,93.0392436,93.1747222,93.3102008,93.4456794,93.581158,93.6801584,93.7791588,93.8781592,
Italy,ITA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.111624,79.562899,80.014174,80.3865612,80.7589484,81.1313356,81.5037228,81.87611,82.2534598,82.6308096,83.0081594,83.3855092,83.762859,84.1913648,84.6198706,85.0483764,85.4768822,85.905388,86.2157958,86.5262036,86.8366114,87.1470192,87.457427,87.757519,88.057611,88.357703,88.657795,88.957887,89.1740814,89.3902758,89.6064702,89.8226646,90.038859,90.2496146,90.4603702,90.6711258,90.8818814,91.092637,91.3115008,91.5303646,91.7492284,91.9680922,92.186956,92.3463948,92.5058336,92.6652724,92.8247112,92.98415,93.0794386,93.1747272,93.2700158,93.3653044,93.460593,93.5640754,93.6675578,93.7710402,93.8745226,93.978005,94.0796028,94.1812006,94.2827984,
Jamaica,JAM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,67.936555,68.355206,68.773857,69.3847226,69.9955882,70.6064538,71.2173194,71.828185,72.3584448,72.8887046,73.4189644,73.9492242,74.479484,74.9161202,75.3527564,75.7893926,76.2260288,76.662665,77.0846742,77.5066834,77.9286926,78.3507018,78.772711,79.0589274,79.3451438,79.6313602,79.9175766,80.203793,80.562258,80.920723,81.279188,81.637653,81.996118,81.9217996,81.8474812,81.7731628,81.6988444,81.624526,81.7175334,81.8105408,81.9035482,81.9965556,82.089563,82.2797428,82.4699226,82.6601024,82.8502822,83.040462,82.9289662,82.8174704,82.7059746,82.5944788,82.482983,82.5869004,82.6908178,82.7947352,82.8986526,83.00257,83.1919358,83.3813016,83.5706674,
Jordan,JOR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,49.1925152,50.2892966,51.386078,52.5989418,53.8118056,55.0246694,56.2375332,57.450397,58.6736868,59.8969766,61.1202664,62.3435562,63.566846,64.6566484,65.7464508,66.8362532,67.9260556,69.015858,69.7878772,70.5598964,71.3319156,72.1039348,72.875954,73.4890412,74.1021284,74.7152156,75.3283028,75.94139,76.3738852,76.8063804,77.2388756,77.6713708,78.103866,78.3870558,78.6702456,78.9534354,79.2366252,79.519815,79.837244,80.154673,80.472102,80.789531,81.10696,81.3884764,81.6699928,81.9515092,82.2330256,82.514542,82.7554582,82.9963744,83.2372906,83.4782068,83.719123,83.9188594,84.1185958,84.3183322,84.5180686,84.717805,84.9106818,85.1035586,85.2964354,
Japan,JPN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.688986,76.745849,77.802712,78.5574906,79.3122692,80.0670478,80.8218264,81.576605,82.1713998,82.7661946,83.3609894,83.9557842,84.550579,85.1453186,85.7400582,86.3347978,86.9295374,87.524277,87.8999376,88.2755982,88.6512588,89.0269194,89.40258,89.6873748,89.9721696,90.2569644,90.5417592,90.826554,90.9734052,91.1202564,91.2671076,91.4139588,91.56081,91.6832162,91.8056224,91.9280286,92.0504348,92.172841,92.3231196,92.4733982,92.6236768,92.7739554,92.924234,93.0223108,93.1203876,93.2184644,93.3165412,93.414618,93.4835442,93.5524704,93.6213966,93.6903228,93.759249,93.8960564,94.0328638,94.1696712,94.3064786,94.443286,94.5306804,94.6180748,94.7054692,
Kazakhstan,KAZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.706786,67.327746,67.948706,68.5669168,69.1851276,69.8033384,70.4215492,71.03976,71.4826,71.92544,72.36828,72.81112,73.25396,73.544096,73.834232,74.124368,74.414504,74.70464,75.1646688,75.6246976,76.0847264,76.5447552,77.004784,77.346671,77.688558,78.030445,78.372332,78.714219,77.773893,76.833567,75.893241,74.952915,74.012589,73.3577932,72.7029974,72.0482016,71.3934058,70.73861,71.2717618,71.8049136,72.3380654,72.8712172,73.404369,73.8975856,74.3908022,74.8840188,75.3772354,75.870452,76.6842458,77.4980396,78.3118334,79.1256272,79.939421,80.9178756,81.8963302,82.8747848,83.8532394,84.831694,84.9992988,85.1669036,85.3345084,
Kenya,KEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.4502542,44.4525286,45.454803,46.215303,46.975803,47.736303,48.496803,49.257303,50.092276,50.927249,51.762222,52.597195,53.432168,54.164058,54.895948,55.627838,56.359728,57.091618,57.80861,58.525602,59.242594,59.959586,60.676578,60.6229386,60.5692992,60.5156598,60.4620204,60.408381,59.194633,57.980885,56.767137,55.553389,54.339641,52.369631,50.399621,48.429611,46.459601,44.489591,44.0610694,43.6325478,43.2040262,42.7755046,42.346983,44.9827202,47.6184574,50.2541946,52.8899318,55.525669,57.3086542,59.0916394,60.8746246,62.6576098,64.440595,65.6565528,66.8725106,68.0884684,69.3044262,70.520384,70.9704974,71.4206108,71.8707242,
Kyrgyz Republic,KGZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.16992,61.826884,62.483848,63.1437146,63.8035812,64.4634478,65.1233144,65.783181,66.2693068,66.7554326,67.2415584,67.7276842,68.21381,68.5307526,68.8476952,69.1646378,69.4815804,69.798523,70.2862548,70.7739866,71.2617184,71.7494502,72.237182,72.7383612,73.2395404,73.7407196,74.2418988,74.743078,74.851061,74.959044,75.067027,75.17501,75.282993,74.930779,74.578565,74.226351,73.874137,73.521923,73.7277772,73.9336314,74.1394856,74.3453398,74.551194,74.9763332,75.4014724,75.8266116,76.2517508,76.67689,77.5745942,78.4722984,79.3700026,80.2677068,81.165411,81.6911558,82.2169006,82.7426454,83.2683902,83.794135,83.9829036,84.1716722,84.3604408,
Cambodia,KHM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.5514564,31.7844582,32.01746,32.3159958,32.6145316,32.9130674,33.2116032,33.510139,32.7006066,31.8910742,31.0815418,30.2720094,29.462477,24.86276154,20.26304608,15.66333062,11.06361516,6.4638997,13.22090716,19.97791462,26.73492208,33.49192954,40.248937,41.9791968,43.7094566,45.4397164,47.1699762,48.900236,49.7684248,50.6366136,51.5048024,52.3729912,53.24118,54.0939596,54.9467392,55.7995188,56.6522984,57.505078,58.753953,60.002828,61.251703,62.500578,63.749453,65.0569016,66.3643502,67.6717988,68.9792474,70.286696,71.0213126,71.7559292,72.4905458,73.2251624,73.959779,74.6110622,75.2623454,75.9136286,76.5649118,77.216195,77.592968,77.969741,78.346514,
Kiribati,KIR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.1086592,43.7741506,44.439642,45.188002,45.936362,46.684722,47.433082,48.181442,48.9027252,49.6240084,50.3452916,51.0665748,51.787858,52.3692172,52.9505764,53.5319356,54.1132948,54.694654,55.1048366,55.5150192,55.9252018,56.3353844,56.745567,57.4305372,58.1155074,58.8004776,59.4854478,60.170418,60.897042,61.623666,62.35029,63.076914,63.803538,64.4336344,65.0637308,65.6938272,66.3239236,66.95402,67.4155664,67.8771128,68.3386592,68.8002056,69.261752,69.580348,69.898944,70.21754,70.536136,70.854732,71.2665154,71.6782988,72.0900822,72.5018656,72.913649,73.2342024,73.5547558,73.8753092,74.1958626,74.516416,74.8477898,75.1791636,75.5105374,
St. Kitts and Nevis,KNA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Korea, Rep.",KOR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,58.3722566,59.1328708,59.893485,60.6543846,61.4152842,62.1761838,62.9370834,63.697983,64.6008666,65.5037502,66.4066338,67.3095174,68.212401,69.0073884,69.8023758,70.5973632,71.3923506,72.187338,73.0445716,73.9018052,74.7590388,75.6162724,76.473506,77.4779252,78.4823444,79.4867636,80.4911828,81.495602,82.241234,82.986866,83.732498,84.47813,85.223762,85.841728,86.459694,87.07766,87.695626,88.313592,88.8315524,89.3495128,89.8674732,90.3854336,90.903394,91.2473844,91.5913748,91.9353652,92.2793556,92.623346,92.8701232,93.1169004,93.3636776,93.6104548,93.857232,94.083705,94.310178,94.536651,94.763124,94.989597,95.0817362,95.1738754,95.2660146,
Kuwait,KWT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.0176302,66.1146956,67.211761,68.1724716,69.1331822,70.0938928,71.0546034,72.015314,72.7253058,73.4352976,74.1452894,74.8552812,75.565273,76.1479366,76.7306002,77.3132638,77.8959274,78.478591,78.9897524,79.5009138,80.0120752,80.5232366,81.034398,81.3880456,81.7416932,82.0953408,82.4489884,82.802636,83.0594414,83.3162468,83.5730522,83.8298576,84.086663,84.2721522,84.4576414,84.6431306,84.8286198,85.014109,85.2031316,85.3921542,85.5811768,85.7701994,85.959222,86.1824772,86.4057324,86.6289876,86.8522428,87.075498,87.424816,87.774134,88.123452,88.47277,88.822088,89.0204184,89.2187488,89.4170792,89.6154096,89.81374,89.9806724,90.1476048,90.3145372,
Latin America & Caribbean (excluding high income),LAC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.87170662,56.68390142,57.4935214,58.16482395,58.83345406,59.49951091,60.16671087,60.83296096,61.54217912,62.25116132,62.96027633,63.67843784,64.3950496,65.08456221,65.7759116,66.4695315,67.16686604,67.86581971,68.4932572,69.12156587,69.7510218,70.38804216,71.02633542,71.57320711,72.12129742,72.67014053,73.22206287,73.77255217,74.2812279,74.79014167,75.29964149,75.80737792,76.31737743,76.78751164,77.2559661,77.72241737,78.19102327,78.65778239,79.0929918,79.52900767,79.96638712,80.40660053,80.84735962,81.15192574,81.45629371,81.76026658,82.06367143,82.36708743,82.59233386,82.81719859,83.04109829,83.26602419,83.49054082,83.68486231,83.87938249,84.07426723,84.27068273,84.4675183,84.64055606,84.81325229,84.98537326,
Lao PDR,LAO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.3880668,36.7781454,37.168224,37.5514612,37.9346984,38.3179356,38.7011728,39.08441,39.4964052,39.9084004,40.3203956,40.7323908,41.144386,41.4916622,41.8389384,42.1862146,42.5334908,42.880767,43.2992574,43.7177478,44.1362382,44.5547286,44.973219,45.6665434,46.3598678,47.0531922,47.7465166,48.439841,49.197917,49.955993,50.714069,51.472145,52.230221,53.1654802,54.1007394,55.0359986,55.9712578,56.906517,57.8219418,58.7373666,59.6527914,60.5682162,61.483641,62.3790824,63.2745238,64.1699652,65.0654066,65.960848,66.7702398,67.5796316,68.3890234,69.1984152,70.007807,70.666187,71.324567,71.982947,72.641327,73.299707,73.835482,74.371257,74.907032,
Lebanon,LBN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.5565434,67.0825482,67.608553,68.0502496,68.4919462,68.9336428,69.3753394,69.817036,70.2788926,70.7407492,71.2026058,71.6644624,72.126319,72.4239254,72.7215318,73.0191382,73.3167446,73.614351,73.8533408,74.0923306,74.3313204,74.5703102,74.8093,75.2066966,75.6040932,76.0014898,76.3988864,76.796283,77.241944,77.687605,78.133266,78.578927,79.024588,79.7791014,80.5336148,81.2881282,82.0426416,82.797155,83.5691908,84.3412266,85.1132624,85.8852982,86.657334,87.2143326,87.7713312,88.3283298,88.8853284,89.442327,89.6343574,89.8263878,90.0184182,90.2104486,90.402479,90.4345764,90.4666738,90.4987712,90.5308686,90.562966,90.6453828,90.7277996,90.8102164,
Liberia,LBR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,28.0863942,28.3820556,28.677717,29.2534054,29.8290938,30.4047822,30.9804706,31.556159,32.3392146,33.1222702,33.9053258,34.6883814,35.471437,36.6408264,37.8102158,38.9796052,40.1489946,41.318384,42.0875442,42.8567044,43.6258646,44.3950248,45.164185,45.2846924,45.4051998,45.5257072,45.6462146,45.766722,45.7012558,45.6357896,45.5703234,45.5048572,45.439391,46.4568276,47.4742642,48.4917008,49.5091374,50.526574,50.2573822,49.9881904,49.7189986,49.4498068,49.180615,51.01817,52.855725,54.69328,56.530835,58.36839,59.1127596,59.8571292,60.6014988,61.3458684,62.090238,62.9546242,63.8190104,64.6833966,65.5477828,66.412169,66.888109,67.364049,67.839989,
Libya,LBY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.4982676,40.6229588,42.74765,44.5990136,46.4503772,48.3017408,50.1531044,52.004468,53.6798848,55.3553016,57.0307184,58.7061352,60.381552,61.6243778,62.8672036,64.1100294,65.3528552,66.595681,67.5485646,68.5014482,69.4543318,70.4072154,71.360099,71.9570034,72.5539078,73.1508122,73.7477166,74.344621,74.9149076,75.4851942,76.0554808,76.6257674,77.196054,77.5365196,77.8769852,78.2174508,78.5579164,78.898382,79.1885806,79.4787792,79.7689778,80.0591764,80.349375,80.87118,81.392985,81.91479,82.436595,82.9584,82.8718356,82.7852712,82.6987068,82.6121424,82.525578,82.7514956,82.9774132,83.2033308,83.4292484,83.655166,83.8647144,84.0742628,84.2838112,
St. Lucia,LCA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.790831,61.071243,62.351655,63.2704742,64.1892934,65.1081126,66.0269318,66.945751,67.3995494,67.8533478,68.3071462,68.7609446,69.214743,69.8678796,70.5210162,71.1741528,71.8272894,72.480426,72.9614388,73.4424516,73.9234644,74.4044772,74.88549,75.177593,75.469696,75.761799,76.053902,76.346005,76.6925696,77.0391342,77.3856988,77.7322634,78.078828,78.4877784,78.8967288,79.3056792,79.7146296,80.12358,80.5966734,81.0697668,81.5428602,82.0159536,82.489047,82.6937024,82.8983578,83.1030132,83.3076686,83.512324,83.5261964,83.5400688,83.5539412,83.5678136,83.581686,83.6883008,83.7949156,83.9015304,84.0081452,84.11476,84.2975366,84.4803132,84.6630898,
Latin America & Caribbean,LCN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,56.68505442,57.49017168,58.29365047,58.96868701,59.63965279,60.3066707,60.97268858,61.63707152,62.34996812,63.06328867,63.77790779,64.50391297,65.22925463,65.91936381,66.61089545,67.30403671,68.00014378,68.69748152,69.31599431,69.9349051,70.55453819,71.18044058,71.80719056,72.33282582,72.85974832,73.38765737,73.9195736,74.45002151,74.93842955,75.4272279,75.91680745,76.40443625,76.89452171,77.34414755,77.79236158,78.23876971,78.687372,79.13436824,79.55720913,79.98107005,80.40642816,80.83487817,81.26407809,81.55265584,81.84121674,82.12950374,82.41715862,82.70488952,82.91642599,83.12764342,83.33801799,83.54856762,83.75871288,83.92667654,84.094953,84.26418644,84.43640543,84.61027206,84.77526255,84.94063811,85.10516368,
Least developed countries: UN classification,LDC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,33.07217304,33.67198198,34.27192916,34.85419109,35.4356486,36.0166847,36.60500139,37.19260463,37.56735531,37.93778167,38.30410615,38.67001079,39.03258108,39.67452332,40.31504876,40.95857927,41.61862118,42.28941444,43.00407493,43.71261164,44.41421747,45.11140479,45.80643192,46.41905296,47.02737831,47.63125431,48.23703187,48.83731875,49.17239699,49.50298965,49.83432323,50.18107031,50.53937932,50.98934651,51.42649582,51.85200389,52.28466428,52.71022835,53.32604775,53.93635924,54.54149625,55.14578831,55.74557068,56.73521401,57.71994468,58.70091227,59.68527395,60.66639275,61.68776015,62.70960319,63.73343805,64.76914437,65.80620534,66.52511579,67.24330531,67.96117325,68.68161018,69.40282266,69.85361983,70.30209696,70.74804215,
Low income,LIC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.93561571,33.52586989,34.12940541,34.79643077,35.45590408,36.09923324,36.77603621,37.42033338,38.06118347,38.70683451,39.36920007,40.03273028,40.71898307,41.33437756,41.94091743,42.52955743,43.1271848,43.7105109,44.20061551,44.69649604,45.20189476,45.74749861,46.28238055,46.76716238,47.24579691,47.71858067,48.17648665,48.63454767,48.77853032,48.90642802,49.02380213,49.17840694,49.34246488,49.41618355,49.47602273,49.52460881,49.57905909,49.62744775,50.19712072,50.75781285,51.31152986,51.86436187,52.41175806,53.44659932,54.48730594,55.53588058,56.61080831,57.69061442,58.77852553,59.85148544,60.90835271,61.95427658,62.99253018,63.71887576,64.44849093,65.18641055,65.93367015,66.69003202,67.16996062,67.65684343,68.15010129,
Liechtenstein,LIE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Sri Lanka,LKA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.2521156,64.8098318,65.367548,66.0886896,66.8098312,67.5309728,68.2521144,68.973256,69.4155666,69.8578772,70.3001878,70.7424984,71.184809,71.6728882,72.1609674,72.6490466,73.1371258,73.625205,74.5491252,75.4730454,76.3969656,77.3208858,78.244806,78.3866758,78.5285456,78.6704154,78.8122852,78.954155,79.2262094,79.4982638,79.7703182,80.0423726,80.314427,80.2207928,80.1271586,80.0335244,79.9398902,79.846256,81.2366596,82.6270632,84.0174668,85.4078704,86.798274,87.0692546,87.3402352,87.6112158,87.8821964,88.153177,88.3953022,88.6374274,88.8795526,89.1216778,89.363803,89.5797596,89.7957162,90.0116728,90.2276294,90.443586,90.5837024,90.7238188,90.8639352,
Lower middle income,LMC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.65431474,39.47149891,40.28853989,41.14443936,41.9946645,42.8383283,43.69058135,44.53607361,45.31251529,46.08643584,46.85869652,47.64322169,48.42397546,49.35307507,50.28021298,51.20659505,52.13998786,53.07258948,53.78142088,54.489973,55.19961724,55.92046199,56.64112912,57.16914926,57.69494248,58.2169827,58.74388585,59.26688957,59.8676723,60.46743271,61.07653024,61.67904522,62.28070535,62.78414107,63.28430254,63.78423375,64.29265179,64.80237191,65.23952182,65.67516048,66.10924017,66.55139228,66.99012234,67.55567799,68.12082616,68.68583629,69.25383505,69.82035291,70.47327089,71.12273789,71.76923583,72.41614417,73.05863116,73.46032589,73.85978797,74.25824145,74.65827181,75.05744392,75.36767553,75.67622157,75.98373957,
Low & middle income,LMY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.88777838,43.50658341,44.11186821,45.63040643,47.14335876,48.64671966,50.15919764,51.66999867,52.7373357,53.80786153,54.87924422,55.96931143,57.05043391,57.94984195,58.84514952,59.73686019,60.64628223,61.5530443,62.17910939,62.81029428,63.44489781,64.10723856,64.77207403,65.28116447,65.78028164,66.27122191,66.76361152,67.24747703,67.6079787,67.96280119,68.31725946,68.66676805,69.02572222,69.35235128,69.67287743,69.98434062,70.32696148,70.65254946,70.9760207,71.30270746,71.63862573,71.97868384,72.32835979,72.83850503,73.34400208,73.84077251,74.33910776,74.82932588,75.38384302,75.93419074,76.48187663,77.03255485,77.58367146,77.92696213,78.26655237,78.60274417,78.93949159,79.27616365,79.47586899,79.67467869,79.87383496,
Lesotho,LSO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,49.374215,49.773372,50.172529,50.5580708,50.9436126,51.3291544,51.7146962,52.100238,52.7012948,53.3023516,53.9034084,54.5044652,55.105522,55.9899404,56.8743588,57.7587772,58.6431956,59.527614,60.3876364,61.2476588,62.1076812,62.9677036,63.827726,64.295543,64.76336,65.231177,65.698994,66.166811,65.5561328,64.9454546,64.3347764,63.7240982,63.11342,60.0438894,56.9743588,53.9048282,50.8352976,47.765767,43.787349,39.808931,35.830513,31.852095,27.873677,27.4175186,26.9613602,26.5052018,26.0490434,25.592885,27.5246874,29.4564898,31.3882922,33.3200946,35.251897,37.4757912,39.6996854,41.9235796,44.1474738,46.371368,47.0636038,47.7558396,48.4480754,
Late-demographic dividend,LTE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,48.92948549,49.46974854,49.9348149,52.15492592,54.37059305,56.55698129,58.75517427,60.95311063,62.23809412,63.53260226,64.84294453,66.17521796,67.51832433,68.47066118,69.42708193,70.38770605,71.34908786,72.31679724,72.87784637,73.44314519,74.01421436,74.59211943,75.17527527,75.62235052,76.07182141,76.52305651,76.97655616,77.43158259,77.64395559,77.86046388,78.08083139,78.30439306,78.52772591,78.803563,79.08202951,79.36527183,79.64704294,79.92922149,80.29574222,80.66343376,81.03283041,81.4057953,81.78221289,82.23271988,82.68163067,83.12816395,83.57396216,84.01678087,84.46468151,84.91155714,85.35859241,85.80554191,86.25268714,86.56722643,86.88069803,87.19274435,87.50423612,87.81486141,87.97750526,88.14012624,88.30351314,
Lithuania,LTU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.5963904,78.4253982,79.254406,79.7464408,80.2384756,80.7305104,81.2225452,81.71458,81.8675468,82.0205136,82.1734804,82.3264472,82.479414,82.388395,82.297376,82.206357,82.115338,82.024319,81.9619858,81.8996526,81.8373194,81.7749862,81.712653,81.964177,82.215701,82.467225,82.718749,82.970273,82.6355178,82.3007626,81.9660074,81.6312522,81.296497,81.4736982,81.6508994,81.8281006,82.0053018,82.182503,82.5797162,82.9769294,83.3741426,83.7713558,84.168569,84.1160064,84.0634438,84.0108812,83.9583186,83.905756,84.3292528,84.7527496,85.1762464,85.5997432,86.02324,86.3280286,86.6328172,86.9376058,87.2423944,87.547183,87.673966,87.800749,87.927532,
Luxembourg,LUX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.2730678,78.8118594,79.350651,79.5317998,79.7129486,79.8940974,80.0752462,80.256395,80.3225988,80.3888026,80.4550064,80.5212102,80.587414,81.0686396,81.5498652,82.0310908,82.5123164,82.993542,83.1966918,83.3998416,83.6029914,83.8061412,84.009291,84.5300958,85.0509006,85.5717054,86.0925102,86.613315,86.7453088,86.8773026,87.0092964,87.1412902,87.273284,87.5502912,87.8272984,88.1043056,88.3813128,88.65832,88.8978016,89.1372832,89.3767648,89.6162464,89.855728,89.9783448,90.1009616,90.2235784,90.3461952,90.468812,90.7620832,91.0553544,91.3486256,91.6418968,91.935168,92.0796036,92.2240392,92.3684748,92.5129104,92.657346,92.7759516,92.8945572,93.0131628,
Latvia,LVA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.9322,79.6626,80.393,80.666,80.939,81.212,81.485,81.758,81.6652,81.5724,81.4796,81.3868,81.294,81.1198,80.9456,80.7714,80.5972,80.423,80.3938,80.3646,80.3354,80.3062,80.277,80.5262,80.7754,81.0246,81.2738,81.523,80.9648,80.4066,79.8484,79.2902,78.732,78.9352,79.1384,79.3416,79.5448,79.748,80.2582,80.7684,81.2786,81.7888,82.299,82.4386,82.5782,82.7178,82.8574,82.997,83.4412688,83.8855376,84.3298064,84.7740752,85.218344,85.4331316,85.6479192,85.8627068,86.0774944,86.292282,86.4244358,86.5565896,86.6887434,
"Macao SAR, China",MAC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.360635,70.243392,71.126149,71.9064204,72.6866918,73.4669632,74.2472346,75.027506,75.9037024,76.7798988,77.6560952,78.5322916,79.408488,80.1520616,80.8956352,81.6392088,82.3827824,83.126356,83.6615808,84.1968056,84.7320304,85.2672552,85.80248,86.2829074,86.7633348,87.2437622,87.7241896,88.204617,88.6535414,89.1024658,89.5513902,90.0003146,90.449239,90.8203596,91.1914802,91.5626008,91.9337214,92.304842,92.5888692,92.8728964,93.1569236,93.4409508,93.724978,93.946409,94.16784,94.389271,94.610702,94.832133,94.9825654,95.1329978,95.2834302,95.4338626,95.584295,95.6584254,95.7325558,95.8066862,95.8808166,95.954947,96.024147,96.093347,96.162547,
St. Martin (French part),MAF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Morocco,MAR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.0501096,47.3449238,47.639738,48.2035968,48.7674556,49.3313144,49.8951732,50.459032,50.95734,51.455648,51.953956,52.452264,52.950572,53.5515388,54.1525056,54.7534724,55.3544392,55.955406,57.2079508,58.4604956,59.7130404,60.9655852,62.21813,63.2731786,64.3282272,65.3832758,66.4383244,67.493373,68.3884524,69.2835318,70.1786112,71.0736906,71.96877,72.425451,72.882132,73.338813,73.795494,74.252175,75.0130024,75.7738298,76.5346572,77.2954846,78.056312,79.3214204,80.5865288,81.8516372,83.1167456,84.381854,84.8760596,85.3702652,85.8644708,86.3586764,86.852882,87.1446022,87.4363224,87.7280426,88.0197628,88.311483,88.5728042,88.8341254,89.0954466,
Monaco,MCO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Moldova,MDA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,67.216059,67.683289,68.150519,68.5117768,68.8730346,69.2342924,69.5955502,69.956808,70.0352616,70.1137152,70.1921688,70.2706224,70.349076,70.349076,70.349076,70.349076,70.349076,70.349076,70.1622476,69.9754192,69.7885908,69.6017624,69.414934,70.3207962,71.2266584,72.1325206,73.0383828,73.944245,74.0178426,74.0914402,74.1650378,74.2386354,74.312233,74.0462536,73.7802742,73.5142948,73.2483154,72.982336,73.2545704,73.5268048,73.7990392,74.0712736,74.343508,74.5126414,74.6817748,74.8509082,75.0200416,75.189175,76.5112514,77.8333278,79.1554042,80.4774806,81.799557,82.013977,82.228397,82.442817,82.657237,82.871657,83.047529,83.223401,83.399273,
Madagascar,MDG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.0635958,32.6722054,33.280815,33.8857834,34.4907518,35.0957202,35.7006886,36.305657,36.9603386,37.6150202,38.2697018,38.9243834,39.579065,40.251168,40.923271,41.595374,42.267477,42.93958,43.4693048,43.9990296,44.5287544,45.0584792,45.588204,45.6710956,45.7539872,45.8368788,45.9197704,46.002662,46.8807684,47.7588748,48.6369812,49.5150876,50.393194,51.2568454,52.1204968,52.9841482,53.8477996,54.711451,55.8180746,56.9246982,58.0313218,59.1379454,60.244569,60.9457964,61.6470238,62.3482512,63.0494786,63.750706,64.5019318,65.2531576,66.0043834,66.7556092,67.506835,68.1767386,68.8466422,69.5165458,70.1864494,70.856353,71.4444808,72.0326086,72.6207364,
Maldives,MDV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,27.188035,27.794779,28.401523,29.1237408,29.8459586,30.5681764,31.2903942,32.012612,32.8108838,33.6091556,34.4074274,35.2056992,36.003971,36.7756846,37.5473982,38.3191118,39.0908254,39.862539,41.4568342,43.0511294,44.6454246,46.2397198,47.834015,49.1801662,50.5263174,51.8724686,53.2186198,54.564771,56.5719532,58.5791354,60.5863176,62.5934998,64.600682,66.2488568,67.8970316,69.5452064,71.1933812,72.841556,74.1409878,75.4404196,76.7398514,78.0392832,79.338715,80.4512218,81.5637286,82.6762354,83.7887422,84.901249,85.7159188,86.5305886,87.3452584,88.1599282,88.974598,89.5404954,90.1063928,90.6722902,91.2381876,91.804085,92.009968,92.215851,92.421734,
Middle East & North Africa,MEA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.14543361,44.93158443,45.73756809,46.6088534,47.47846035,48.33798671,49.18965873,50.04863758,50.85669866,51.66802209,52.48478301,53.30601085,54.12112253,55.13302988,56.13261761,57.12340141,58.10431667,59.08210467,60.25980035,61.44147947,62.62507493,63.81740878,65.01164381,66.01134853,67.00782782,68.00603867,69.00570226,70.00189499,70.73505069,71.46698488,72.21501573,72.96604046,73.63331107,74.2462885,74.85696652,75.51498199,76.12003693,76.722734,77.18625926,77.64850834,78.10979384,78.56821015,79.02667673,79.51837843,80.01029102,80.50305071,81.00402282,81.5040829,81.87749847,82.24672536,82.60854259,82.96065216,83.30936951,83.59211624,83.8697754,84.14350306,84.42080215,84.69311494,84.89645299,85.10127634,85.30887144,
Mexico,MEX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.4018316,58.3069088,59.211986,59.7397948,60.2676036,60.7954124,61.3232212,61.85103,62.6059718,63.3609136,64.1158554,64.8707972,65.625739,66.6023534,67.5789678,68.5555822,69.5321966,70.508811,71.292008,72.075205,72.858402,73.641599,74.424796,75.0115864,75.5983768,76.1851672,76.7719576,77.358748,77.888409,78.41807,78.947731,79.477392,80.007053,80.2799618,80.5528706,80.8257794,81.0986882,81.371597,81.8460476,82.3204982,82.7949488,83.2693994,83.74385,83.8196832,83.8955164,83.9713496,84.0471828,84.123016,84.1074316,84.0918472,84.0762628,84.0606784,84.045094,84.0406382,84.0361824,84.0317266,84.0272708,84.022815,84.1076902,84.1925654,84.2774406,
Marshall Islands,MHL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Middle income,MIC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.54764321,44.17473373,44.78552705,46.36498977,47.93859115,49.50092072,51.07020804,52.63755067,53.72984312,54.82580786,55.92356046,57.03872714,58.14570218,59.06532627,59.98162547,60.89524969,61.82562844,62.75420485,63.38880738,64.02798747,64.67029642,65.33529389,66.00395973,66.5112415,67.01046628,67.50330823,67.99836742,68.48667707,68.86669903,69.24382283,69.62240648,69.99608698,70.37964988,70.73554359,71.08721792,71.43165871,71.80116566,72.15655116,72.47453758,72.79675627,73.12888429,73.46645044,73.81436264,74.2984085,74.7782329,75.24975774,75.72032686,76.18321544,76.71543185,77.24404929,77.7703286,78.29890054,78.8275826,79.15724623,79.48334259,79.80592355,80.12810742,80.44968917,80.64799987,80.84500434,81.04174217,
North Macedonia,MKD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.5064724,62.6465432,63.786614,64.9327216,66.0788292,67.2249368,68.3710444,69.517152,70.434051,71.35095,72.267849,73.184748,74.101647,74.6067,75.111753,75.616806,76.121859,76.626912,76.7577362,76.8885604,77.0193846,77.1502088,77.281033,77.801458,78.321883,78.842308,79.362733,79.883158,80.1791898,80.4752216,80.7712534,81.0672852,81.363317,81.8381988,82.3130806,82.7879624,83.2628442,83.737726,84.1758432,84.6139604,85.0520776,85.4901948,85.928312,85.983949,86.039586,86.095223,86.15086,86.206497,86.483181,86.759865,87.036549,87.313233,87.589917,87.6983858,87.8068546,87.9153234,88.0237922,88.132261,88.2992964,88.4663318,88.6333672,
Mali,MLI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,18.2374678,18.4608144,18.684161,19.2817412,19.8793214,20.4769016,21.0744818,21.672062,22.582995,23.493928,24.404861,25.315794,26.226727,27.236986,28.247245,29.257504,30.267763,31.278022,32.3953808,33.5127396,34.6300984,35.7474572,36.864816,37.6355496,38.4062832,39.1770168,39.9477504,40.718484,41.2650152,41.8115464,42.3580776,42.9046088,43.45114,43.3392602,43.2273804,43.1155006,43.0036208,42.891741,43.696952,44.502163,45.307374,46.112585,46.917796,47.9963618,49.0749276,50.1534934,51.2320592,52.310625,52.8590044,53.4073838,53.9557632,54.5041426,55.052522,55.8164502,56.5803784,57.3443066,58.1082348,58.872163,59.4792082,60.0862534,60.6932986,
Malta,MLT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.7149014,77.1141352,77.513369,77.9845482,78.4557274,78.9269066,79.3980858,79.869265,80.2600638,80.6508626,81.0416614,81.4324602,81.823259,82.1457544,82.4682498,82.7907452,83.1132406,83.435736,83.6837654,83.9317948,84.1798242,84.4278536,84.675883,85.3465766,86.0172702,86.6879638,87.3586574,88.029351,88.4255066,88.8216622,89.2178178,89.6139734,90.010129,90.2605258,90.5109226,90.7613194,91.0117162,91.262113,91.3491612,91.4362094,91.5232576,91.6103058,91.697354,91.820943,91.944532,92.068121,92.19171,92.315299,92.4604204,92.6055418,92.7506632,92.8957846,93.040906,93.1333746,93.2258432,93.3183118,93.4107804,93.503249,93.5954238,93.6875986,93.7797734,
Myanmar,MMR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.859492,37.614419,38.369346,39.2762898,40.1832336,41.0901774,41.9971212,42.904065,43.6744204,44.4447758,45.2151312,45.9854866,46.755842,47.4286902,48.1015384,48.7743866,49.4472348,50.120083,50.791901,51.463719,52.135537,52.807355,53.479173,54.1583476,54.8375222,55.5166968,56.1958714,56.875046,57.3489308,57.8228156,58.2967004,58.7705852,59.24447,59.7106408,60.1768116,60.6429824,61.1091532,61.575324,62.0449086,62.5144932,62.9840778,63.4536624,63.923247,64.6091082,65.2949694,65.9808306,66.6666918,67.352553,68.1077554,68.8629578,69.6181602,70.3733626,71.128565,71.766488,72.404411,73.042334,73.680257,74.31818,74.659279,75.000378,75.341477,
Middle East & North Africa (excluding high income),MNA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.2125943,43.99785869,44.79159868,45.65671159,46.51793022,47.37317027,48.2262689,49.07394937,49.86060139,50.64858993,51.43845712,52.22945682,53.02062317,54.01393689,55.00255149,55.98579952,56.95930796,57.92776874,59.12990913,60.33379899,61.54100343,62.75432373,63.97072068,64.99415929,66.01762542,67.04047933,68.06788487,69.09234678,69.82050227,70.54970306,71.30192642,72.0403707,72.78074839,73.40912849,74.03504394,74.65739525,75.27723243,75.89387711,76.38048908,76.8669739,77.35390742,77.83717864,78.32202068,78.85354341,79.38423987,79.91446033,80.449777,80.98414961,81.36199881,81.73387354,82.09926794,82.45444315,82.80607997,83.09868542,83.38705014,83.67252247,83.96430886,84.25162574,84.45658209,84.66348108,84.87387669,
Montenegro,MNE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,68.2472678,69.1649534,70.082639,71.1280526,72.1734662,73.2188798,74.2642934,75.309707,76.5288802,77.7480534,78.9672266,80.1863998,81.405573,81.8629252,82.3202774,82.7776296,83.2349818,83.692334,83.7972884,83.9022428,84.0071972,84.1121516,84.217106,84.4143496,84.6115932,84.8088368,85.0060804,85.203324,85.3834574,85.5635908,85.7437242,85.9238576,86.103991,85.7090332,85.3140754,84.9191176,84.5241598,84.129202,84.129202,84.129202,84.129202,84.129202,84.129202,84.243318,84.357434,84.47155,84.585666,84.699782,85.350656,86.00153,86.652404,87.303278,87.954152,88.130242,88.306332,88.482422,88.658512,88.834602,88.9989944,89.1633868,89.3277792,
Mongolia,MNG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.9244434,49.1067872,50.289131,51.2898742,52.2906174,53.2913606,54.2921038,55.292847,56.0876074,56.8823678,57.6771282,58.4718886,59.266649,59.4226882,59.5787274,59.7347666,59.8908058,60.046845,60.2070656,60.3672862,60.5275068,60.6877274,60.847948,61.5645216,62.2810952,62.9976688,63.7142424,64.430816,64.2989514,64.1670868,64.0352222,63.9033576,63.771493,63.604142,63.436791,63.26944,63.102089,62.934738,64.0689796,65.2032212,66.3374628,67.4717044,68.605946,69.6732346,70.7405232,71.8078118,72.8751004,73.942389,74.5908248,75.2392606,75.8876964,76.5361322,77.184568,77.5586334,77.9326988,78.3067642,78.6808296,79.054895,79.3633214,79.6717478,79.9801742,
Northern Mariana Islands,MNP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Mozambique,MOZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,32.8277616,33.5278078,34.227854,34.4209492,34.6140444,34.8071396,35.0002348,35.19333,35.5351462,35.8769624,36.2187786,36.5605948,36.902411,37.3751708,37.8479306,38.3206904,38.7934502,39.26621,39.2951508,39.3240916,39.3530324,39.3819732,39.410914,39.7091316,40.0073492,40.3055668,40.6037844,40.902002,41.339138,41.776274,42.21341,42.650546,43.087682,43.251404,43.415126,43.578848,43.74257,43.906292,43.8274954,43.7486988,43.6699022,43.5911056,43.512309,43.4028232,43.2933374,43.1838516,43.0743658,42.96488,43.9926248,45.0203696,46.0481144,47.0758592,48.103604,50.5922268,53.0808496,55.5694724,58.0580952,60.546718,61.2609172,61.9751164,62.6893156,
Mauritania,MRT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.37624,39.474335,40.57243,41.557274,42.542118,43.526962,44.511806,45.49665,46.197551,46.898452,47.599353,48.300254,49.001155,49.78517,50.569185,51.3532,52.137215,52.92123,53.7026482,54.4840664,55.2654846,56.0469028,56.828321,57.490512,58.152703,58.814894,59.477085,60.139276,60.5417948,60.9443136,61.3468324,61.7493512,62.15187,62.3617958,62.5717216,62.7816474,62.9915732,63.201499,63.3929102,63.5843214,63.7757326,63.9671438,64.158555,64.4174796,64.6764042,64.9353288,65.1942534,65.453178,65.8101248,66.1670716,66.5240184,66.8809652,67.237912,67.5881534,67.9383948,68.2886362,68.6388776,68.989119,69.3147068,69.6402946,69.9658824,
Mauritius,MUS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.7577288,59.4105964,61.063464,61.9468916,62.8303192,63.7137468,64.5971744,65.480602,65.949632,66.418662,66.887692,67.356722,67.825752,68.7742626,69.7227732,70.6712838,71.6197944,72.568305,73.3268078,74.0853106,74.8438134,75.6023162,76.360819,76.5146932,76.6685674,76.8224416,76.9763158,77.13019,77.3907422,77.6512944,77.9118466,78.1723988,78.432951,78.7160094,78.9990678,79.2821262,79.5651846,79.848243,79.8905858,79.9329286,79.9752714,80.0176142,80.059957,80.5289656,80.9979742,81.4669828,81.9359914,82.405,82.7592,83.1134,83.4676,83.8218,84.176,84.2710022,84.3660044,84.4610066,84.5560088,84.651011,84.8167168,84.9824226,85.1481284,
Malawi,MWI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,30.3461264,30.7192392,31.092352,31.4212986,31.7502452,32.0791918,32.4081384,32.737085,33.3984396,34.0597942,34.7211488,35.3825034,36.043858,36.6645984,37.2853388,37.9060792,38.5268196,39.14756,39.7273182,40.3070764,40.8868346,41.4665928,42.046351,42.3085938,42.5708366,42.8330794,43.0953222,43.357565,43.0717796,42.7859942,42.5002088,42.2144234,41.928638,40.8773754,39.8261128,38.7748502,37.7235876,36.672325,35.9734588,35.2745926,34.5757264,33.8768602,33.177994,35.2079942,37.2379944,39.2679946,41.2979948,43.327995,46.7741338,50.2202726,53.6664114,57.1125502,60.558689,61.9436022,63.3285154,64.7134286,66.0983418,67.483255,68.2307908,68.9783266,69.7258624,
Malaysia,MYS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,60.7715398,61.5559984,62.340457,63.0161574,63.6918578,64.3675582,65.0432586,65.718959,66.654464,67.589969,68.525474,69.460979,70.396484,71.0353888,71.6742936,72.3131984,72.9521032,73.591008,74.3214968,75.0519856,75.7824744,76.5129632,77.243452,77.6368106,78.0301692,78.4235278,78.8168864,79.210245,79.635892,80.061539,80.487186,80.912833,81.33848,81.598706,81.858932,82.119158,82.379384,82.63961,82.8163572,82.9931044,83.1698516,83.3465988,83.523346,83.7507418,83.9781376,84.2055334,84.4329292,84.660325,84.865799,85.071273,85.276747,85.482221,85.687695,85.8734352,86.0591754,86.2449156,86.4306558,86.616396,86.7895766,86.9627572,87.1359378,
North America,NAC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.50204524,78.67644176,78.8509007,78.98859484,79.12659059,79.26493025,79.40405788,79.54365744,79.81128322,80.07822043,80.34457144,80.61474302,80.88060627,81.30782002,81.73540498,82.16282801,82.58941752,83.0155615,83.26791472,83.52014432,83.7733063,84.02646332,84.27958317,84.41555679,84.55146774,84.68713129,84.82318703,84.96012631,85.12043253,85.28207763,85.44238448,85.60156834,85.76036007,85.91019741,86.06023492,86.2101065,86.36001862,86.50959562,86.62900562,86.74840481,86.86826504,86.98902912,87.11006427,87.26858345,87.42688436,87.58506949,87.74412574,87.9027998,88.00053644,88.09864108,88.1968177,88.29454053,88.39273681,88.30554421,88.21792664,88.12909408,88.04200899,87.95548654,88.03192863,88.10884423,88.18236007,
Namibia,NAM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.705158,43.683848,44.662538,45.4680726,46.2736072,47.0791418,47.8846764,48.690211,49.5478266,50.4054422,51.2630578,52.1206734,52.978289,54.0615596,55.1448302,56.2281008,57.3113714,58.394642,58.8887408,59.3828396,59.8769384,60.3710372,60.865136,61.607732,62.350328,63.092924,63.83552,64.578116,64.5583726,64.5386292,64.5188858,64.4991424,64.479399,61.3230058,58.1666126,55.0102194,51.8538262,48.697433,46.3084438,43.9194546,41.5304654,39.1414762,36.752487,37.1367594,37.5210318,37.9053042,38.2895766,38.673849,42.3983218,46.1227946,49.8472674,53.5717402,57.296213,58.73518,60.174147,61.613114,63.052081,64.491048,65.1646536,65.8382592,66.5118648,
New Caledonia,NCL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.675244,56.880264,58.085284,59.1704444,60.2556048,61.3407652,62.4259256,63.511086,64.470977,65.430868,66.390759,67.35065,68.310541,69.1650458,70.0195506,70.8740554,71.7285602,72.583065,73.3449784,74.1068918,74.8688052,75.6307186,76.392632,77.0528628,77.7130936,78.3733244,79.0335552,79.693786,80.2414432,80.7891004,81.3367576,81.8844148,82.432072,82.8688096,83.3055472,83.7422848,84.1790224,84.61576,84.968795,85.32183,85.674865,86.0279,86.380935,86.6605752,86.9402154,87.2198556,87.4994958,87.779136,88.0165112,88.2538864,88.4912616,88.7286368,88.966012,89.1555616,89.3451112,89.5346608,89.7242104,89.91376,90.0698102,90.2258604,90.3819106,
Niger,NER,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,25.5674932,25.7364676,25.905442,26.0351628,26.1648836,26.2946044,26.4243252,26.554046,26.8600536,27.1660612,27.4720688,27.7780764,28.084084,28.6359916,29.1878992,29.7398068,30.2917144,30.843622,31.7180082,32.5923944,33.4667806,34.3411668,35.215553,36.0847534,36.9539538,37.8231542,38.6923546,39.561555,40.3369864,41.1124178,41.8878492,42.6632806,43.438712,44.1002492,44.7617864,45.4233236,46.0848608,46.746398,47.4401674,48.1339368,48.8277062,49.5214756,50.215245,51.1543844,52.0935238,53.0326632,53.9718026,54.910942,55.9377134,56.9644848,57.9912562,59.0180276,60.044799,60.8204636,61.5961282,62.3717928,63.1474574,63.923122,64.532898,65.142674,65.75245,
Nigeria,NGA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.3704606,29.9731888,30.575917,31.0626312,31.5493454,32.0360596,32.5227738,33.009488,33.5676188,34.1257496,34.6838804,35.2420112,35.800142,36.4293482,37.0585544,37.6877606,38.3169668,38.946173,39.4390776,39.9319822,40.4248868,40.9177914,41.410696,41.3875968,41.3644976,41.3413984,41.3182992,41.2952,41.2749868,41.2547736,41.2345604,41.2143472,41.194134,40.9847654,40.7753968,40.5660282,40.3566596,40.147291,40.1067088,40.0661266,40.0255444,39.9849622,39.94438,40.6643456,41.3843112,42.1042768,42.8242424,43.544208,44.1948712,44.8455344,45.4961976,46.1468608,46.797524,47.502328,48.207132,48.911936,49.61674,50.321544,50.8325194,51.3434948,51.8544702,
Nicaragua,NIC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.0925174,43.0320242,43.971531,44.990657,46.009783,47.028909,48.048035,49.067161,50.094857,51.122553,52.150249,53.177945,54.205641,55.2326868,56.2597326,57.2867784,58.3138242,59.34087,60.0986454,60.8564208,61.6141962,62.3719716,63.129747,63.9960386,64.8623302,65.7286218,66.5949134,67.461205,68.115663,68.770121,69.424579,70.079037,70.733495,71.3080812,71.8826674,72.4572536,73.0318398,73.606426,74.3145814,75.0227368,75.7308922,76.4390476,77.147203,77.5390938,77.9309846,78.3228754,78.7147662,79.106657,79.5339646,79.9612722,80.3885798,80.8158874,81.243195,81.6176044,81.9920138,82.3664232,82.7408326,83.115242,83.361718,83.608194,83.85467,
Netherlands,NLD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,84.3196594,84.6166042,84.913549,84.9695606,85.0255722,85.0815838,85.1375954,85.193607,85.3613154,85.5290238,85.6967322,85.8644406,86.032149,86.263919,86.495689,86.727459,86.959229,87.190999,87.3795412,87.5680834,87.7566256,87.9451678,88.13371,88.2085746,88.2834392,88.3583038,88.4331684,88.508033,88.5620882,88.6161434,88.6701986,88.7242538,88.778309,88.8531456,88.9279822,89.0028188,89.0776554,89.152492,89.2366846,89.3208772,89.4050698,89.4892624,89.573455,89.7816432,89.9898314,90.1980196,90.4062078,90.614396,90.7895134,90.9646308,91.1397482,91.3148656,91.489983,91.768229,92.046475,92.324721,92.602967,92.881213,92.9845996,93.0879862,93.1913728,
Norway,NOR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,85.0217092,85.1755686,85.329428,85.493603,85.657778,85.821953,85.986128,86.150303,86.3619884,86.5736738,86.7853592,86.9970446,87.20873,87.343507,87.478284,87.613061,87.747838,87.882615,88.0213396,88.1600642,88.2987888,88.4375134,88.576238,88.5637908,88.5513436,88.5388964,88.5264492,88.514002,88.675944,88.837886,88.999828,89.16177,89.323712,89.456164,89.588616,89.721068,89.85352,89.985972,90.1079782,90.2299844,90.3519906,90.4739968,90.596003,90.7817846,90.9675662,91.1533478,91.3391294,91.524911,91.707014,91.889117,92.07122,92.253323,92.435426,92.5226204,92.6098148,92.6970092,92.7842036,92.871398,92.9741656,93.0769332,93.1797008,
Nepal,NPL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,24.3125278,24.7048474,25.097167,25.840972,26.584777,27.328582,28.072387,28.816192,29.601797,30.387402,31.173007,31.958612,32.744217,33.549243,34.354269,35.159295,35.964321,36.769347,37.7655532,38.7617594,39.7579656,40.7541718,41.750378,42.8573418,43.9643056,45.0712694,46.1782332,47.285197,48.6282126,49.9712282,51.3142438,52.6572594,54.000275,55.307314,56.614353,57.921392,59.228431,60.53547,61.68564,62.83581,63.98598,65.13615,66.28632,67.2091908,68.1320616,69.0549324,69.9778032,70.900674,71.6493542,72.3980344,73.1467146,73.8953948,74.644075,75.2349726,75.8258702,76.4167678,77.0076654,77.598563,78.117778,78.636993,79.156208,
Nauru,NRU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
New Zealand,NZL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,80.0668078,80.3190134,80.571219,80.5775372,80.5838554,80.5901736,80.5964918,80.60281,80.7383728,80.8739356,81.0094984,81.1450612,81.280624,81.480023,81.679422,81.878821,82.07822,82.277619,82.583867,82.890115,83.196363,83.502611,83.808859,83.992589,84.176319,84.360049,84.543779,84.727509,85.1064,85.485291,85.864182,86.243073,86.621964,86.878029,87.134094,87.390159,87.646224,87.902289,88.2164544,88.5306198,88.8447852,89.1589506,89.473116,89.7125404,89.9519648,90.1913892,90.4308136,90.670238,90.832053,90.993868,91.155683,91.317498,91.479313,91.6161304,91.7529478,91.8897652,92.0265826,92.1634,92.274524,92.385648,92.496772,
OECD members,OED,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.83536136,76.30294654,76.77664617,77.09389375,77.40895113,77.71907354,78.02661877,78.33089446,78.65137677,78.97255517,79.29440514,79.63167587,79.96480525,80.37635808,80.79027703,81.20683409,81.62508985,82.04764354,82.38080331,82.71715003,83.05591537,83.39694436,83.73912822,84.00347548,84.2704521,84.54102287,84.81444902,85.09103819,85.32676852,85.56577217,85.80567656,86.04784755,86.29136827,86.52156896,86.75205394,86.98364131,87.21649449,87.45038344,87.66848499,87.8874911,88.10861852,88.33176426,88.55718076,88.7152126,88.87272167,89.03037459,89.1904198,89.35095262,89.46854777,89.58458577,89.70010197,89.8127852,89.92739991,89.98219794,90.03721657,90.09153094,90.14754622,90.20416665,90.29385378,90.38341105,90.46956764,
Oman,OMN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.5041924,39.5925212,40.68085,41.7251404,42.7694308,43.8137212,44.8580116,45.902302,46.9284132,47.9545244,48.9806356,50.0067468,51.032858,52.5577392,54.0826204,55.6075016,57.1323828,58.657264,60.0455482,61.4338324,62.8221166,64.2104008,65.598685,66.7469106,67.8951362,69.0433618,70.1915874,71.339813,72.2468576,73.1539022,74.0609468,74.9679914,75.875036,76.6325544,77.3900728,78.1475912,78.9051096,79.662628,80.2814368,80.9002456,81.5190544,82.1378632,82.756672,83.2578178,83.7589636,84.2601094,84.7612552,85.262401,85.5417218,85.8210426,86.1003634,86.3796842,86.659005,86.9484956,87.2379862,87.5274768,87.8169674,88.106458,88.288315,88.470172,88.652029,
Other small states,OSS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,52.46097102,53.07389678,53.69315981,54.2523734,54.80330701,55.33349763,55.83617415,56.31030353,56.77856011,57.25372579,57.74300582,58.3437001,58.94213433,59.43996838,59.93833827,60.44804425,61.01364919,61.58723499,62.26648043,62.92099075,63.548841,64.15144284,64.74434999,65.21422272,65.66380599,66.11198515,66.56052017,66.99894196,66.86941736,66.74380665,66.62551294,66.56412174,66.4927108,65.80654019,65.11892364,64.4107893,63.69908979,62.97759303,62.20054764,61.44433213,60.70036307,60.0029146,59.33903153,59.86383771,60.40693378,60.96791151,61.56768489,62.17764683,63.57195485,64.93480748,66.26727492,67.56740145,68.84637413,69.78617287,70.7096947,71.62467562,72.54368015,73.45605462,73.79135228,74.12252469,74.4416703,
Pakistan,PAK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,39.9521472,41.1247936,42.29744,43.3175586,44.3376772,45.3577958,46.3779144,47.398033,48.2544734,49.1109138,49.9673542,50.8237946,51.680235,52.4323478,53.1844606,53.9365734,54.6886862,55.440799,56.0822818,56.7237646,57.3652474,58.0067302,58.648213,59.2001072,59.7520014,60.3038956,60.8557898,61.407684,61.846103,62.284522,62.722941,63.16136,63.599779,64.0042118,64.4086446,64.8130774,65.2175102,65.621943,65.9046796,66.1874162,66.4701528,66.7528894,67.035626,67.3411466,67.6466672,67.9521878,68.2577084,68.563229,69.147276,69.731323,70.31537,70.899417,71.483464,71.7196334,71.9558028,72.1919722,72.4281416,72.664311,72.9209498,73.1775886,73.4342274,
Panama,PAN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,61.662465,62.591005,63.519545,64.3117476,65.1039502,65.8961528,66.6883554,67.480558,68.3244678,69.1683776,70.0122874,70.8561972,71.700107,72.480392,73.260677,74.040962,74.821247,75.601532,76.2619956,76.9224592,77.5829228,78.2433864,78.90385,79.4612642,80.0186784,80.5760926,81.1335068,81.690921,81.9935158,82.2961106,82.5987054,82.9013002,83.203895,83.3770042,83.5501134,83.7232226,83.8963318,84.069441,84.2057206,84.3420002,84.4782798,84.6145594,84.750839,84.8792572,85.0076754,85.1360936,85.2645118,85.39293,85.585123,85.777316,85.969509,86.161702,86.353895,86.5446952,86.7354954,86.9262956,87.1170958,87.307896,87.4465018,87.5851076,87.7237134,
Peru,PER,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.270342,48.207042,49.143742,49.913083,50.682424,51.451765,52.221106,52.990447,54.2248742,55.4593014,56.6937286,57.9281558,59.162583,60.060755,60.958927,61.857099,62.755271,63.653443,64.366589,65.079735,65.792881,66.506027,67.219173,67.9679016,68.7166302,69.4653588,70.2140874,70.962816,71.7575848,72.5523536,73.3471224,74.1418912,74.93666,75.5373394,76.1380188,76.7386982,77.3393776,77.940057,78.465854,78.991651,79.517448,80.043245,80.569042,80.990277,81.411512,81.832747,82.253982,82.675217,83.0428022,83.4103874,83.7779726,84.1455578,84.513143,84.8349148,85.1566866,85.4784584,85.8002302,86.122002,86.3436358,86.5652696,86.7869034,
Philippines,PHL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.8187032,66.5839996,67.349296,67.715025,68.080754,68.446483,68.812212,69.177941,69.314775,69.451609,69.588443,69.725277,69.862111,69.9364918,70.0108726,70.0852534,70.1596342,70.234015,70.7678458,71.3016766,71.8355074,72.3693382,72.903169,73.1070856,73.3110022,73.5149188,73.7188354,73.922752,74.5484338,75.1741156,75.7997974,76.4254792,77.051161,77.32687,77.602579,77.878288,78.153997,78.429706,78.3683074,78.3069088,78.2455102,78.1841116,78.122713,78.1584284,78.1941438,78.2298592,78.2655746,78.30129,78.4085236,78.5157572,78.6229908,78.7302244,78.837458,78.945291,79.053124,79.160957,79.26879,79.376623,79.5508162,79.7250094,79.8992026,
Palau,PLW,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Papua New Guinea,PNG,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,26.4786142,27.3514906,28.224367,29.2722584,30.3201498,31.3680412,32.4159326,33.463824,34.6508002,35.8377764,37.0247526,38.2117288,39.398705,40.5274844,41.6562638,42.7850432,43.9138226,45.042602,46.2987924,47.5549828,48.8111732,50.0673636,51.323554,51.8880856,52.4526172,53.0171488,53.5816804,54.146212,54.6923818,55.2385516,55.7847214,56.3308912,56.877061,57.3443894,57.8117178,58.2790462,58.7463746,59.213703,59.5928336,59.9719642,60.3510948,60.7302254,61.109356,61.687337,62.265318,62.843299,63.42128,63.999261,64.4308172,64.8623734,65.2939296,65.7254858,66.157042,66.5505558,66.9440696,67.3375834,67.7310972,68.124611,68.5306112,68.9366114,69.3426116,
Poland,POL,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.055216,77.005724,77.956232,78.439541,78.92285,79.406159,79.889468,80.372777,80.6134778,80.8541786,81.0948794,81.3355802,81.576281,81.6663338,81.7563866,81.8464394,81.9364922,82.026545,82.0473564,82.0681678,82.0889792,82.1097906,82.130602,82.1695648,82.2085276,82.2474904,82.2864532,82.325416,82.521034,82.716652,82.91227,83.107888,83.303506,83.6847828,84.0660596,84.4473364,84.8286132,85.20989,85.5596408,85.9093916,86.2591424,86.6088932,86.958644,87.074698,87.190752,87.306806,87.42286,87.538914,87.8217216,88.1045292,88.3873368,88.6701444,88.952952,89.1555112,89.3580704,89.5606296,89.7631888,89.965748,90.0933466,90.2209452,90.3485438,
Pre-demographic dividend,PRE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.99565284,32.59812403,33.19595671,33.75004275,34.30549294,34.86483122,35.4321799,36.0038325,36.64858671,37.29121538,37.92970178,38.57095449,39.20945058,39.82996523,40.44867096,41.06645259,41.69281092,42.31520137,42.89011674,43.46691251,44.04760921,44.64100948,45.23844425,45.5519039,45.85908687,46.15734944,46.44970312,46.73214225,46.71848345,46.69966442,46.68028377,46.6758852,46.67648835,46.51955033,46.3583202,46.19013635,46.01883208,45.83821778,46.09034652,46.33722708,46.58212958,46.83518359,47.09065824,48.06955683,49.045471,50.01714695,50.98302124,51.94480939,53.00049705,54.06204039,55.13177771,56.22355738,57.32078072,58.22120153,59.11691949,60.0060432,60.88968868,61.76929115,62.28842978,62.80579632,63.32256258,
Puerto Rico,PRI,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.141911,76.658902,77.175893,77.7110584,78.2462238,78.7813892,79.3165546,79.85172,80.3627836,80.8738472,81.3849108,81.8959744,82.407038,82.6417776,82.8765172,83.1112568,83.3459964,83.580736,83.679873,83.77901,83.878147,83.977284,84.076421,84.4249112,84.7734014,85.1218916,85.4703818,85.818872,85.9015662,85.9842604,86.0669546,86.1496488,86.232343,86.370321,86.508299,86.646277,86.784255,86.922233,87.2226246,87.5230162,87.8234078,88.1237994,88.424191,88.538662,88.653133,88.767604,88.882075,88.996546,89.1118394,89.2271328,89.3424262,89.4577196,89.573013,89.6835442,89.7940754,89.9046066,90.0151378,90.125669,90.2456054,90.3655418,90.4854782,
"Korea, Dem. People's Rep.",PRK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,46.476691,47.18643,47.896169,49.665587,51.435005,53.204423,54.973841,56.743259,58.314939,59.886619,61.458299,63.029979,64.601659,65.7554306,66.9092022,68.0629738,69.2167454,70.370517,71.0655236,71.7605302,72.4555368,73.1505434,73.84555,74.3709974,74.8964448,75.4218922,75.9473396,76.472787,77.4304556,78.3881242,79.3457928,80.3034614,81.26113,79.3308486,77.4005672,75.4702858,73.5400044,71.609723,72.6276134,73.6455038,74.6633942,75.6812846,76.699175,76.799992,76.900809,77.001626,77.102443,77.20326,77.892596,78.581932,79.271268,79.960604,80.64994,81.0118004,81.3736608,81.7355212,82.0973816,82.459242,82.7255346,82.9918272,83.2581198,
Portugal,PRT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,72.5148682,73.1734136,73.831959,74.3884578,74.9449566,75.5014554,76.0579542,76.614453,77.154417,77.694381,78.234345,78.774309,79.314273,79.8987154,80.4831578,81.0676002,81.6520426,82.236485,82.733047,83.229609,83.726171,84.222733,84.719295,85.0617426,85.4041902,85.7466378,86.0890854,86.431533,86.6707624,86.9099918,87.1492212,87.3884506,87.62768,87.884745,88.14181,88.398875,88.65594,88.913005,89.1925794,89.4721538,89.7517282,90.0313026,90.310877,90.6011334,90.8913898,91.1816462,91.4719026,91.762159,91.9555378,92.1489166,92.3422954,92.5356742,92.729053,92.8931198,93.0571866,93.2212534,93.3853202,93.549387,93.656401,93.763415,93.870429,
Paraguay,PRY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,69.5091004,69.8552562,70.201412,70.3831202,70.5648284,70.7465366,70.9282448,71.109953,71.2692794,71.4286058,71.5879322,71.7472586,71.906585,72.0629658,72.2193466,72.3757274,72.5321082,72.688489,72.8812372,73.0739854,73.2667336,73.4594818,73.65223,73.7214698,73.7907096,73.8599494,73.9291892,73.998429,74.2097914,74.4211538,74.6325162,74.8438786,75.055241,75.202674,75.350107,75.49754,75.644973,75.792406,75.9975968,76.2027876,76.4079784,76.6131692,76.81836,77.1103036,77.4022472,77.6941908,77.9861344,78.278078,78.536869,78.79566,79.054451,79.313242,79.572033,79.8655912,80.1591494,80.4527076,80.7462658,81.039824,81.1960598,81.3522956,81.5085314,
West Bank and Gaza,PSE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,46.017086,46.696055,47.375024,48.3374334,49.2998428,50.2622522,51.2246616,52.187071,53.1869178,54.1867646,55.1866114,56.1864582,57.186305,58.0081018,58.8298986,59.6516954,60.4734922,61.295289,62.4661268,63.6369646,64.8078024,65.9786402,67.149478,68.075669,69.00186,69.928051,70.854242,71.780433,72.476262,73.172091,73.86792,74.563749,75.259578,75.7975096,76.3354412,76.8733728,77.4113044,77.949236,78.3681564,78.7870768,79.2059972,79.6249176,80.043838,80.388689,80.73354,81.078391,81.423242,81.768093,81.997698,82.227303,82.456908,82.686513,82.916118,83.1072098,83.2983016,83.4893934,83.6804852,83.871577,84.1311164,84.3906558,84.6501952,
Pacific island small states,PSS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,56.40093639,57.2104064,58.03304053,58.63386579,59.22853036,59.81513374,60.38797865,60.95448276,61.36854107,61.78064525,62.19078068,62.60044499,63.00728426,63.50535894,64.00026983,64.49064645,64.95618462,65.42187596,65.78736148,66.15697652,66.53148862,66.91173736,67.29321911,67.64589794,67.98937089,68.32272011,68.64212561,68.9548403,68.99023927,69.03010008,69.0757757,69.13446752,69.19323783,69.31912384,69.44880728,69.58168682,69.7181627,69.85932323,70.24121913,70.62619098,71.01557921,71.41613967,71.82103537,72.10454698,72.39203556,72.6822486,72.98551487,73.2886753,73.69301719,74.09763172,74.50565777,74.92801496,75.35532997,75.67974051,76.00484682,76.32936988,76.65431989,76.9791367,77.27072044,77.56251218,77.85517157,
Post-demographic dividend,PST,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.89051521,78.36051498,78.83177154,79.14114944,79.45184724,79.76352894,80.07366119,80.38480283,80.68686618,80.98918134,81.29076233,81.59727316,81.90208302,82.26088686,82.62115583,82.98262782,83.34533738,83.71012667,83.98855652,84.26887036,84.55112442,84.83488055,85.11991849,85.37242621,85.6266451,85.88308176,86.13984742,86.39736133,86.56916068,86.74304679,86.91735247,87.09194773,87.26642539,87.43832577,87.61122488,87.78383183,87.95655362,88.1263423,88.29871524,88.47100152,88.64492263,88.82381534,89.00437259,89.16302124,89.32002649,89.47530592,89.63255076,89.78899583,89.94506279,90.09878623,90.25212154,90.40453673,90.55727628,90.61885152,90.68095084,90.74110964,90.80224471,90.86410593,90.96208995,91.05910999,91.14888389,
French Polynesia,PYF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,50.3631048,51.2491784,52.135252,53.0502276,53.9652032,54.8801788,55.7951544,56.71013,57.3521416,57.9941532,58.6361648,59.2781764,59.920188,60.5631876,61.2061872,61.8491868,62.4921864,63.135186,64.5637552,65.9923244,67.4208936,68.8494628,70.278032,70.7872824,71.2965328,71.8057832,72.3150336,72.824284,73.1338226,73.4433612,73.7528998,74.0624384,74.371977,75.3925858,76.4131946,77.4338034,78.4544122,79.475021,80.1225642,80.7701074,81.4176506,82.0651938,82.712737,83.2030356,83.6933342,84.1836328,84.6739314,85.16423,85.4462754,85.7283208,86.0103662,86.2924116,86.574457,86.9254366,87.2764162,87.6273958,87.9783754,88.329355,88.5010194,88.6726838,88.8443482,
Qatar,QAT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,66.0627872,66.9526406,67.842494,68.691333,69.540172,70.389011,71.23785,72.086689,72.6735942,73.2604994,73.8474046,74.4343098,75.021215,75.5276854,76.0341558,76.5406262,77.0470966,77.553567,77.9437596,78.3339522,78.7241448,79.1143374,79.50453,79.8495642,80.1945984,80.5396326,80.8846668,81.229701,81.5640746,81.8984482,82.2328218,82.5671954,82.901569,83.2378426,83.5741162,83.9103898,84.2466634,84.582937,84.9656828,85.3484286,85.7311744,86.1139202,86.496666,86.911677,87.326688,87.741699,88.15671,88.571721,88.9567584,89.3417958,89.7268332,90.1118706,90.496908,90.8163916,91.1358752,91.4553588,91.7748424,92.094326,92.1931572,92.2919884,92.3908196,
Romania,ROU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,73.379994,74.879992,76.37999,76.394606,76.409222,76.423838,76.438454,76.45307,76.8783218,77.3035736,77.7288254,78.1540772,78.579329,78.7455382,78.9117474,79.0779566,79.2441658,79.410375,79.4935408,79.5767066,79.6598724,79.7430382,79.826204,79.7962552,79.7663064,79.7363576,79.7064088,79.67646,79.782908,79.889356,79.995804,80.102252,80.2087,80.2249858,80.2412716,80.2575574,80.2738432,80.290129,80.7207908,81.1514526,81.5821144,82.0127762,82.443438,82.8937292,83.3440204,83.7943116,84.2446028,84.694894,85.0769122,85.4589304,85.8409486,86.2229668,86.604985,86.8010784,86.9971718,87.1932652,87.3893586,87.585452,87.7308258,87.8761996,88.0215734,
Russian Federation,RUS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.148271,77.034983,77.921695,78.2291548,78.5366146,78.8440744,79.1515342,79.458994,79.5015412,79.5440884,79.5866356,79.6291828,79.67173,79.4301236,79.1885172,78.9469108,78.7053044,78.463698,78.4198156,78.3759332,78.3320508,78.2881684,78.244286,78.6690856,79.0938852,79.5186848,79.9434844,80.368284,79.8057884,79.2432928,78.6807972,78.1183016,77.555806,77.3392104,77.1226148,76.9060192,76.6894236,76.472828,76.1879072,75.9029864,75.6180656,75.3331448,75.048224,75.6005992,76.1529744,76.7053496,77.2577248,77.8101,78.5545124,79.2989248,80.0433372,80.7877496,81.532162,81.9708854,82.4096088,82.8483322,83.2870556,83.725779,83.8964286,84.0670782,84.2377278,
Rwanda,RWA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,36.868389,37.287148,37.705907,38.0200084,38.3341098,38.6482112,38.9623126,39.276414,39.4090346,39.5416552,39.6742758,39.8068964,39.939517,40.2505986,40.5616802,40.8727618,41.1838434,41.494925,42.6132448,43.7315646,44.8498844,45.9682042,47.086524,46.5476454,46.0087668,45.4698882,44.9310096,44.392131,38.2078482,32.0235654,25.8392826,19.6549998,13.470717,17.9107928,22.3508686,26.7909444,31.2310202,35.671096,37.0034428,38.3357896,39.6681364,41.0004832,42.33283,45.8353294,49.3378288,52.8403282,56.3428276,59.845327,61.8784916,63.9116562,65.9448208,67.9779854,70.01115,70.9233012,71.8354524,72.7476036,73.6597548,74.571906,75.09147,75.611034,76.130598,
South Asia,SAS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,30.2148881,31.09956704,31.98969933,33.06852437,34.142169,35.20874107,36.27584273,37.33616318,38.4121226,39.48712325,40.56331157,41.64119997,42.72187982,43.89855843,45.07409213,46.24821488,47.42554225,48.60129903,49.34278811,50.08521411,50.82890687,51.57548138,52.32304381,52.88903731,53.45323547,54.0149864,54.57584513,55.13417955,56.00032283,56.86383859,57.72504579,58.58248653,59.43737872,60.25110987,61.06564018,61.88184735,62.70188121,63.52374667,64.13811729,64.75149027,65.36314825,65.97235473,66.57958421,67.13900182,67.69821544,68.25752975,68.81768273,69.37803524,70.05072715,70.72286586,71.39423815,72.06525635,72.73401153,73.1186477,73.5040427,73.89024379,74.27785537,74.66644468,75.03975191,75.41187121,75.78317746,
Saudi Arabia,SAU,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.2424054,43.8917842,44.541163,45.408327,46.275491,47.142655,48.009819,48.876983,50.3519378,51.8268926,53.3018474,54.7768022,56.251757,57.7459442,59.2401314,60.7343186,62.2285058,63.722693,64.9649752,66.2072574,67.4495396,68.6918218,69.934104,70.86111,71.788116,72.715122,73.642128,74.569134,75.679011,76.788888,77.898765,79.008642,80.118519,80.576311,81.034103,81.491895,81.949687,82.407479,82.5249824,82.6424858,82.7599892,82.8774926,82.994996,83.0262034,83.0574108,83.0886182,83.1198256,83.151033,83.4333356,83.7156382,83.9979408,84.2802434,84.562546,84.6790024,84.7954588,84.9119152,85.0283716,85.144828,85.378604,85.61238,85.846156,
Sudan,SDN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,44.5414654,45.1425552,45.743645,46.3077334,46.8718218,47.4359102,47.9999986,48.564087,49.0775446,49.5910022,50.1044598,50.6179174,51.131375,51.408863,51.686351,51.963839,52.241327,52.518815,52.6521264,52.7854378,52.9187492,53.0520606,53.185372,53.3906488,53.5959256,53.8012024,54.0064792,54.211756,54.4973314,54.7829068,55.0684822,55.3540576,55.639633,56.1388244,56.6380158,57.1372072,57.6363986,58.13559,58.7257634,59.3159368,59.9061102,60.4962836,61.086457,61.6782746,62.2700922,62.8619098,63.4537274,64.045545,64.6738514,65.3021578,65.9304642,66.5587706,67.187077,67.589124,67.991171,68.393218,68.795265,69.197312,69.5758718,69.9544316,70.3329914,
Senegal,SEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.9386788,30.2989374,30.659196,30.6642894,30.6693828,30.6744762,30.6795696,30.684663,31.4460596,32.2074562,32.9688528,33.7302494,34.491646,36.1730618,37.8544776,39.5358934,41.2173092,42.898725,44.3896842,45.8806434,47.3716026,48.8625618,50.353521,51.8917876,53.4300542,54.9683208,56.5065874,58.044854,58.5217086,58.9985632,59.4754178,59.9522724,60.429127,60.261942,60.094757,59.927572,59.760387,59.593202,59.9983784,60.4035548,60.8087312,61.2139076,61.619084,62.5178122,63.4165404,64.3152686,65.2139968,66.112725,67.2724662,68.4322074,69.5919486,70.7516898,71.911431,72.5471754,73.1829198,73.8186642,74.4544086,75.090153,75.548281,76.006409,76.464537,
Singapore,SGP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,71.3014,71.9202,72.539,73.132545,73.72609,74.319635,74.91318,75.506725,75.9097498,76.3127746,76.7157994,77.1188242,77.521849,78.0782792,78.6347094,79.1911396,79.7475698,80.304,80.8059056,81.3078112,81.8097168,82.3116224,82.813528,83.1793478,83.5451676,83.9109874,84.2768072,84.642627,85.095417,85.548207,86.000997,86.453787,86.906577,87.175974,87.445371,87.714768,87.984165,88.253562,88.825159,89.396756,89.968353,90.53995,91.111547,91.350577,91.589607,91.828637,92.067667,92.306697,92.4941576,92.6816182,92.8690788,93.0565394,93.244,93.4199778,93.5959556,93.7719334,93.9479112,94.123889,94.2088426,94.2937962,94.3787498,
Solomon Islands,SLB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.802541,44.781146,45.759751,46.7174598,47.6751686,48.6328774,49.5905862,50.548295,51.52406,52.499825,53.47559,54.451355,55.42712,56.3674184,57.3077168,58.2480152,59.1883136,60.128612,60.5681154,61.0076188,61.4471222,61.8866256,62.326129,62.4409092,62.5556894,62.6704696,62.7852498,62.90003,63.0293544,63.1586788,63.2880032,63.4173276,63.546652,64.1721446,64.7976372,65.4231298,66.0486224,66.674115,67.5169588,68.3598026,69.2026464,70.0454902,70.888334,71.6111128,72.3338916,73.0566704,73.7794492,74.502228,75.1478168,75.7934056,76.4389944,77.0845832,77.730172,78.210325,78.690478,79.170631,79.650784,80.130937,80.3348812,80.5388254,80.7427696,
Sierra Leone,SLE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,23.9695026,24.3184338,24.667365,25.16307,25.658775,26.15448,26.650185,27.14589,27.7092388,28.2725876,28.8359364,29.3992852,29.962634,30.408875,30.855116,31.301357,31.747598,32.193839,32.3821164,32.5703938,32.7586712,32.9469486,33.135226,32.6794734,32.2237208,31.7679682,31.3122156,30.856463,30.036287,29.216111,28.395935,27.575759,26.755583,26.6616272,26.5676714,26.4737156,26.3797598,26.285804,27.5372582,28.7887124,30.0401666,31.2916208,32.543075,33.9173126,35.2915502,36.6657878,38.0400254,39.414263,40.578007,41.741751,42.905495,44.069239,45.232983,45.8849908,46.5369986,47.1890064,47.8410142,48.493022,49.0448354,49.5966488,50.1484622,
El Salvador,SLV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,49.2228956,50.3489038,51.474912,52.3405678,53.2062236,54.0718794,54.9375352,55.803191,56.591116,57.379041,58.166966,58.954891,59.742816,60.1725062,60.6021964,61.0318866,61.4615768,61.891267,62.3217928,62.7523186,63.1828444,63.6133702,64.043896,65.126499,66.209102,67.291705,68.374308,69.456911,70.5552818,71.6536526,72.7520234,73.8503942,74.948765,75.410504,75.872243,76.333982,76.795721,77.25746,77.6451494,78.0328388,78.4205282,78.8082176,79.195907,79.4724078,79.7489086,80.0254094,80.3019102,80.578411,80.8797956,81.1811802,81.4825648,81.7839494,82.085334,82.3824088,82.6794836,82.9765584,83.2736332,83.570708,83.8133372,84.0559664,84.2985956,
San Marino,SMR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Somalia,SOM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,29.3918042,29.9106676,30.429531,30.9668378,31.5041446,32.0414514,32.5787582,33.116065,33.6346966,34.1533282,34.6719598,35.1905914,35.709223,36.2264296,36.7436362,37.2608428,37.7780494,38.295256,38.7673,39.239344,39.711388,40.183432,40.655476,40.8894828,41.1234896,41.3574964,41.5915032,41.82551,41.3996386,40.9737672,40.5478958,40.1220244,39.696153,41.0150876,42.3340222,43.6529568,44.9718914,46.290826,46.7401556,47.1894852,47.6388148,48.0881444,48.537474,49.0267862,49.5160984,50.0054106,50.4947228,50.984035,51.46091,51.937785,52.41466,52.891535,53.36841,53.9812626,54.5941152,55.2069678,55.8198204,56.432673,56.869245,57.305817,57.742389,
Serbia,SRB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,67.3885176,68.2715118,69.154506,70.1481896,71.1418732,72.1355568,73.1292404,74.122924,74.672367,75.22181,75.771253,76.320696,76.870139,77.275008,77.679877,78.084746,78.489615,78.894484,79.0718878,79.2492916,79.4266954,79.6040992,79.781503,80.1104814,80.4394598,80.7684382,81.0974166,81.426395,81.598256,81.770117,81.941978,82.113839,82.2857,82.3329998,82.3802996,82.4275994,82.4748992,82.522199,82.658024,82.793849,82.929674,83.065499,83.201324,83.5508678,83.9004116,84.2499554,84.5994992,84.949043,85.2636012,85.5781594,85.8927176,86.2072758,86.521834,86.7318732,86.9419124,87.1519516,87.3619908,87.57203,87.740377,87.908724,88.077071,
Sub-Saharan Africa (excluding high income),SSA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,34.00435501,34.61024846,35.21306622,35.73752148,36.26266836,36.78979142,37.32476458,37.86076254,38.45860831,39.05493842,39.64892642,40.24983174,40.84711994,41.42929396,42.00858318,42.58578385,43.16478104,43.74103828,44.21441064,44.68889857,45.1645195,45.65620425,46.1453513,46.49758288,46.84741225,47.19428227,47.54245334,47.88637297,47.79992283,47.70907797,47.61979123,47.55682921,47.50771021,47.18027914,46.83328782,46.46734929,46.09418161,45.71256495,45.68106439,45.64953415,45.6203102,45.59987071,45.58572024,46.62482149,47.66710331,48.71255711,49.76438133,50.82025147,52.19943985,53.57444333,54.94562748,56.31685653,57.68604982,58.62643505,59.5636415,60.49732711,61.4325478,62.36439854,62.89325111,63.42038039,63.94616156,
South Sudan,SSD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,22.5729744,23.0886242,23.604274,24.1417452,24.6792164,25.2166876,25.7541588,26.29163,26.7611928,27.2307556,27.7003184,28.1698812,28.639444,29.1709176,29.7023912,30.2338648,30.7653384,31.296812,31.4866988,31.6765856,31.8664724,32.0563592,32.246246,32.8827188,33.5191916,34.1556644,34.7921372,35.42861,36.366146,37.303682,38.241218,39.178754,40.11629,40.7780958,41.4399016,42.1017074,42.7635132,43.425319,43.7383798,44.0514406,44.3645014,44.6775622,44.990623,45.5798756,46.1691282,46.7583808,47.3476334,47.936886,48.872942,49.808998,50.745054,51.68111,52.617166,53.149326,53.681486,54.213646,54.745806,55.277966,55.707519,56.137072,56.566625,
Sub-Saharan Africa,SSF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,34.01090329,34.61669124,35.21935767,35.74370944,36.26877528,36.7958532,37.33076458,37.86672144,38.46455037,39.0608537,39.65480586,40.25574136,40.85307225,41.43522237,42.01450623,42.59173741,43.17075594,43.74704396,44.22032349,44.69473269,45.17027764,45.66192493,46.15098886,46.50308276,46.852811,47.1995901,47.54762398,47.89159616,47.80510086,47.71421651,47.62487323,47.56198661,47.5128758,47.18552434,46.83864101,46.47274751,46.09962318,45.71803913,45.6865463,45.65501853,45.62573097,45.60524753,45.59119019,46.62999988,47.67202693,48.71726805,49.76890943,50.82452817,52.20350125,53.57822505,54.94923142,56.32011348,57.68910144,58.62936432,59.56643841,60.50000742,61.43508947,62.36679739,62.8955496,63.42257936,63.94826498,
Small states,SST,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,56.3310006,56.93508914,57.54420987,58.0726575,58.59196904,59.09254314,59.57219152,60.02523122,60.43972821,60.85943138,61.29275988,61.82842058,62.36340938,62.83955984,63.31745743,63.80259305,64.33345891,64.86540746,65.44593141,66.00424399,66.54041934,67.06783896,67.58497004,67.988398,68.37664399,68.76153931,69.13824229,69.50663148,69.45972205,69.41231084,69.36776748,69.37549323,69.37737464,68.90777469,68.4347732,67.94634381,67.45243465,66.94471182,66.44105814,65.94389746,65.45163533,65.00506564,64.58136107,65.01982747,65.46776634,65.92342896,66.40464806,66.88937319,67.901564,68.8987283,69.88126649,70.85103649,71.80935578,72.52761211,73.23631108,73.94044722,74.64996921,75.35649641,75.64294938,75.92623209,76.20101161,
Sao Tome and Principe,STP,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.4950758,48.2658614,49.036647,49.6996094,50.3625718,51.0255342,51.6884966,52.351459,53.0473232,53.7431874,54.4390516,55.1349158,55.83078,56.6509324,57.4710848,58.2912372,59.1113896,59.931542,60.2976974,60.6638528,61.0300082,61.3961636,61.762319,61.341218,60.920117,60.499016,60.077915,59.656814,59.5131072,59.3694004,59.2256936,59.0819868,58.93828,59.4565232,59.9747664,60.4930096,61.0112528,61.529496,62.5708988,63.6123016,64.6537044,65.6951072,66.73651,67.7653444,68.7941788,69.8230132,70.8518476,71.880682,72.7001688,73.5196556,74.3391424,75.1586292,75.978116,76.534021,77.089926,77.645831,78.201736,78.757641,79.0430648,79.3284886,79.6139124,
Suriname,SUR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.8257686,60.4322478,61.038727,61.6444868,62.2502466,62.8560064,63.4617662,64.067526,64.7226454,65.3777648,66.0328842,66.6880036,67.343123,67.7561246,68.1691262,68.5821278,68.9951294,69.408131,70.0620582,70.7159854,71.3699126,72.0238398,72.677767,72.991173,73.304579,73.617985,73.931391,74.244797,74.3416978,74.4385986,74.5354994,74.6324002,74.729301,74.7702048,74.8111086,74.8520124,74.8929162,74.93382,74.9943364,75.0548528,75.1153692,75.1758856,75.236402,75.776586,76.31677,76.856954,77.397138,77.937322,78.2758614,78.6144008,78.9529402,79.2914796,79.630019,79.7992702,79.9685214,80.1377726,80.3070238,80.476275,80.677138,80.878001,81.078864,
Slovak Republic,SVK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,79.5063604,80.2302542,80.954148,80.9998594,81.0455708,81.0912822,81.1369936,81.182705,81.1884064,81.1941078,81.1998092,81.2055106,81.211212,81.3519554,81.4926988,81.6334422,81.7741856,81.914929,81.990668,82.066407,82.142146,82.217885,82.293624,82.3900826,82.4865412,82.5829998,82.6794584,82.775917,82.9898138,83.2037106,83.4176074,83.6315042,83.845401,84.1475734,84.4497458,84.7519182,85.0540906,85.356263,85.6345126,85.9127622,86.1910118,86.4692614,86.747511,86.9181592,87.0888074,87.2594556,87.4301038,87.600752,87.8447894,88.0888268,88.3328642,88.5769016,88.820939,89.0025948,89.1842506,89.3659064,89.5475622,89.729218,89.8590514,89.9888848,90.1187182,
Slovenia,SVN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,75.9338442,76.5237916,77.113739,77.3459204,77.5781018,77.8102832,78.0424646,78.274646,78.6177452,78.9608444,79.3039436,79.6470428,79.990142,80.4723724,80.9546028,81.4368332,81.9190636,82.401294,82.5427888,82.6842836,82.8257784,82.9672732,83.108768,83.4905546,83.8723412,84.2541278,84.6359144,85.017701,85.2404494,85.4631978,85.6859462,85.9086946,86.131443,86.4565768,86.7817106,87.1068444,87.4319782,87.757112,88.0427732,88.3284344,88.6140956,88.8997568,89.185418,89.5551538,89.9248896,90.2946254,90.6643612,91.034097,91.2304674,91.4268378,91.6232082,91.8195786,92.015949,92.1303918,92.2448346,92.3592774,92.4737202,92.588163,92.7171056,92.8460482,92.9749908,
Sweden,SWE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,83.9396946,84.2356928,84.531691,84.7568764,84.9820618,85.2072472,85.4324326,85.657618,85.8481012,86.0385844,86.2290676,86.4195508,86.610034,86.7695612,86.9290884,87.0886156,87.2481428,87.40767,87.6175104,87.8273508,88.0371912,88.2470316,88.456872,88.590537,88.724202,88.857867,88.991532,89.125197,89.2513978,89.3775986,89.5037994,89.6300002,89.756201,89.949708,90.143215,90.336722,90.530229,90.723736,90.8433294,90.9629228,91.0825162,91.2021096,91.321703,91.4656414,91.6095798,91.7535182,91.8974566,92.041395,92.1963108,92.3512266,92.5061424,92.6610582,92.815974,92.9171054,93.0182368,93.1193682,93.2204996,93.321631,93.4221178,93.5226046,93.6230914,
Eswatini,SWZ,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.258698,38.739809,39.22092,39.7446616,40.2684032,40.7921448,41.3158864,41.839628,42.712883,43.586138,44.459393,45.332648,46.205903,47.196697,48.187491,49.178285,50.169079,51.159873,52.3480912,53.5363094,54.7245276,55.9127458,57.100964,58.2406522,59.3803404,60.5200286,61.6597168,62.799405,62.6682096,62.5370142,62.4058188,62.2746234,62.143428,59.426279,56.70913,53.991981,51.274832,48.557683,44.2671812,39.9766794,35.6861776,31.3956758,27.105174,26.7252758,26.3453776,25.9654794,25.5855812,25.205683,27.7278404,30.2499978,32.7721552,35.2943126,37.81647,42.0731408,46.3298116,50.5864824,54.8431532,59.099824,59.7425638,60.3853036,61.0280434,
Sint Maarten (Dutch part),SXM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Seychelles,SYC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,68.2368806,68.5349048,68.832929,69.3758918,69.9188546,70.4618174,71.0047802,71.547743,72.2261086,72.9044742,73.5828398,74.2612054,74.939571,75.5421576,76.1447442,76.7473308,77.3499174,77.952504,78.2791954,78.6058868,78.9325782,79.2592696,79.585961,79.7289178,79.8718746,80.0148314,80.1577882,80.300745,80.6914538,81.0821626,81.4728714,81.8635802,82.254289,82.3983458,82.5424026,82.6864594,82.8305162,82.974573,82.9755116,82.9764502,82.9773888,82.9783274,82.979266,83.0688844,83.1585028,83.2481212,83.3377396,83.427358,83.4965562,83.5657544,83.6349526,83.7041508,83.773349,83.8597012,83.9460534,84.0324056,84.1187578,84.20511,84.3227698,84.4404296,84.5580894,
Syrian Arab Republic,SYR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,49.27443,50.230747,51.187064,52.1883218,53.1895796,54.1908374,55.1920952,56.193353,57.4138628,58.6343726,59.8548824,61.0753922,62.295902,63.377168,64.458434,65.5397,66.620966,67.702232,68.7233782,69.7445244,70.7656706,71.7868168,72.807963,73.832608,74.857253,75.881898,76.906543,77.931188,78.6005128,79.2698376,79.9391624,80.6084872,81.277812,81.6896604,82.1015088,82.5133572,82.9252056,83.337054,83.6339862,83.9309184,84.2278506,84.5247828,84.821715,85.112387,85.403059,85.693731,85.984403,86.275075,85.9930864,85.7110978,85.4291092,85.1471206,84.865132,85.2502262,85.6353204,86.0204146,86.4055088,86.790603,87.3851604,87.9797178,88.5742752,
Turks and Caicos Islands,TCA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Chad,TCD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,31.4143392,31.6443376,31.874336,32.12232,32.370304,32.618288,32.866272,33.114256,33.7503694,34.3864828,35.0225962,35.6587096,36.294823,36.6359944,36.9771658,37.3183372,37.6595086,38.00068,38.4083126,38.8159452,39.2235778,39.6312104,40.038843,40.364937,40.691031,41.017125,41.343219,41.669313,41.7944946,41.9196762,42.0448578,42.1700394,42.295221,42.3186664,42.3421118,42.3655572,42.3890026,42.412448,42.3492016,42.2859552,42.2227088,42.1594624,42.096216,42.49174,42.887264,43.282788,43.678312,44.073836,44.8768768,45.6799176,46.4829584,47.2859992,48.08904,48.5098724,48.9307048,49.3515372,49.7723696,50.193202,50.6082618,51.0233216,51.4383814,
East Asia & Pacific (IDA & IBRD countries),TEA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,39.74284547,40.07696801,40.38050766,43.18887898,45.99262689,48.78886283,51.58915427,54.39005227,56.06513306,57.74219418,59.41894534,61.09491279,62.76388564,63.97333724,65.18157176,66.3896356,67.60629294,68.82392044,69.58949219,70.3539792,71.11479352,71.87660686,72.63867656,73.14006327,73.63682302,74.13153439,74.62713511,75.12035741,75.44248578,75.7637843,76.08635334,76.40166976,76.72361984,77.08322105,77.44053634,77.79314492,78.15579441,78.50945763,78.86886481,79.23105496,79.60029797,79.97228875,80.35186124,80.82063975,81.28687378,81.7474567,82.20222833,82.65290793,83.10039106,83.5453645,83.98869512,84.42878841,84.87006038,85.18477797,85.49698621,85.80621598,86.11538187,86.42262281,86.57918994,86.7361235,86.89467628,
Europe & Central Asia (IDA & IBRD countries),TEC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,72.62854281,73.4750716,74.33221468,74.7212935,75.10615013,75.48085822,75.85420775,76.22026307,76.4057888,76.59262927,76.78202567,76.98052882,77.18261959,77.18621375,77.19068224,77.19558941,77.20386723,77.21363915,77.28374242,77.35769828,77.43772769,77.52409378,77.61566208,77.92685196,78.23886076,78.5504696,78.86414048,79.17830796,78.96457206,78.75625025,78.55216627,78.35571246,78.16593072,78.1553002,78.15111199,78.14821,78.14533132,78.1475321,78.27048948,78.39498724,78.51400751,78.64068669,78.77564517,79.19256807,79.60885511,80.02395519,80.44135778,80.8534453,81.43486168,82.0181417,82.60030348,83.18589848,83.77547952,84.13221117,84.48982768,84.84739345,85.20857266,85.57003785,85.74880981,85.9265941,86.10343798,
Togo,TGO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,33.6360672,34.6105146,35.584962,36.5710082,37.5570544,38.5431006,39.5291468,40.515193,41.507755,42.500317,43.492879,44.485441,45.478003,46.4064156,47.3348282,48.2632408,49.1916534,50.120066,50.9979714,51.8758768,52.7537822,53.6316876,54.509593,54.9944332,55.4792734,55.9641136,56.4489538,56.933794,56.629489,56.325184,56.020879,55.716574,55.412269,54.4417298,53.4711906,52.5006514,51.5301122,50.559573,50.546184,50.532795,50.519406,50.506017,50.492628,50.8805502,51.2684724,51.6563946,52.0443168,52.432239,53.6061296,54.7800202,55.9539108,57.1278014,58.301692,58.8143194,59.3269468,59.8395742,60.3522016,60.864829,61.4284818,61.9921346,62.5557874,
Thailand,THA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,54.1063644,54.8440552,55.581746,56.0601642,56.5385824,57.0170006,57.4954188,57.973837,58.7297712,59.4857054,60.2416396,60.9975738,61.753508,62.560044,63.36658,64.173116,64.979652,65.786188,66.604575,67.422962,68.241349,69.059736,69.878123,71.2539768,72.6298306,74.0056844,75.3815382,76.757392,77.1339442,77.5104964,77.8870486,78.2636008,78.640153,78.7028784,78.7656038,78.8283292,78.8910546,78.95378,79.101938,79.250096,79.398254,79.546412,79.69457,80.2390698,80.7835696,81.3280694,81.8725692,82.417069,83.0000254,83.5829818,84.1659382,84.7488946,85.331851,85.7638796,86.1959082,86.6279368,87.0599654,87.491994,87.6490086,87.8060232,87.9630378,
Tajikistan,TJK,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,48.3038122,48.7553496,49.206887,49.6610118,50.1151366,50.5692614,51.0233862,51.477511,52.0715436,52.6655762,53.2596088,53.8536414,54.447674,54.992577,55.53748,56.082383,56.627286,57.172189,57.4025332,57.6328774,57.8632216,58.0935658,58.32391,59.08945,59.85499,60.62053,61.38607,62.15161,61.8929434,61.6342768,61.3756102,61.1169436,60.858277,61.1720976,61.4859182,61.7997388,62.1135594,62.42738,63.7472336,65.0670872,66.3869408,67.7067944,69.026648,70.2467472,71.4668464,72.6869456,73.9070448,75.127144,75.8636496,76.6001552,77.3366608,78.0731664,78.809672,79.222588,79.635504,80.04842,80.461336,80.874252,81.1966518,81.5190516,81.8414514,
Turkmenistan,TKM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,57.0617714,57.6973882,58.333005,58.9717676,59.6105302,60.2492928,60.8880554,61.526818,61.9913226,62.4558272,62.9203318,63.3848364,63.849341,64.1375404,64.4257398,64.7139392,65.0021386,65.290338,65.757632,66.224926,66.69222,67.159514,67.626808,67.8978494,68.1688908,68.4399322,68.7109736,68.982015,69.1677376,69.3534602,69.5391828,69.7249054,69.910628,69.886933,69.863238,69.839543,69.815848,69.792153,70.059111,70.326069,70.593027,70.859985,71.126943,71.5526188,71.9782946,72.4039704,72.8296462,73.255322,73.6169716,73.9786212,74.3402708,74.7019204,75.06357,75.292915,75.52226,75.751605,75.98095,76.210295,76.4221988,76.6341026,76.8460064,
Latin America & the Caribbean (IDA & IBRD countries),TLA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,55.94887549,56.75331055,57.55930633,58.23226201,58.90240814,59.56884802,60.24039811,60.90782154,61.6346378,62.36271204,63.09352945,63.8311577,64.57067137,65.28445032,65.99826784,66.71158954,67.42835178,68.14408819,68.7805868,69.41808117,70.05755391,70.70257618,71.35040787,71.89576334,72.44153536,72.9868981,73.53599571,74.08242615,74.59104683,75.10042131,75.61111165,76.12030482,76.63187615,77.0893323,77.54528415,77.99925592,78.45468761,78.90875158,79.34133339,79.77459931,80.20906148,80.64652607,81.08420282,81.3797334,81.67524105,81.97061959,82.26551706,82.56056138,82.77895371,82.99669441,83.21316105,83.4299798,83.64612998,83.81889666,83.9919822,84.16592634,84.34292734,84.52161249,84.69054066,84.85865247,85.02516013,
Timor-Leste,TLS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,22.6432622,23.2476896,23.852117,24.4907742,25.1294314,25.7680886,26.4067458,27.045403,27.7220194,28.3986358,29.0752522,29.7518686,30.428485,28.3738356,26.3191862,24.2645368,22.2098874,20.155238,22.1993052,24.2433724,26.2874396,28.3315068,30.375574,32.4006734,34.4257728,36.4508722,38.4759716,40.501071,41.6386948,42.7763186,43.9139424,45.0515662,46.18919,47.9765338,49.7638776,51.5512214,53.3385652,55.125909,56.7034054,58.2809018,59.8583982,61.4358946,63.013391,64.6738608,66.3343306,67.9948004,69.6552702,71.31574,72.0320962,72.7484524,73.4648086,74.1811648,74.897521,75.4476278,75.9977346,76.5478414,77.0979482,77.648055,77.976532,78.305009,78.633486,
Middle East & North Africa (IDA & IBRD countries),TMN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,43.2125943,43.99785869,44.79159868,45.65671159,46.51793022,47.37317027,48.2262689,49.07394937,49.86060139,50.64858993,51.43845712,52.22945682,53.02062317,54.01393689,55.00255149,55.98579952,56.95930796,57.92776874,59.12990913,60.33379899,61.54100343,62.75432373,63.97072068,64.99415929,66.01762542,67.04047933,68.06788487,69.09234678,69.82050227,70.54970306,71.28094896,72.01946835,72.75994709,73.38882732,74.01523611,74.63806021,75.25839276,75.87547335,76.36275216,76.84987721,77.33742299,77.82123299,78.30662297,78.8397585,79.37204644,79.90385308,80.44080371,80.97683301,81.35597384,81.72912401,82.09577109,82.4521422,82.80497293,83.09859839,83.387969,83.67444365,83.96732504,84.25570576,84.46012958,84.66649813,84.87638458,
Tonga,TON,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,58.8722682,59.2550036,59.637739,60.2183544,60.7989698,61.3795852,61.9602006,62.540816,63.1408172,63.7408184,64.3408196,64.9408208,65.540822,66.1592676,66.7777132,67.3961588,68.0146044,68.63305,69.1642196,69.6953892,70.2265588,70.7577284,71.288898,71.8149368,72.3409756,72.8670144,73.3930532,73.919092,74.1354716,74.3518512,74.5682308,74.7846104,75.00099,75.121864,75.242738,75.363612,75.484486,75.60536,75.8838218,76.1622836,76.4407454,76.7192072,76.997669,77.1923478,77.3870266,77.5817054,77.7763842,77.971063,78.1669952,78.3629274,78.5588596,78.7547918,78.950724,79.112609,79.274494,79.436379,79.598264,79.760149,79.9847978,80.2094466,80.4340954,
South Asia (IDA & IBRD),TSA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,30.2148881,31.09956704,31.98969933,33.06852437,34.142169,35.20874107,36.27584273,37.33616318,38.4121226,39.48712325,40.56331157,41.64119997,42.72187982,43.89855843,45.07409213,46.24821488,47.42554225,48.60129903,49.34278811,50.08521411,50.82890687,51.57548138,52.32304381,52.88903731,53.45323547,54.0149864,54.57584513,55.13417955,56.00032283,56.86383859,57.72504579,58.58248653,59.43737872,60.25110987,61.06564018,61.88184735,62.70188121,63.52374667,64.13811729,64.75149027,65.36314825,65.97235473,66.57958421,67.13900182,67.69821544,68.25752975,68.81768273,69.37803524,70.05072715,70.72286586,71.39423815,72.06525635,72.73401153,73.1186477,73.5040427,73.89024379,74.27785537,74.66644468,75.03975191,75.41187121,75.78317746,
Sub-Saharan Africa (IDA & IBRD countries),TSS,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,34.01090329,34.61669124,35.21935767,35.74370944,36.26877528,36.7958532,37.33076458,37.86672144,38.46455037,39.0608537,39.65480586,40.25574136,40.85307225,41.43522237,42.01450623,42.59173741,43.17075594,43.74704396,44.22032349,44.69473269,45.17027764,45.66192493,46.15098886,46.50308276,46.852811,47.1995901,47.54762398,47.89159616,47.80510086,47.71421651,47.62487323,47.56198661,47.5128758,47.18552434,46.83864101,46.47274751,46.09962318,45.71803913,45.6865463,45.65501853,45.62573097,45.60524753,45.59119019,46.62999988,47.67202693,48.71726805,49.76890943,50.82452817,52.20350125,53.57822505,54.94923142,56.32011348,57.68910144,58.62936432,59.56643841,60.50000742,61.43508947,62.36679739,62.8955496,63.42257936,63.94826498,
Trinidad and Tobago,TTO,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.5377324,65.4332482,66.328764,66.6040106,66.8792572,67.1545038,67.4297504,67.704997,67.9798318,68.2546666,68.5295014,68.8043362,69.079171,69.453936,69.828701,70.203466,70.578231,70.952996,71.2082516,71.4635072,71.7187628,71.9740184,72.229274,72.3751364,72.5209988,72.6668612,72.8127236,72.958586,73.1889496,73.4193132,73.6496768,73.8800404,74.110404,74.2117108,74.3130176,74.4143244,74.5156312,74.616938,75.0967962,75.5766544,76.0565126,76.5363708,77.016229,77.5185844,78.0209398,78.5232952,79.0256506,79.528006,79.8338664,80.1397268,80.4455872,80.7514476,81.057308,81.2249502,81.3925924,81.5602346,81.7278768,81.895519,82.067952,82.240385,82.412818,
Tunisia,TUN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,34.1400022,34.9917496,35.843497,37.1008396,38.3581822,39.6155248,40.8728674,42.13021,43.9142562,45.6983024,47.4823486,49.2663948,51.050441,52.4642704,53.8780998,55.2919292,56.7057586,58.119588,59.923677,61.727766,63.531855,65.335944,67.140033,68.1761756,69.2123182,70.2484608,71.2846034,72.320746,73.6129768,74.9052076,76.1974384,77.4896692,78.7819,79.7319716,80.6820432,81.6321148,82.5821864,83.532258,83.8766324,84.2210068,84.5653812,84.9097556,85.25413,85.493283,85.732436,85.971589,86.210742,86.449895,86.5548586,86.6598222,86.7647858,86.8697494,86.974713,87.1803038,87.3858946,87.5914854,87.7970762,88.002667,88.205891,88.409115,88.612339,
Turkiye,TUR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,46.392165,47.361279,48.330393,49.230485,50.130577,51.030669,51.930761,52.830853,53.7798748,54.7288966,55.6779184,56.6269402,57.575962,58.5792238,59.5824856,60.5857474,61.5890092,62.592271,63.5818788,64.5714866,65.5610944,66.5507022,67.54031,68.3552168,69.1701236,69.9850304,70.7999372,71.614844,72.383671,73.152498,73.921325,74.690152,75.458979,76.3140026,77.1690262,78.0240498,78.8790734,79.734097,80.4030946,81.0720922,81.7410898,82.4100874,83.079085,83.6099666,84.1408482,84.6717298,85.2026114,85.733493,86.1394472,86.5454014,86.9513556,87.3573098,87.763264,88.0894796,88.4156952,88.7419108,89.0681264,89.394342,89.5977794,89.8012168,90.0046542,
Tuvalu,TUV,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Tanzania,TZA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,38.2441582,38.6194376,38.994717,39.4135756,39.8324342,40.2512928,40.6701514,41.08901,41.6088522,42.1286944,42.6485366,43.1683788,43.688221,44.2836264,44.8790318,45.4744372,46.0698426,46.665248,46.8629244,47.0606008,47.2582772,47.4559536,47.65363,47.7319112,47.8101924,47.8884736,47.9667548,48.045036,47.4634392,46.8818424,46.3002456,45.7186488,45.137052,44.6095586,44.0820652,43.5545718,43.0270784,42.499585,42.9917772,43.4839694,43.9761616,44.4683538,44.960546,46.0493402,47.1381344,48.2269286,49.3157228,50.404517,52.7129546,55.0213922,57.3298298,59.6382674,61.946705,63.337471,64.728237,66.119003,67.509769,68.900535,69.4327122,69.9648894,70.4970666,
Uganda,UGA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,39.4952264,40.2774782,41.05973,41.7996988,42.5396676,43.2796364,44.0196052,44.759574,45.0379384,45.3163028,45.5946672,45.8730316,46.151396,46.2144864,46.2775768,46.3406672,46.4037576,46.466848,46.4699784,46.4731088,46.4762392,46.4793696,46.4825,45.8347752,45.1870504,44.5393256,43.8916008,43.243876,41.974048,40.70422,39.434392,38.164564,36.894736,36.3636858,35.8326356,35.3015854,34.7705352,34.239485,35.4680854,36.6966858,37.9252862,39.1538866,40.382487,42.0990618,43.8156366,45.5322114,47.2487862,48.965361,50.7515084,52.5376558,54.3238032,56.1099506,57.896098,59.261822,60.627546,61.99327,63.358994,64.724718,65.2953982,65.8660784,66.4367586,
Ukraine,UKR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,77.8531928,78.6134294,79.373666,79.6961976,80.0187292,80.3412608,80.6637924,80.986324,81.0660062,81.1456884,81.2253706,81.3050528,81.384735,81.2345514,81.0843678,80.9341842,80.7840006,80.633817,80.5778992,80.5219814,80.4660636,80.4101458,80.354228,80.6258082,80.8973884,81.1689686,81.4405488,81.712129,81.3489356,80.9857422,80.6225488,80.2593554,79.896162,79.533099,79.170036,78.806973,78.44391,78.080847,78.1479574,78.2150678,78.2821782,78.3492886,78.416399,78.4574396,78.4984802,78.5395208,78.5805614,78.621602,79.456599,80.291596,81.126593,81.96159,82.796587,83.0556504,83.3147138,83.5737772,83.8328406,84.091904,84.2771114,84.4623188,84.6475262,
Upper middle income,UMC,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,47.79091434,48.3169044,48.77629561,50.9949428,53.20661285,55.39276187,57.58341996,59.77162621,61.12033614,62.47920386,63.85309652,65.2503464,66.653001,67.58635615,68.52353376,69.46434565,70.40789433,71.35825744,71.95066811,72.54689947,73.14713924,73.75388846,74.36501049,74.85073562,75.33745963,75.82521562,76.31457174,76.8049902,77.03111351,77.2605886,77.49363925,77.72814631,77.96875443,78.24151293,78.51480579,78.78715059,79.0641579,79.33845023,79.62078421,79.90376591,80.19016824,80.47834412,80.77209474,81.20167224,81.62865575,82.05120803,82.47278451,82.8896893,83.36409873,83.83685997,84.30919442,84.78071293,85.25211591,85.57324502,85.89301177,86.21126875,86.52903666,86.84624706,87.00394346,87.16112003,87.31842681,
Uruguay,URY,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,76.2297206,76.6341428,77.038565,77.130504,77.222443,77.314382,77.406321,77.49826,77.5895602,77.6808604,77.7721606,77.8634608,77.954761,78.270255,78.585749,78.901243,79.216737,79.532231,79.8989958,80.2657606,80.6325254,80.9992902,81.366055,81.6397866,81.9135182,82.1872498,82.4609814,82.734713,82.947036,83.159359,83.371682,83.584005,83.796328,84.0240166,84.2517052,84.4793938,84.7070824,84.934771,85.0700484,85.2053258,85.3406032,85.4758806,85.611158,85.7443188,85.8774796,86.0106404,86.1438012,86.276962,86.4064588,86.5359556,86.6654524,86.7949492,86.924446,87.0443328,87.1642196,87.2841064,87.4039932,87.52388,87.6444586,87.7650372,87.8856158,
United States,USA,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,78.3115746,78.4661878,78.620801,78.7495798,78.8783586,79.0071374,79.1359162,79.264695,79.5330154,79.8013358,80.0696562,80.3379766,80.606297,81.044022,81.481747,81.919472,82.357197,82.794922,83.037859,83.280796,83.523733,83.76667,84.009607,84.1357556,84.2619042,84.3880528,84.5142014,84.64035,84.7970694,84.9537888,85.1105082,85.2672276,85.423947,85.5728894,85.7218318,85.8707742,86.0197166,86.168659,86.2855322,86.4024054,86.5192786,86.6361518,86.753025,86.9143444,87.0756638,87.2369832,87.3983026,87.559622,87.6482302,87.7368384,87.8254466,87.9140548,88.002663,87.8964036,87.7901442,87.6838848,87.5776254,87.471366,87.5426358,87.6139056,87.6851754,
Uzbekistan,UZB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,64.8495654,65.3892692,65.928973,66.469367,67.009761,67.550155,68.090549,68.630943,69.0231958,69.4154486,69.8077014,70.1999542,70.592207,70.8684462,71.1446854,71.4209246,71.6971638,71.973403,72.1571506,72.3408982,72.5246458,72.7083934,72.892141,73.0429862,73.1938314,73.3446766,73.4955218,73.646367,73.531612,73.416857,73.302102,73.187347,73.072592,73.1656124,73.2586328,73.3516532,73.4446736,73.537694,73.8359748,74.1342556,74.4325364,74.7308172,75.029098,75.3953392,75.7615804,76.1278216,76.4940628,76.860304,77.404225,77.948146,78.492067,79.035988,79.579909,79.8872728,80.1946366,80.5020004,80.8093642,81.116728,81.3049222,81.4931164,81.6813106,
St. Vincent and the Grenadines,VCT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,62.88463,64.03254,65.18045,65.6642136,66.1479772,66.6317408,67.1155044,67.599268,68.0342404,68.4692128,68.9041852,69.3391576,69.77413,70.333194,70.892258,71.451322,72.010386,72.56945,73.0931966,73.6169432,74.1406898,74.6644364,75.188183,75.5002138,75.8122446,76.1242754,76.4363062,76.748337,76.6543532,76.5603694,76.4663856,76.3724018,76.278418,76.3380322,76.3976464,76.4572606,76.5168748,76.576489,76.9366282,77.2967674,77.6569066,78.0170458,78.377185,78.6924822,79.0077794,79.3230766,79.6383738,79.953671,79.9799246,80.0061782,80.0324318,80.0586854,80.084939,80.1636882,80.2424374,80.3211866,80.3999358,80.478685,80.6831458,80.8876066,81.0920674,
"Venezuela, RB",VEN,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,58.7074612,59.6935856,60.67971,61.677992,62.676274,63.674556,64.672838,65.67112,66.6977528,67.7243856,68.7510184,69.7776512,70.804284,71.4397806,72.0752772,72.7107738,73.3462704,73.981767,74.4074396,74.8331122,75.2587848,75.6844574,76.11013,76.4120868,76.7140436,77.0160004,77.3179572,77.619914,77.899015,78.178116,78.457217,78.736318,79.015419,79.371708,79.727997,80.084286,80.440575,80.796864,81.2382324,81.6796008,82.1209692,82.5623376,83.003706,83.119879,83.236052,83.352225,83.468398,83.584571,83.5956166,83.6066622,83.6177078,83.6287534,83.639799,83.4384054,83.2370118,83.0356182,82.8342246,82.632831,82.677487,82.722143,82.766799,
British Virgin Islands,VGB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Virgin Islands (U.S.),VIR,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,70.9867134,71.4321642,71.877615,72.371679,72.865743,73.359807,73.853871,74.347935,74.8739538,75.3999726,75.9259914,76.4520102,76.978029,77.4465436,77.9150582,78.3835728,78.8520874,79.320602,79.7303672,80.1401324,80.5498976,80.9596628,81.369428,81.8335648,82.2977016,82.7618384,83.2259752,83.690112,84.1169922,84.5438724,84.9707526,85.3976328,85.824513,86.2027044,86.5808958,86.9590872,87.3372786,87.71547,88.0167158,88.3179616,88.6192074,88.9204532,89.221699,89.3998906,89.5780822,89.7562738,89.9344654,90.112657,90.4857248,90.8587926,91.2318604,91.6049282,91.977996,92.1055576,92.2331192,92.3606808,92.4882424,92.615804,92.7240734,92.8323428,92.9406122,
Vietnam,VNM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,65.6829256,66.7850558,67.887186,68.5124714,69.1377568,69.7630422,70.3883276,71.013613,69.9940666,68.9745202,67.9549738,66.9354274,65.915881,68.0928608,70.2698406,72.4468204,74.6238002,76.80078,77.2782712,77.7557624,78.2332536,78.7107448,79.188236,79.5815904,79.9749448,80.3682992,80.7616536,81.155008,81.536336,81.917664,82.298992,82.68032,83.061648,83.3337628,83.6058776,83.8779924,84.1501072,84.422222,84.6104718,84.7987216,84.9869714,85.1752212,85.363471,85.4815732,85.5996754,85.7177776,85.8358798,85.953982,86.0296174,86.1052528,86.1808882,86.2565236,86.332159,86.4011924,86.4702258,86.5392592,86.6082926,86.677326,86.7741292,86.8709324,86.9677356,
Vanuatu,VUT,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,42.8215866,43.5363878,44.251189,45.1737122,46.0962354,47.0187586,47.9412818,48.863805,49.6619318,50.4600586,51.2581854,52.0563122,52.854439,53.7929874,54.7315358,55.6700842,56.6086326,57.547181,58.4827752,59.4183694,60.3539636,61.2895578,62.225152,62.9888742,63.7525964,64.5163186,65.2800408,66.043763,66.6271572,67.2105514,67.7939456,68.3773398,68.960734,69.5727328,70.1847316,70.7967304,71.4087292,72.020728,72.569036,73.117344,73.665652,74.21396,74.762268,75.2501762,75.7380844,76.2259926,76.7139008,77.201809,77.5959558,77.9901026,78.3842494,78.7783962,79.172543,79.4807068,79.7888706,80.0970344,80.4051982,80.713362,80.9892004,81.2650388,81.5408772,
World,WLD,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,52.70744333,53.30151912,53.86677187,55.00431924,56.12997246,57.23126295,58.34711641,59.45225388,60.2351457,61.02189537,61.81512375,62.65087601,63.47632431,64.18365864,64.89001431,65.59639849,66.31811199,67.04054587,67.52951758,68.02420031,68.52231533,69.04517539,69.56874874,69.95911287,70.34258033,70.72073073,71.10536039,71.48361603,71.76051311,72.03641905,72.31334544,72.59775871,72.88316348,73.14330373,73.39924211,73.65311627,73.92625423,74.19154861,74.45509495,74.72000965,74.98978707,75.27049103,75.55617014,75.96280674,76.36924157,76.77273896,77.18174772,77.58800002,78.04400892,78.49558391,78.94393546,79.39250368,79.84482888,80.11419234,80.38231322,80.64895738,80.91914393,81.18950301,81.35361358,81.51694638,81.68147445,
Samoa,WSM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,59.1961418,59.5844254,59.972709,60.3302028,60.6876966,61.0451904,61.4026842,61.760178,62.2225564,62.6849348,63.1473132,63.6096916,64.07207,64.5472944,65.0225188,65.4977432,65.9729676,66.448192,66.9905096,67.5328272,68.0751448,68.6174624,69.15978,69.6119476,70.0641152,70.5162828,70.9684504,71.420618,71.8004288,72.1802396,72.5600504,72.9398612,73.319672,73.8539052,74.3881384,74.9223716,75.4566048,75.990838,76.5844464,77.1780548,77.7716632,78.3652716,78.95888,79.4353446,79.9118092,80.3882738,80.8647384,81.341203,81.8275908,82.3139786,82.8003664,83.2867542,83.773142,84.0397816,84.3064212,84.5730608,84.8397004,85.10634,85.3114276,85.5165152,85.7216028,
Kosovo,XKX,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Yemen, Rep.",YEM,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,22.8539352,23.0208746,23.187814,24.012083,24.836352,25.660621,26.48489,27.309159,28.5447518,29.7803446,31.0159374,32.2515302,33.487123,34.9421982,36.3972734,37.8523486,39.3074238,40.762499,42.5154086,44.2683182,46.0212278,47.7741374,49.527047,50.7926572,52.0582674,53.3238776,54.5894878,55.855098,56.4500898,57.0450816,57.6400734,58.2350652,58.830057,59.215668,59.601279,59.98689,60.372501,60.758112,61.5197578,62.2814036,63.0430494,63.8046952,64.566341,65.3816998,66.1970586,67.0124174,67.8277762,68.643135,69.0797668,69.5163986,69.9530304,70.3896622,70.826294,70.8414742,70.8566544,70.8718346,70.8870148,70.902195,71.0063538,71.1105126,71.2146714,
South Africa,ZAF,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,46.7917594,47.2584312,47.725103,48.2532982,48.7814934,49.3096886,49.8378838,50.366079,51.028629,51.691179,52.353729,53.016279,53.678829,54.3775128,55.0761966,55.7748804,56.4735642,57.172248,57.8431356,58.5140232,59.1849108,59.8557984,60.526686,61.6354662,62.7442464,63.8530266,64.9618068,66.070587,66.7533612,67.4361354,68.1189096,68.8016838,69.484458,67.62581,65.767162,63.908514,62.049866,60.191218,57.437934,54.68465,51.931366,49.178082,46.424798,46.41821,46.411622,46.405034,46.398446,46.391858,49.0635706,51.7352832,54.4069958,57.0787084,59.750421,60.9975418,62.2446626,63.4917834,64.7389042,65.986025,66.4580592,66.9300934,67.4021276,
Zambia,ZMB,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,41.821065,42.390413,42.959761,43.3730108,43.7862606,44.1995104,44.6127602,45.02601,45.6651556,46.3043012,46.9434468,47.5825924,48.221738,48.619021,49.016304,49.413587,49.81087,50.208153,50.290289,50.372425,50.454561,50.536697,50.618833,50.3600606,50.1012882,49.8425158,49.5837434,49.324971,46.9778496,44.6307282,42.2836068,39.9364854,37.589364,36.2660652,34.9427664,33.6194676,32.2961688,30.97287,31.40957,31.84627,32.28297,32.71967,33.15637,34.940938,36.725506,38.510074,40.294642,42.07921,45.0827082,48.0862064,51.0897046,54.0932028,57.096701,59.006574,60.916447,62.82632,64.736193,66.646066,67.1459366,67.6458072,68.1456778,
Zimbabwe,ZWE,"Survival to age 65, female (% of cohort)",SP.DYN.TO65.FE.ZS,51.1162566,51.7501168,52.383977,52.9652866,53.5465962,54.1279058,54.7092154,55.290525,55.7200482,56.1495714,56.5790946,57.0086178,57.438141,57.8699654,58.3017898,58.7336142,59.1654386,59.597263,60.3936682,61.1900734,61.9864786,62.7828838,63.579289,63.5278106,63.4763322,63.4248538,63.3733754,63.321897,60.6246882,57.9274794,55.2302706,52.5330618,49.835853,46.3432612,42.8506694,39.3580776,35.8654858,32.372894,30.7426956,29.1124972,27.4822988,25.8521004,24.221902,24.5983674,24.9748328,25.3512982,25.7277636,26.104229,30.695923,35.287617,39.879311,44.471005,49.062699,50.409265,51.755831,53.102397,54.448963,55.795529,56.3187742,56.8420194,57.3652646,